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Summary
Helix-helix interactions between membrane-spanning transmembrane (TM)
domains have been shown to drive the assembly of α-helical membrane proteins
within biological membranes. However, the rules that determine these interactions
are not yet fully understood, despite such interactions being found in an increasing
number of proteins. Recent work has implicated TM domain interactions in the
formation of the protein complex Ii-MHC, formed from the association of Major
Histocompatibility Complex Class II (MHC) and the MHC-associated-Invariant
Chain (Ii) proteins. Following biosynthesis, three MHC α/βheterodimers bind to
the Ii homotrimer to form a nonameric Ii-MHC complex within the endoplasmic
reticulum. This is a critical step in the export of MHC molecules to the antigen
presentation system and hence the activation of an immune response to a
pathogen. In this study we have explored the TM domain interactions within the
Ii-MHC complex. Results from in vivo and in vitro experiments revealed the TM
domains of the α- and β-chains of MHC have a propensity to self-associate into
homo-dimers and to associate with one another to form hetero-dimers. Highly
conserved GxxxG motifs (known to drive dimerization) were implicated in these
interactions. The TM domain of Ii was confirmed to self-associate to form trimers
by in vivo and in vitro methods, but surprisingly also displayed additional
oligomeric states suggesting the interaction is not as specific as was previously
thought. Furthermore, we show that in vivo, the TM domain of Ii can associate
with those of the α- and β-chains of MHC, whilst in vitro methods suggested Ii
preferentially binds toα-chains. Collectively, these findings strongly suggest that
the TM domains of Ii and MHC have a role to play in the assembly of the Ii-MHC
complex, and hence the very important process of antigen presentation.
Additionally, in this study we have undertaken development of NMR
spectroscopy methods that have the potential to increase our understanding of not
only the Ii-MHC complex, but protein-protein interactions in general.
Chapter 1. Introduction
1
1 Introduction
1.1 Membrane Proteins
With around 30% of sequenced genomes encoding for membrane-associated
proteins and around two thirds of all drugs targeting these proteins, the
importance of membrane proteins is now well established (MacKenzie, 2006;
Rath, Johnson et al., 2007). These proteins are involved in a myriad of functions
critical to survival of individual cells and multicellular organisms, including the
transport of small molecules and ions, and receptors for signalling molecules.
Furthermore, the malfunction of membrane proteins has been implicated in
several diseases, such as autoimmunity, diabetes and cancer (Sanders and Myers,
2004).
Figure 1.1. The fluid mosaic model of biological membranes
A cross-sectional schematic of the fluid mosaic model of biological membranes, which represents
our current understanding of these highly heterogeneous mixtures of lipids of various types and
proteins. The external face of membrane is often coated with carbohydrate molecules that are
either embedded in the bilayer or are associated with proteins known as glycoproteins. Proteins
can span the membrane (integral) or associate with the outside of the membrane (peripheral).
Cholesterol
Glycoprotein
Cytoskeleton
filamentsPeripheral
Protein
Integral
protein
Glycolipid
Carbohydrate
Phospholipid
bilayer
Chapter 1. Introduction
2
Cellular membranes define the boundary of individual cells and are important
features of the internal structure of cells, where they define organelles and serve to
compartmentalise cellular functions. The fluid mosaic model first proposed by
Singer and Nicholson and represented in cartoon form in Figure 1.1, summarises
our current understanding of the organisation of biological membranes (Singer
and Nicolson, 1972). Membranes are highly complex heterogeneous environments
mainly composed of a bilayer of amphiphilic phospholipids into which are
embedded other components such as glycolipids, cholesterol and proteins
(Engelman, 2005). Proteins that associate with the membrane can be embedded in
the membrane via bilayer spanning regions (i.e. integral membrane proteins),
bound reversibly or irreversibly to the surface of the membrane (peripheral
membrane proteins), or be tethered to the membrane by a lipid anchor.
Figure 1.2. Observed folds of integral membrane proteins
To date the only two folds that have been observed for the membrane spanning domains of integral
membrane proteins are (a) α-helical and (b) β-barrel. These proteins insert into and span
heterogeneous cell membranes composed of amphiphilic lipids that are arranged as bilayers with
polar interfacial regions (interface) and a hydrocarbon core (HC).
Across a single leaflet of the lipid bilayer the environment changes from an
aqueous solvent, to an interfacial region of polar, zwitterionic, or charged lipid
headgroups, to a central core primarily composed of hydrophobic hydrocarbon
chains. This complex amphiphilic nature of membranes is a significant contributor
to the stability of membrane proteins making it very difficult to study their
structures and interactions in isolation from their native environment. As a result
of these technical challenges there is much less biochemical and structural data on
membrane proteins compared to soluble proteins, yet improved techniques and
Interface
HC
Interface
(a) (b)
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advances in membrane mimetics are beginning to address this problem (King and
Dixon, 2008).
Remarkably, the structures of membrane spanning regions (or transmembrane
(TM) domains) of integral membrane proteins have so far been observed to take
one of only two structural forms, namely alpha helices or beta barrels (Bowie,
2005). In the cases of the beta barrel, the polypeptide chain transverses the
membrane several times whilst for alpha helical proteins the chain may cross the
membrane several times, to form a bundle of alpha helices or only once for
proteins that contain only one TM domain. Representative models for these two
structural motifs are shown in Figure 1.2. It is likely that the conformational space
available to membrane proteins is constrained by the fact that the burial of
hydrophilic peptide bonds in the hydrophobic core of a biological membrane is
energetically costly (White, 2003). These two structural motifs allow for the
formation of the greatest number of internal hydrogen bonds, which is able to
offset the high energetic cost of desolvating the protein upon insertion into the
membrane (White, 2003).
Since the focus of this study is on discerning the rules that govern the folding of
alpha helical membrane proteins we will now consider in more detail the
properties of this important class of proteins.
1.2 Helix-helix interactions in α-helical membrane
proteins
The most abundant class of integral membrane proteins are those that span the
membrane with a domain comprised of stretches of residues with alpha helical
secondary structure; often termed transmembrane (TM) helices. A typical TM
helix is formed from around 20 predominantly hydrophobic amino acids that span
a lipid bilayer with a 30 Å thick hydrocarbon core (Hessa, White et al., 2005).The
hydrophobic effect from the burial of hydrophobic residues in the core of the
bilayer has a free energy of ~40 kcal mol -1 whilst the energetic cost to desolvate
the hydrophilic backbone is only ~30 kcal mol-1. Thus, there is a favourable free
energy of ~10 kcal mol-1 for stabilising the helix in the membrane (Hessa, White
Chapter 1. Introduction
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et al., 2005). A single protein may be polytopic and possess several helices that
span the membrane bilayer, as is the case for the well known family of G-protein
coupled receptors or monotopic and possess a single TM helix, as exemplified by
the protein Glycophorin A (GpA) from erythrocytes (Lemmon, Flanagan et al.,
1992; Kobilka, 2007).
Over the last twenty years or so it has become increasingly apparent that these TM
helices serve a much more important function than merely anchoring the proteins
within the bilayer. Study into the factors that drove the association of GpA
monomers into a dimer revealed the ability of helix-helix interactions between
TM domains to govern the folding of membrane proteins (Lemmon, Flanagan et
al., 1992; MacKenzie, Prestegard et al., 1997). Specifically, in the case of GpA it
was found that the specific arrangement of two Gly residues within the TM
domains was responsible for the formation of the GpA dimer. Much has been
achieved in delineating the rules that govern helix-helix interactions leading to the
identification of several motifs that drive assembly of alpha helical proteins within
membranes (Harrington and Ben-Tal, 2009). However, there still remains much to
do to completely understand these assemblies.
Figure 1.3. The two stage model ofα-helical membrane protein folding
As proposed by Popot et al the two stage model describes how alpha helical membrane proteins
can attain their native conformation. Membrane spanning stretches composed predominantly of
hydrophobic amino acids that insert across membrane as (a) independently stable α-helices within
the plane of the bilayer then (b) associate through lateral helix-helix interactions to form bundles
of helices.
An important framework for understanding the association of α-helical
transmembrane domains in membrane proteins is the “Two Stage Model” as
proposed by Popot et al (Popot and Engelman, 1990). In this model (see Figure
(a) (b)
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1.3), stretches of predominantly hydrophobic amino acids insert into the
membrane as independently stable α-helices (stage 1) and subsequently laterally
associate in the plane of the bilayer (stage 2). This determines the folding and
assembly of many integral membrane proteins. Perhaps, the most important
contribution of the two stage model to the field of membrane protein folding is
that individual transmembrane helices can be thought of as independently stable
domains. This has guided the development of strategies for studying the assembly
of alpha helical membrane proteins using protein fragments corresponding to the
TM domains. A further key contribution of the two stage model is that it suggests
the side-chain interactions are the determinants of specificity in helix-helix
interactions. Other models for the assembly of membrane proteins have been
proposed, namely the three stage model (Jacobs and White, 1989) and four stage
model (White and Wimley, 1999), which expands upon the two stage model of
Popot et al to incorporate the means by which the TM domain enters the
membrane.
It is important to note that the two stage model says nothing about how the protein
becomes inserted into the membrane but rather focuses attention on how the
amino acid sequence of the helices might determine their interactions and
proposes the question “What are the sequence determinants that drive association
of transmembrane helices and hence determine the stability of membrane
proteins?”
1.2.1 Helix-helix interaction motifs
The first indication that TM helix-helix interactions have sufficient specificity to
drive tertiary structure formation came from early experiments performed on the
α-helical membrane protein bacteriorhodopsin, in which the native protein fold
was reconstituted from fragments (Popot, Trewhella et al., 1986; Popot,
Gerchman et al., 1987). Similarly, this has also been shown for other proteins
including lactose permease (Bibi and Kaback, 1990), rhodopsin (Ridge, Lee et al.,
1995) and the red cell anion exchanger protein (Groves and Tanner, 1995).
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For soluble proteins the hydrophobic effect is generally considered to be the major
driving force for driving their folding. However, this cannot be the force driving
association of TMα-helices because the hydrophobic effect arises solely from the
increase in entropy upon dehydration of a non polar surface, and this is expended
after the helices are inserted within the membrane (Von Heijne, 2003). Therefore,
helix-helix association is more likely to be driven by van der Waals forces, such
as the London dispersion force, or hydrogen bonding (White, Ladokhin et al.,
2001; White, 2006). The presence of a polar amino acid which can form H bonds
in the hydrophobic core of a membrane is energetically unfavourable but it can be
compensated for by the insertion of the surrounding hydrophobic residues. The
high energetic cost of breaking H-bonds in the hydrocarbon core of the bilayer
should provide a strong stabilising force for helix association. However, such
bonds are thought to have weak specificity relative to Van der Waals interactions
and are believed to cause non-specific aggregation (White, 2006). It has been
proposed that van der Waals interactions in close packing helices are the main
determinants for TM helix association and that H-bonds serve to stabilize a
preformed oligomer (Schneider, 2004).
Over the last two decades several amino acid sequence motifs have been
identified that mediate helix-helix interactions within membranes (Senes, Engel et
al., 2004; Harrington and Ben-Tal, 2009). One very significant motif is the small-
xxx-small motif which frequently occurs in TM helices, and is found conserved
amongst families of proteins whose functions include signal transduction,
channels, transporters, toxins, and enzymes (Russ and Engelman, 2000). In this
motif, two small residues such as alanine, serine or more commonly glycine are
separated by three other residues. The GxxxG motif occurs most frequently and is
over represented in statistical analysis of TM domains and is very often found
flanked by β-branched amino acids (Senes, Gerstein et al., 2000). It was work
carried out primarily in the Engelman lab on the protein Glycophorin A
(Lemmon, Flanagan et al., 1992; Lemmon, Flanagan et al., 1992; Adams,
Engelman et al., 1996) that identified the importance of the glycine variant of this
motif, the GxxxG motif, for stabilising the GpA dimer and culminated in the
determination of the solution NMR structure of the dimeric GpA TM domain
(MacKenzie, Prestegard et al., 1997).
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The separation of the two small residues by three other residues in the small-xxx-
small sequence motif has the effect of placing the two small residues sequentially
on the same face of the helix. The lack of bulky side groups at this position
creates a pocket that allows the close approach of two TM helices, facilitating the
formation of van der Waals interactions. The strength of the interaction is
dependent on the sequence context, and can be enhanced by the presence of
nearby β-branched residues (Russ and Engelman, 2000) and that GxxxG motifs
located centrally in the TM helix mediate stronger helix-helix interactions than
those at the ends (Johnson, Rath et al., 2006). It is possible that the close
proximity of the protein backbones from the two helices establish networks of
weak interhelical hydrogen bonds forming between alpha protons and carbonyl O
atoms. Furthermore, the small-xxx-small motif may also act as a pivot point about
which structural rearrangement can occur, as is observed when Ca2+ dissociates
from Ca2+-ATPase (Senes, Engel et al., 2004). It should be noted however, that
although the presence of a GxxxG motif is highly indicative of a propensity for a
helix to oligomerise, it has also been found in some cases to play no role in helix-
helix interactions (Kobus and Fleming, 2005).
1.3 MHC Class II and Invariant Chain proteins
To further our understanding of the structural determinants for the assembly of
TM helices in alpha helical membrane proteins this study has focused on two very
important alpha helical membrane proteins, namely the Major Histocompatibility
Class II protein (MHC) and the MHC-associated Invariant Chain. These proteins
play a role in the immune system, and previous research has suggested they
display helix-helix interactions within and between their TM domains. We will
now consider what is currently known about these proteins.
1.3.1 MHC Class II proteins
Major Histocompatibility Class II proteins (MHC) are a diverse family of
heterodimeric membrane proteins encoded by a large array of genes found in most
vertebrates. They are composed of two polypeptide chains ofαandβ, that are 230
and 240 residues long with molecular weights of 33 kDa and 28 kDa,
respectively. MHC proteins are part of the endosomal antigen presentation system
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(Watts, 2004; Vyas, Van der Veen et al., 2008). They are responsible for the
display of self or foreign peptides (termed antigens) to T-helper cells through the
binding of the CD4+ receptor on T-helper cells, which either ignore the self-
peptides or recognise the foreign peptide and trigger an immune response, in a
process called antigen presentation. MHC Class II proteins to be loaded with the
antigenic peptide of 3 to 18 residues in length which occupies a groove formed by
the association of MHC αand βchains, and transported to the cell surface. The
initial stages of antigen presentation following the biosynthesis of MHC involves
the chaperone protein MHC Class II associated invariant chain (Cresswell, 1994).
Figure 1.4. The mammalian antigen presentation pathway
Within the rough endoplasmic reticulum (ER) of antigen presenting cells (APCs) three MHC
hetero-dimers bind to an invariant chain trimer (Ii) enabling export of the Ii-MHC complex to the
Golgi complex for post translational modification of MHC. Ii is then digested by proteolysis
leaving part of Ii known as the CLIP domain bound in the antigen binding domain of MHC. MHC
is subsequently loaded with antigenic peptide derived from an invading pathogen. The loaded
MHC is then transported to the plasma membrane and the complex presented to T cells at the APC
surface.
The process of antigen presentation, outlined in Figure 1.4, takes place in
specialised cells called antigen presenting cells (e.g. Dendritic cells, macrophages,
and B-cells). Mutations in the MHC Class II proteins that disrupt antigen
presentation are associated with diseases such as rheumatoid arthritis (Holmdahl,
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2000), type I diabetes (Jones, Fugger et al., 2006), muscular sclerosis (Jones,
Fugger et al., 2006), HIV infection (Schindler, Wurfl et al., 2003), asthma (Ye,
Finn et al., 2003), and certain cancers (Ishigami, Natsugoe et al., 2001).
1.3.2 MHC Class II-associated Invariant Chain
As illustrated in Figure 1.4, a critical step in the endosomal pathway is the
association of MHC Class II αand β-subunits with the MHC Class II-associated
invariant chain (Ii)(Anderson and Miller, 1992). This has been shown to occur in
the endoplasmic reticulum (ER) shortly after synthesis (Anderson and Miller,
1992; Peterson and Miller, 1992; Germain and Rinker, 1993; Romagnoli, Layet et
al., 1993; Simonsen, Momburg et al., 1993). Ii is a 216 residue integral membrane
protein that forms a homotrimer in the ER (Marks, Blum et al., 1990; Lamb and
Cresswell, 1992). A single Ii trimer binds to three Class II α/βheterodimers to
form a nonameric (nine chain) complex (Sung and Jones, 1981; Kvist, Wiman et
al., 1982). It is only as part of this complex that MHC Class II proteins can be
released from the ER, avoid rapid degradation, and be targeted to the endosomal
pathway for use in antigen presentation (Ericson, Sundstrom et al., 1994; Thery,
Brachet et al., 1998). Trimerisation of Ii is therefore a vital first step in antigen
presentation and subsequently a vital step for activation of an immune response.
Figure 1.5. Schematic of the organisation of Invariant Chain
Schematic diagram of Human Invariant Chain showing the organisation running from the N- to the
C-term of (a) the transmembrane domain (TMD) composed of residues 30-55 (b) the CLIP region
which occupies the antigen binding site of MHC Class II proteins and (c) the luminal domain
composed of residues 118-192 which is known to trimerise, Recent work has also implicated the
TM domain in playing a role in the self-association of Ii.
Due to the significant role Ii plays in the immune system several studies have
focused on investigating the structure of the Ii trimer in recent years.
Trimerisation of Ii is thought to be mediated by the C-terminal lumenal domain
TMD
30 55
ClumenalCLIP
118 192
N
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composed of residues 118-192 (Bijlmakers, Benaroch et al., 1994; Jasanoff,
Wagner et al., 1998) (see Figure 1.5). It has been shown conclusively by structure
determination that the lumenal domain forms a trimeric structure leading to the
belief that this domain was solely responsible for trimerisation of Ii (Bijlmakers,
Benaroch et al., 1994; Bertolino, Staschewski et al., 1995; Gedde-Dahl,
Freisewinkel et al., 1997; Jasanoff, Wagner et al., 1998). However, there are
indications that the transmembrane (TM) domain composed of residues 30-56 also
has a role to play in the self association of Ii (Ashman and Miller, 1999).
In the last decade studies have shown that the TM domain of Ii is a site of
important helix-helix interactions that impact upon both the structure and function
of Ii. The sequence of the TM domain is highly conserved across species
(Bremnes, Rode et al., 2000) and mutations in this region can prevent formation
of the nonameric complex (Ashman and Miller, 1999) and therefore disrupt
antigen presentation (Frauwirth and Shastri, 2001). It is unclear at present whether
this is a result of the mutations destabilising the MHC Ii trimer or disrupting
interactions between Ii and MHC Class II molecules. An 80-residue fragment of Ii
derived from the N-terminal and TM domains has been shown to form trimers
(Ashman and Miller, 1999). Mutational studies revealed that the mutation of the
polar residues Gln49, Thr49 and Thr50 in the TM domain could prevent
trimerisation of the full length Ii protein (Ashman 1999). Subsequently the
secondary structure and tilt angle of the Ii TM domain in a bilayer was
determined, leading to the prediction of a left-handed coiled coil trimeric model
for the Ii TM (Kukol, Torres et al., 2002). This model suggested the presence of a
stabilising hydrogen bonding network involving Gln47, Thr49 and Thr50
(Gratkowski, Lear et al., 2001; Zhou, Merianos et al., 2001).
Following on from this work, an investigation of a fragment of Ii corresponding to
the TM domain (residues K26-R60), using the in vivo TOXCAT assay and
biophysical methods, showed that in isolation the TM domain of Ii can form
trimers and were able to determine a dissociation constant for the trimer in
detergent micelles of DPC (Dixon, Stanley et al., 2006). Furthermore, the same
study rationalised the deleterious effects of mutating Gln47 and Thr50 (Q47A,
T50A) in terms of the large disruptions these could cause in Ii TM domain helix-
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helix interactions by removing the potential for inter-helical hydrogen bonding.
This study also showed that the role of the Ii TM domain in trimer formation can
be conceptualised using the “two-stage model” of membrane protein folding
described above.
As a result of this work on the TM domain of Ii a revised model for MHC Class II
complex assembly was proposed (see Figure 1.6), that recognises the importance
of Ii TM domain trimerisation in the formation of the nine-chain complex (Dixon,
Stanley et al., 2006). However, the dissociation constant for the luminal domain
has not been determined so the relative contributions of the TM and luminal
domains to the trimerisation of Ii cannot be assessed.
Figure 1.6. Proposed structure of Ii-MHC complex
Within the ER of mammalian cells, Invariant chain (blue) forms a trimer by association of the
luminal and possibly also the transmembrane domains. Three MHC class II heterodimers ofαand
βchains (grey) associate with the Invariant Chain trimer through interactions between the CLIP
domain of invariant chain and the antigen binding sites of the MHC molecule forming a nine chain
(nonameric) complex that is subsequently exported from the ER to the antigen presentation
pathway. The TM domains of MHC have also been implicated as playing a role in stabilising the
complex. The formation of this complex is an absolute requirement for MHC to be exported from
the ER.
The TM domains of Ii and MHC Class II proteins have been shown to be a
possible site of important protein-protein interactions. The TM domains of MHC
Class II proteins are thought to be important for intracellular trafficking and
Lumenal
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antigen presentation (Barabanova, Kang et al., 2004). It has been shown that the Ii
TM domain can interact directly and specifically with MHC class II proteins
(Castellino, Han et al., 2001).
1.4 Development of NMR methods for studying
helix-helix interactions
In addition to investigating the helix-helix interactions within the MHC-Ii
complex we have also investigated the use of solution state NMR methods to
further our understanding of helix-helix interactions in α-helical membrane
proteins. The use of solution NMR to solve the atomic structure of a TM domain
oligomer was investigated using E5 as a test subject for developing protocols for
the optimisation of sample preparation and experimental parameters. We also
investigated the use of paramagnetic NMR techniques and designed a novel
method for determining helix-helix interactions. The development of NMR
methods is discussed further in Chapter five.
1.5 Aims and objectives
The aim of this study was to further our understanding of the role of interactions
between α-helical TM domains in driving the assembly of membrane protein
complexes. Specifically, we have focussed on the complex formed between MHC
and Ii, of key importance to the immune response. Using a wide range of methods
we have investigated the formation of Ii trimers, and the role of helix-helix
interactions in the formation of the MHC hetero-dimer and the Ii-MHC complex.
Our results have allowed us to construct a model of the Ii-MHC complex
stabilised by TM interactions.
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2 Materials and methods
2.1 Reagents and materials
All laboratory reagents and materials used in this study were of the highest grade
available and unless otherwise stated were supplied by Sigma Aldrich (UK),
Fisher Scientific (UK), Avanti-polar lipids (USA), Pierce (UK) or Cole-Parmer
(UK).
2.2 Bacterial Strains
Table 2.1 provides a list of the Escherichia coli used in this study. These were
either commercially available or kindly provided by other research groups, as
indicated.
Strain Notes Source Reference
DH5α supE44 ΔlacU169
(Ø80lacZΔM15)
hsdR17 recA1
endA1 gyrA96 thi-
Novagen (UK) (Sambrook and
Russell, 2001)
NT326 F−(argF-lac)U169,
rpsL150, relA1, rbsR,
flbB5301, ptsF25, thi-1,
deoC1, ΔmalE444, recA, 
srlA
D.Engelman
(Yale
University,
USA)
(Treptow and
Shuman, 1985)
BL21(DE3) Deficient in lon and ompT
proteases, ompT hsdSB(rB-
mB-) gal dcm
Novagen (UK)
SU101 Possesses Wt LexA
promotor
D. Schneider
(University of
Freiburg,
Germany)
(Dmitrova,
Younes-Cauet et
al., 1998)
SU202 Possesses hybrid wt/mutant
LexA promotor
D. Schneider
(University of
Freiburg,
Germany)
(Dmitrova,
Younes-Cauet et
al., 1998)
Table 2.1. E. coli strains used in this study
Chapter 2. Materials and Methods
14
2.3 Vectors
Table 2.2 provides a list of the plasmids used in this study. These were either
commercially available or kindly provided by other research groups, as indicated.
Name Notes Source Reference
pCC-Kan New England Biolabs
pMAL-c2 and –p2
vectors (pBR322 +
lacI and Maltose
binding protein)
D.Engelman (Yale
University, USA)
(Russ and Engelman, 1999)
pCC-GpA pCC-KAN with
glycophorin A (GpA)
transmembrane (TM)
domain
D.Engelman (Yale
University, USA)
(Russ and Engelman, 1999)
pCC-G83I pCC-GpA with Gly83
to Ile substitution
D.Engelman (Yale
University, USA)
(Russ and Engelman, 1999)
pALM100 Tetracycline resistant,
IPTG inducible
D. Schneider
(University of
Freiburg, Germany)
(Schneider and Engelman,
2003)
pBLM100 Ampicillin resistant,
IPTG inducible
D. Schneider
(University of
Freiburg, Germany)
(Schneider and Engelman,
2003)
pBLM-GpA Ampicillin resistant,
IPTG inducible
D. Schneider
(University of
Freiburg, Germany)
(Schneider and Engelman,
2003)
pBLM-G83I Ampicillin resistant,
IPTG inducible
D. Schneider
(University of
Freiburg, Germany)
(Schneider and Engelman,
2003)
pALM-GpA Tetracycline resistant,
IPTG inducible
D. Schneider
(University of
Freiburg, Germany)
(Schneider and Engelman,
2003)
pALM-G83I Tetracycline resistant,
IPTG inducible
D. Schneider
(University of
Freiburg, Germany)
(Schneider and Engelman,
2003)
pGEX-6p-3 GST expression
vector, Ampicillin
resistant
GE Healthcare
(UK)
pET31b(+) IPTG inducible
Ampicillin resistant
Invitrogen (UK)
Table 2.2. DNA vectors used in this study
2.4 Affinity tags
A 6-amino acid His tag was present at the carboxy-terminus of KSI fusion
proteins in peptides expressed using the pET31b(+) expression system. A
glutathione S-transferase (GST) fusion tag was incorporated into fusion proteins
in expression using the pGEX expression system.
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2.5 Methods concerning growth of E. coli strains
E. coli cells were routinely cultured in Luria-Bertani (LB) liquid medium.
Typically, growth of the culture was achieved by inoculating the LB medium with
a single colony from an agar plate, followed by incubating for 16 hrs at 37°C
under aerobic conditions (shaking at 250 rpm). For growth on agar plates (LB
medium plus agar), cultures were incubated in a 37°C oven for 16 hrs. Stocks of
each strain were maintained on agar plates stored at 4°C and were re-plated every
two months.
2.5.1 Antibiotics
The following antibiotics were added where necessary and used at the following
concentrations: ampicillin (100 μg/mL); chloramphenicol (34 μg/mL);
tetracycline (3μg/mL).
2.6 Cloning methods
2.6.1 Preparation of competent E. coli cells
Transformation competent cells were prepared using the calcium chloride method
described in Sambrook and Russell (Sambrook and Russell, 2001). 10 mL of a
mid-exponential phase culture (OD600 ~0.6) was pelleted and re-suspended in 10
mL of 100 mM MgCl2 and incubated on ice for 5 mins. The cells were then
pelleted and re-suspended in 1 mL of 100 mM CaCl2. Cells were incubated for 2-
24 hrs at 4°C before use.
2.6.2 Purification of vector DNA
Vector DNA was isolated from 2 - 5 mL of stationary phase overnight culture
using a “QIAprep Mini-Prep” kit from Qiagen (Germany). The method was
carried out as detailed in the manufacturer's instructions.
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2.6.3 Digestion of vector DNA and purification
Restriction endonuclease digestions of vector DNA were carried out according to
the enzyme manufacturer’s guidelines. Where possible, a double digest was
performed simultaneously using a suitable buffer that would maintain activity of
both enzymes. A typical double digest reaction contained: 17 μL vector DNA
(from a 50μL plasmid mini-prep), 2μL buffer (as supplied with the enzyme), and
0.5μL of each restriction enzyme. Typically, reactions were incubated for 1 hr in
a 37°C water bath. DNA was purified by gel extraction. DNA was excised from
agarose gels and extracted using a QIAprep Gel Extraction kit (Qiagen, Germany)
according to the manufacturer's instructions.
2.6.4 Preparation of phosphorylated oligonucleotide inserts
The TM domain sequences are cloned into the TOXCAT and GALLEX assays by
using annealed long oligonucleotide primers that must first be phosphorylated for
use in the ligation reaction. Complementary forward and reverse oligonucleotides
encompassing the TM domain sequence of interest and restriction digest products
at the 5’ and 3’ ends, were designed and purchased from Invitrogen (UK). 10 μM
stock solutions were prepared of forward and reverse oligonucleotides. The
oligonucleotides were phosphorylated in a reaction that typically contained 5 μL
10 M oligonucleotide, 2 μL 10× kinase buffer (500 mM Tris-HCl (pH 7.6 at
25°C), 100 mM MgCl2 , 50 mM DTT, 1 mM spermidine and 1 mM EDTA), 1μL
10 mM adenosine triphosphate (ATP), 2 μL T4 Pol Kinase (Fermentas), 10 μL
sterile deionised H2O (dH2O). The reaction was incubated at 37°C for 30 mins
followed by heating to 56°C for 10 mins to inactivate the kinase. Phosphorylated
oligonucleotides were annealed in a reaction that typically contained 4μL forward
oligonucleotide, 4 μL reverse oligonucleotide, 2 μL annealing buffer (250 mM
tris-HCl pH7.5, 20 mM MgCl2, 600 mM NaCl), and 10 μL sterile dH2O. The
reaction was incubated at 95°C for 7 mins and then allowed to cool to room
temperature.
2.6.5 Ligation of digested vector and phosphorylated insert
Ligation reactions were carried out according to the guidelines supplied with the
T4 DNA ligase (Fermentas, UK). Digested vector and phosphorylated insert were
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combined in a 1:3 ratio respectively, in a total reaction volume of 20μL. Ligation
reactions typically contained 6 μL 10 mM oligonucleotide insert, 2 μL digested
vector, 2 μL 10× ligase buffer (400 mM Tris-HCl pH 7.8, 100 mM MgCl2, 100
mM DTT, 5 mM ATP), 1 μL 10 mM ATP, 1.5μL T4 DNA Ligase (Fermentas),
7.5μL H2O. The reaction was incubated at room temperature for 1-4 hrs and then
overnight on ice.
2.6.6 Transformation of competent cells
Typically, 2μL of plasmid DNA or 10μL of a ligation mix was added to 0.1 mL
of competent E. coli cells and incubated on ice for 30 mins. The cells were then
heat shocked at 42°C in a water bath for 90 secs, after which 0.5 mL of LB was
added and the cells incubated at 37°C for 30 mins. The cells were pelleted and re-
suspended in 100 μL of LB before being spread on to agar plates containing
appropriate antibiotic for plasmid resistance followed by incubation overnight at
37°C.
2.6.7 DNA sequencing
All DNA sequencing reactions were performed by the Molecular Biology Service,
University of Warwick or GATC Biotech (Germany). The sequencing primers
used in this study are given in Table 2.3.
Name Sequence
pcckan_f CCTTCATCAGCCACTGTAGTGAAC
pGEX_f GGGCTGGCAAGCCACGTTTGGTG
pABLM_f GGGATTCGTCTGTTGCAGGAAGAGGAAGAA
Table 2.3. Sequencing primers used in this study
2.7 Analytical gel electrophoresis (SDS-PAGE)
SDS sample loading buffer (60 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol,
and 0.01% bromophenol blue) was added to all samples. Electrophoresis was
carried out at room temperature on 4-12% NuPAGE NOVEX Bis-Tris Mini Gels
(Invitrogen) in MOPS-SDS running buffer.
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Detection of protein bands by Coomassie blue staining: Protein gels were placed
in fixer solution (50% methanol, 10% acetic acid) for 30 mins, then in stain
solution (56 mL dH20, 4 mL glacial acetic acid, 0.01 g Coomassie Brilliant Blue)
for 1 hr or overnight with gentle shaking. Gels were then destained (20%
methanol, and 7 % glacial acetic acid), until proteins bands were visible (1-2 hrs).
Gels were rinsed well with deionised water before an image was taken.
Detection of protein bands by silver staining: Gels used in cross-linking analyses
were stained using silver nitrate. Polyacrylamide gels were soaked in fixer
solution (60 mL 50% acetone, 1.5 mL 50% TCA, 25 μL formaldehyde) for 15
mins with gentle shaking. The gel was then washed three times with dH2O and
soaked in dH2O for a further 5 min. The gel was washed again 3 times with dH2O
before soaking in 50% acetone for 5 mins. The gel was then soaked in sodium
thiosulphate solution (10 mg Na2S2O3 in 60 mL dH2O) for 1 min followed by 3
washes with dH2O. The gel was then soaked in stain solution (160 mg silver
nitrate, 600 μL formaldehyde, 60 mL dH2O) for 8 min. Following two washes
with dH2O, the gel was soaked in developer (1.2 g Na2CO3, 25μL formaldehyde,
25 mg Na2S2O3 in 60 mL dH2O) for 10-20 seconds. The development of protein
bands was quenched by discarding the stain solution and soaking the gel in a 1%
acetic acid solution in dH2O for 1-2 mins. The gel was then rinsed and stored in
dH2O until an image was taken.
2.8 TCA precipitation of samples for SDS-PAGE
Trichloroacetic acid (TCA) dehydrates proteins and leading to aggregation of
hydrophobic regions and the eventual precipitation of the protein. 40 μL samples
were brought up to a total volume of 100μL with H2O. 100 μL of 10% TCA was
added and the reaction left on ice for 20 mins. Samples were centrifuged for 15
mins at 15,000 × g. The resulting pellet was washed with ethanol and allowed to
dry in air. The pellet was re-suspended in LDS loading buffer and loaded onto a
gel immediately after boiling for 7 mins at 95°C.
2.9 Detection of proteins by immuno-blotting
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The transfer of proteins from an acrylamide gel to a nitrocellulose membrane was
achieved using the NuPAGE western blotting system according to the supplied
instructions (Invitrogen, UK). After transfer, the membranes were blocked with
3% milk solution (1.2 g dried milk in 20 mL TTBS buffer (8 g NaCl, 2 g KCl, 3 g
Tris base, 999 mL dH2O, 1 mL Tween-20, pH 7.4)) for 1 hr or overnight. The
membrane was then incubated under agitation with primary antibody, Anti-MBP
(Sigma, UK), in 3% milk solution for 1 hr followed by washing in TTBS
(typically, 3×5min washes). The membrane was then incubated with the
secondary antibody, anti-mouse (alkaline phosphatise conjugate), in 3% milk
solution for 1 hr with agitation. Immuno-reactive bands were detected using
Sigma Fast BCIP/NBT Detection kit (Sigma, UK) according to the supplied
instructions. BCIP (5-Bromo-4-chloro-3-indolyl phosphate dipotassium) is
hydrolysed by alkaline phosphatise to form a blue intermediate which is then
oxidised by NBT (nitrotetrazolium blue chloride) to produce an insoluble, dark
purple dye. All antibodies used in this study were purchased from Sigma (UK)
and included Anti His c-term, Anti MBP and Anti Mouse.
2.10 Synthesis and purification of synthetic
peptides
2.10.1 Peptide synthesis
Peptides corresponding to the TM domains of interest, with amino acid sequences
given in the relevant sections, were synthesised at the Keck Facility, Yale
University, using standard Fmoc (N-(9-fluorenyl) methoxycarbonyl) chemistry
(Fisher and Engelman, 2001).
2.10.2 RP-HPLC purification of peptides
Synthetic peptides were supplied as a crude reaction product and subsequently
purified by optimised reversed-phase high performance liquid chromatography
using strategies based on those reported to be effective for hydrophobic peptides
(Lew and London, 1997; Kochendoerfer, Salom et al., 1999; Jones, Ball et al.,
2000; Fisher and Engelman, 2001; Tiburu, Dave et al., 2003). Typically, 4 - 6 mg
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of the crude product was dissolved in 400μL trifluoroacetic acid (TFA), 200μL
trifluoroethanol (TFE), 400μL acetonitrile (ACN), 70/30 ACN/H2O ACN and 200
μL of HPLC grade water or 400 μL of a mixture of formic acid-acetic acid-
chloroform-trifluoroethanol (FACT) (Jones, Ball et al., 2000). or 1:4 formic
acid:hexaflouroisopropanol (HFIP), 200μL 70:30 HPLC grade isopropanol: ACN
and 200 μL of HPLC grade water or 400 μL of a mixture of formic acid-acetic
acid-chloroform-trifluoroethanol (FACT) (Jones, Ball et al., 2000). Samples were
loaded onto either Phenomenex Jupiter 5 µm C4 (250 mm × 10 mm) or a
Phenomenex Luna 5μm CN (250 mm × 10 mm) reversed phase columns with a
typical flow rate of 2 mL/min. The mobile phase was composed of water (Buffer
A) and either 100% ACN or 70:30 isopropanol:ACN (Buffer B). Typically, initial
experiments used gradients of 1% per min before being optimised to 0.3 – 0.5 %
min following determination of the retention time of the desired peptide. The
optimised gradients along with the HPLC spectra for each peptide will be shown
in the following chapters when the results for purification are presented. Elution
was monitored by absorbance of aromatic residues at 280 nm. All solvents were
HPLC grade. Fractions containing the pure peptide were identified by mass
spectrometry as described in Section 2.11. Multiple runs of RP-HPLC purification
were performed, and fractions containing pure peptide were pooled and
lyophilised. Following lyophilisation, the purity of the peptide was assessed by
mass spectrometry as described in Section 2.11. Purified peptides were then
stored at -20°C until required.
2.11 Mass spectrometry analysis of peptides
HPLC fractions and purified peptides were analysed by electrospray ionisation
time-of-flight mass spectrometry (ESI-MS) on a Bruker MicroTOF or matrix-
assisted laser desorption ionisation mass spectrometry (MALDI-MS) on a Bruker
MALDI-TOF. For analysis by ESI-MS, 10 μL of 10% formic acid solution was
added to 90μL of samples prior to analysis. Spectra were acquired in positive ion
mode and detection was between 50 and 3000 mass/charge (m/z). Spectra were
typically recorded for 2 mins, averaged and deconvoluted to determine the mass
of the main species. For analyses by MALDI-MS, samples were prepared by
combining 5 μL of peptide with 5 μL of matrix solution (10 mg/mL α-cyano-4-
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hydroxy cinnamic acid in 50% ACN, 50% H2O and 0.1 % TFA). 1 μL of the
sample/matrix solution was spotted onto a MALDI target plate and allowed to air
dry for 30 mins. MALDI-MS spectra were acquired in the positive ion and linear
mode. The mass range from m/z 2000 to 5000 was externally calibrated with
polyethyleneglycol 2000.
2.12 Peptide concentration determination
Peptide concentration was determined by measuring the UV absorbance at 280
nm. For each peptide, the extinction coefficient at 280 nm was determined using
ProtParam (Gasteiger, Hoogland et al., 2005) and used to calculate the peptide
concentration using the Beer-Lambert law (1)
where, A is the absorbance at 280 nm, εis the extinction coefficient (M-1 cm-1), l
is the optical path length (cm) and c is concentration (mol L-1).
2.13 Covalent cross-linking of peptides
Cross-linking reactions were carried out for 20 μM solutions of the peptide of
interest in 20 mM sodium phosphate (pH 7), 0.15 mM NaCl and detergent in a
reaction volume of 40 uL The concentrations of detergents were varied to give
different micelle:peptide ratios using equation 2,
where [detergent] is the detergent concentration in mol L-1, [peptide] is the
peptide concentration, R is the peptide:micelle ratio, and A and CMC are the
aggregation number and critical micelle concentration of the detergent,
respectively. A 20 fold excess of the cross-linker Bis[sulfosuccinimidyl]-suberate
(BS3) (Pierce, UK) was used to cross-link the peptide in solution according to the
manufacturer’s protocol. BS3 reacts specifically with the terminal NH2 groups on
lysine side chains provided that the reactive groups are within 11.4 Å of one
another (Staros, 1982). The reaction was incubated at room temperature for 30
mins before being quenched by the addition of 1 M Tris-HCl (pH 7.5) to a final
concentration of 20μM and incubation at room temperature for 15 mins. Samples
A =εlc (1)
[detergent] = [peptide] x R x A + CMC (2)
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uncross-linked and cross-linked in SDS were prepared as controls. 10 μL of 4X
NUPAGE SDS loading buffer was added to all samples prior to analysis by SDS-
PAGE and visualization of protein bands was achieved by staining with silver
nitrate as described in Section 2.7.
2.14 Peptide reconstitution into lipid vesicles
Lipids and proteins were co-dissolved in TFE (0.25 mg/mL of peptide and 2.5
mg/mL lipid in 200μL final volume). Solvent was then removed under a stream
of nitrogen gas. The sample was then held under vacuum overnight to ensure total
removal of solvent. The sample was redissolved in 50 mM NaPO4 buffer, pH 7.
Samples were then freeze-thawed six times using an ethanol-dry-ice bath and a
water bath at 40°C followed by sonication for 5 mins at 40°C. This resulted in a
loss of sample turbidity.
2.15 Heterologous expression of TM domain
peptides
A GST protein expression system (GE Healthcare, UK) was employed in this
study to generate a TM domain peptide fused with a lanthanide binding tag (LBT)
sequence. The fusion protein was purified using a GST affinity column and the
peptide released from the GST moiety by on-column cleavage with Prescission
protease (GE Healthcare, UK). The protease is itself a GST fusion and remains
bound to the column whilst the TM peptide is released and eluted. Expected yields
from the system are up to 50 mg of pure peptide per 1 L of liquid culture (GE
Healthcare, UK).
2.15.1 Cloning into the pGEX GST fusion expression
system
An oligonucleotide insert was produced encoding for the TM of interest and the
LBT sequence and possessing BamHI and XhoI restriction sites at the 3’ and 5’
ends, respectively (Genscript, USA). The synthetic gene was digested with
BamHI and XhoI and purified by gel electrophoresis. DNA was excised from
agarose gels and extracted using a QIAprep Gel Extraction kit (Qiagen, Germany)
according to the manufactures instructions. The plasmid pGEX-6P-3 was digested
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with BamHI and XhoI and purified as outlined in Section 2.6.3. The
oligonucleotide insert was ligated downstream of a Glutathione-S Transferase
(GST) gene to produce the construct pGEX-TM-LBT as outlined in section 2.6.5.
The expression host E. coli BL21 was made competent as describe in section
2.6.1, and then transformed with pGEX-TM-LBT as outlined in Section 2.6.6.
The success of ligation was confirmed by DNA sequencing of transformants using
the primer pGEX_f as described in Section 2.6.7.
2.15.2 Induction checks of GST fusion protein constructs
Expression of the fusion protein from 10 mL cultures of BL21 cells transformed
with the plasmid pGEX-TM-LBT was induced by the addition of 1 mM
Isopropyl-β-D-1-thiogalactoside (IPTG) to the culture medium when an OD600 of
~0.3 was achieved. Aliquots normalised to an OD600 of 0.1 were taken prior to
induction and every hour for ~6hrs post-induction for analysis of protein
expression level by SDS-PAGE.
2.15.3 Small scale purification analysis of GST constructs
20 mL of cell culture was resuspended in 2 mL 1 × PBS (140 mM NaCl, 2.7 mM
KCl, 10.1 mM Na2HPO4 , 1.8 mM KH2PO4, pH 7.3). 2 μL of 100 mg/mL DNAse
and 100 mg/mL lysozyme were then added and the suspension incubated on ice
for 15 mins. The detergent sarkosyl was then added to a final concentration of 1%
w/v. The suspension was then sonicated using a probe sonicator for 3 × 30 secs on
ice followed by centrifugation for 15 mins at 1700 × g to pellet insoluble material.
A sample was taken prior to centrifugation for SDS-PAGE analysis of the protein
content of the whole cell fraction. The supernatant was mixed with 100μL of 75%
Glutathione Sepharose™ 4B (GE Healthcare, UK), that had previously been
washed four times with 800μL of 1× PBS and 1% sarkosyl, to remove all traces
of ethanol from the storage buffer. The sample-sepharose mixture was incubated
at 4°C for 2 hrs with gentle mixing. Fusion protein bound to the sepharose was
pelleted by a few seconds of centrifugation. A sample of the supernatant was
taken for SDS-PAGE analysis in order to assess the level of fusion-protein
binding to the sepharose. The sepharose was then washed four times with
cleavage buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, pH
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7) plus detergent. Samples of washes were taken for SDS-PAGE analysis. All
residual buffer was removed from the sepharose. 4μL of Prescission Protease (GE
Healthcare, UK) was added to 96 μL of cleavage buffer and this was then added
to the sepharose. The cleavage reaction was incubated for 16 hrs at 4 °C and then
for a further 2 hrs at room temperature. The sepharose was pelleted and the
supernatant removed. A sample of the supernatant was taken for analysis by SDS-
PAGE. 20μL of 2× NUPAGE LDS sample buffer was added to the sepharose and
all other samples, and samples were then heated at 90°C for 7 mins before being
analysed by SDS-PAGE. Protein bands were visualised by Coomassie staining.
2.16 Molecular modelling using CHI
Computational analysis of the helical interactions was performed using the CNS
searching of helix interactions (CHI) program, the details of which have been
described previously (Adams, Arkin et al., 1995; Adams, Engelman et al., 1996;
Adams, Lee et al., 1998), on an 8-node dual 2.66-GHz Xenon processor Linux
cluster (Streamline Computing, Warwick). The CHI program uses in vacuo
computational modelling and molecular dynamics to generate an in silico
representation of TM domains that can be used to identify oligomeric structures
with energetically favourable interhelical interactions. Using CHI, canonical α-
helices were built with sequences indicated in the Results sections. The starting
structures incorporated both right-handed (-25°) and left-handed (25°) crossing
angles and an axis-to-axis distance between the helices of 10.4 Å. During the
search of interactions for TM domain dimers, the two helices were simultaneously
rotated about their central axis in 30° increments from 0 to 360°. After each
rotation, molecular dynamics (MD) simulations were performed using simulated
annealing of atomic coordinates. Four different MD simulations were performed
for each structure generated by helical rotation. Groups of structures with a
backbone root mean squared deviation (rmsd) of ≤1 Å were placed in clusters of
10 or more members, followed by calculation of an average structure for each
cluster and energy minimisation.
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2.17 TOXCAT assay for homo-association of TM
domains
2.17.1 Principle of the TOXCAT assay
Figure 2.1. Principle of the TOXCAT assay
The TOXCAT assay is used to monitor self-association of α-helical TM domains. A chimeric
protein is constructed of Maltose Binding Protein (MalE), the transmembrane domain (TM) of
interest and the ToxR promoter. ToxR is a functional dimer that is incapable of dimerizing alone.
Interactions between TMDs drive dimerisation of ToxR, which binds the ctx promoter activating
transcription of the reporter gene Chloramphenicol Acyltransferase (CAT).
The propensity for TM domains to form homo-oligomers in E. coli membranes
was investigated using the TOXCAT assay (Russ and Engelman, 1999). An
overview of the assay is presented in Figure 2.1. This assay uses cloning
techniques to insert the DNA sequence encoding the TM domain of interest into a
gene encoding a fusion protein with the structure ToxR-TM-MBP, where ToxR is
a dimerisation-dependent transcriptional activator from vibrio cholera, and MBP
(maltose binding protein) is a monomeric periplasmic anchor protein that
correctly orients the construct in the membrane. The TM domain being assayed
replaces the native TM domain of the ToxR protein. Oligomerisation of the TM
domain in the periplasmic membrane of E. coli allows the ToxR domains to
dimerise and bind the ctx promoter, resulting in expression of the reporter gene
product, chloramphenicol acetyltransferase (CAT). The amount of CAT expressed
is directly proportional to the extent of oligomerisation. The TM domain of
ctx
Reporter gene (CAT)
ToxR
MBP
Plasma
MembraneTM
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glycophorin A (GpA), which is known to strongly dimerise, and its dimerisation
defective mutant (G83I), were used as a positive and negative controls
respectively.
2.17.2 Cloning TM domains into the TOXCAT assay
Using the restriction enzymes NheI and BamHI, oligonucleotide inserts
corresponding to the DNA sequence of the TMD of interest (see Table 2.4) were
generated from long primers and ligated into the vector pccKan, and the resulting
plasmid was transformed into the host strain E. coli NT326, using the methods
described in Section 2.6. Oligonucleotides were purchased as primers from
Invitrogen, UK.
Name Sequence
MHCα_F CTAGCACTGTGGTCTGTGCCCTGGGGTTGTCTGTGGGC
CTCGTGGGCATCGTGGTGGGCACCATCTTCATCATTCA
AGGCCTGGG
MHCα_R GATCCCCAGGCCTTGAATGATGAAGATGGTGCCCACC
ACGATGCCCACGAGGCCCACAGACAACCCCAGGGCAC
AGACCACAGTG
MHCαG225LG229L_F CTAGCACTGTGGTCTGTGCCCTGCTGTTGTCTGTGCTG
CTCGTGGGCATCGTGGTGGGCACCATCTTCATCATTCA
AGGCCTGGG
MHCαG225LG229L_R GATCCCCAGGCCTTGAATGATGAAGATGGTGCCCACC
ACGATGCCCACGAGCAGCACAGACAACAGCAGGGCAC
AGACCACAGTG
MHCαG232LG236L_F CTAGCACTGTGGTCTGTGCCCTGGGGTTGTCTGTGGGC
CTCGTGCTGATCGTGGTGCTGACCATCTTCATCATTCA
AGGCCTGGG
MHCαG232LG236L_R GATCCCCAGGCCTTGAATGATGAAGATGGTCAGCACCACGA
TCAGCACGAGGCCCACAGACAACCCCAGGGCACAGACCAC
AGTG
MHCβ_F CTAGCATGCTGAGCGGCATTGGCGGCTGCGTGCTGGGCGTG
ATTTTTCTGGGCCTGGGCCTGTTTATTGG
MHCβ_R GATCCCAATAAACAGGCCCAGGCCCAGAAAAATCACG
CCCAGCACGCAGCCGCCAATGCCGCTCAGCATG
MHCβG233LG237L_F CTAGCATGCTGAGCGGCATTGGCCTGTGCGTGCTGCTG
GTGATTTTTCTGGGCCTGGGCCTGTTTATTGG
MHCβG233LG237L_R GATCCCAATAAACAGGCCCAGGCCCAGAAAAATCACC
AGCAGCACGCACAGGCCAATGCCGCTCAGCATG
Table 2.4. Oligonucleotide sequences used in the TOXCAT assay
Forward (_F) and their complementary reverse (_R) oligonucleotides corresponding to the TM
domain of interest were ordered from Invitrogen and used as inserts for cloning into the TOXCAT
assay.
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2.17.3 Disc diffusion assay for CAT activity
Cells to be assayed were incubated at 37°C until they reached mid-exponential
phase (OD600 = 0.6-0.8). An aliquot of the cells was then normalised to give an
OD600 of 0.1, and 100 μL of cells were plated out on LB-agar media containing
100 μg/mL ampicillin. 42 μL of 90 mg/mL chloramphenicol (CAM) in ethanol
was dried onto a Whatman grade 1 filter paper disk (diameter 30 mm) and placed
in the centre of the plate. The plate was then incubated overnight at 37°C. The
zone of cell growth inhibition surrounding the disk was then measured.
2.17.4 Chloramphenicol acetyltransferase activity assay
Cells to be assayed were incubated at 37°C until an OD600 of 0.6 was reached. 200
μL of cells were centrifuged at 14,000 rpm for 10 mins and resuspended in 50μL
of 100 mM tris-HCl, pH 8.0. 20μL of lysis solution (100 mM EDTA, 100 mM
DTT, 50mM tris-HCl, pH 8.0) was then added. A drop of toluene was added to
the top of the solution and the solution incubated at 30°C for 30 mins. The levels
of CAT expression were assayed using the FAST CAT® Green (deoxy)
Chloramphenicol Acetyltransferase assay kit (Invitrogen) according to the
manufacturer’s instructions. The reaction was terminated by adding 300 μL of
xylene. The reaction was then mixed and centrifuged for 3 mins at 12,000 rpm
and the upper phase collected. The fluorescence emission of the upper phase at
525 nm (excitation of 495 nm) was then measured using a Perkin Elmer LS50B
fluorimeter. Emission from samples was normalised to that of the positive control,
GpA.
2.17.5 Analysis of expression levels for TOXCAT chimera
Cells were grown until mid-exponential phase (OD600 ~0.6). 1 mL samples
normalised to OD600 of 0.1 were centrifuged and the cell pellet resuspended in 80
μL of SDS loading buffer and analysed by SDS-PAGE. MBP bands were
visualised by immunoblotting with anti-MBP and anti-mouse as described in
Section 2.9.
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2.17.6 Maltose plate assay for determining insertion and
orientation
Overnight cell cultures were streaked out on maltose minimal media agar plates,
containing M9 salts (48 mM Na2HPO4; 22 mM KH2PO4; 8.6 mM NaCl; 18.7 mM
NH4Cl), 2 mM MgSO4, 100 μM CaCl, 0.4% maltose, and 15% (w/v) agar, and
incubated at 37 °C for 2-3 days. If the construct is correctly oriented in the
membrane (i.e. MBP on the periplasmic side), then the bacteria were able to
utilise maltose as a carbon source as evidenced by growth of the colonies.
2.18 GALLEX assay for determining homo- and
hetero-association of TM domains
2.18.1 Principle of the GALLEX assay
Whilst the TOXCAT assay is a valuable tool for the study of TM domain
interactions, it is limited to studying the self-association of TM domains only. The
GALLEX assay was designed by Schneider et al to allow the in vivo monitoring
of the hetero-association of α-helical TM domains (Schneider and Engelman,
2003; Finger, Volkmer et al., 2006). Conveniently, the GALLEX assay can also
be use to monitor homo-association providing a means of corroborating the
findings from the TOXCAT assay.
An overview of the principle of the GALLEX assay is shown in Figure 2.2.
Similar to the TOXCAT assay it involves the generation of a fusion protein
containing the TM domain, MBP, and a DNA binding promoter. However, the
promoter is the N-terminal part (residues 1-87) of LexA protein from E.coli. Two
plasmids are used in the assay depending on whether homo- or hetero- association
is being studied. The plasmid pBLM100 and the E. coli strain SU101 are
employed to determine homo-association, whilst both pBLM100 and pALM100
and the E .coli strain SU202 are used to study hetero-association. A homo-
associating fusion protein from the wt-LexA plasmid pBLM will bind to the wt-
LexA promoter/operator and repress expression of lacZ (encodesβ-Galactosidase)
in the genome of the reporter strain SU101.
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Figure 2.2. Principle of the GALLEX assay
The GALLEX assay can be used to monitor homo- and hetero-association of TMDs. In the homo-
association assay a fusion protein composed of maltose binding protein (MalE), TMD of interest,
and wild type LexA repressor (wt-LexA) is expressed from pBLM plasmid. Oligomerisation of
this construct driven by the association of the TMDs enables LexA to dimerise and bind to the
wild type (wt) lacZ promoter in E. coli SU101, repressing the expression of the enzyme β-
Galactosidase. In the hetero-association assay two fusion proteins are expressed from pALM and
pBLM plasmids. pBLM constructs are identical to those of the homo- assay whilst pALM
constructs possess a mutant LexA domain (Mu-LexA). Oligomerisation of the different TMDs
enables dimerisation of the wild type and mutant LexA domains, which bind a wild-type/mutant
hybrid lacZ promoter (wt/mu) in E.coli SU202, repressing expression of β-galactosidase. The
activity ofβ-galactosidase can be measured using a standard Miller assay.
For monitoring hetero-association fusion proteins are simultaneously expressed
from a wt-LexA plasmid (pBLM) and from a mutated-LexA plasmid (pALM). A
hetero-associated fusion protein will bind to the hybrid LexA promoter/operator
and repress the expression of lacZ in the genome of the reporter strain SU202. In
the E. coli strains SU101 and SU202, the lacZ reporter genes are under the control
of the wild-type LexA recognition sequence (op+), and op408/op+ hybrid
recognition sequence, respectively, which have been integrated into the genome of
the host. The op408/op+ hybrid operator is composed of half of the wild-type
promoter plus an altered half that recognises the mutant LexA domain (LexA408).
The homodimers do not recognise the hydrid operator so do not interfere with the
Homo-association Hetero-association
pBLM constructs pBLM
construct
pALM
construct
lacZ lacZ
Repression ofβ-galactosidase
Expression
MalE MalE
TMD
Wt-LexA
1 1 1 2
wt wt mu
TMD
Wt-LexA Mu-LexA
E. coli SU101 E. coli SU202
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measurement of hetero-association. Association of fusion constructs is then
monitored by the activity ofβ-galactosidase (Daines and Silver, 2000).
2.18.2 Cloning TM domains into GALLEX plasmids
Name Sequence
MHCα_F CGACTGTGGTCTGTGCCCTGGGGTTGTCTGTGGGCCTCGTGGGCATCGT
GGTGGGCACCATCTTCATCATTCAAGGCCTGA
MHCα_R CTAGTCAGGCCTTGAATGATGAAGATGGTGCCCACCACGATGCCCACGA
GGCCCACAGACAACCCCAGGGCACAGACCACAGTCGAGCT
MHCβ_F CGATGCTGAGCGGCATTGGCGGCTGCGTGCTGGGCGTGATTTTTCTGGGCCTG
GGCCTGTTTATTA
MHCβ_R CTAGTAATAAACAGGCCCAGGCCCAGAAAAATCACGCCCAGCACGCAGCCGC
CAATGCCGCTCAGCATCGAGCT
MHCα-16_F CGGCTCTTGGTCTTTCTGTTGGTCTTGTTGGTATTGTTGTTGGTACTGT
TA
MHCα-16_R CTAGTAACAGTACCAACAACAATACCAACAAGACCAACAGAAAGACCAA
GAGCCGAGCT
MHCα-17_F CGGCTCTTGGTCTTTCTGTTGGTCTTGTTGGTATTGTTGTTGGTACTGT
TTTTA
MHCα-17_R CTAGTAAAAACAGTACCAACAACAATACCAACAAGACCAACAGAAAGAC
CAAGAGCCGAGCT
MHCα-18_F CGGCTCTTGGTCTTTCTGTTGGTCTTGTTGGTATTGTTGTTGGTACTGT
TTTTATTA
MHCα-18_R CTAGTAATAAAAACAGTACCAACAACAATACCAACAAGACCAACAGAAA
GACCAAGAGCCGAGCT
MHCβ-19_F CGGCTCTTGGTCTTTCTGTTGGTCTTGTTGGTATTGTTGTTGGTACTGT
TTTTATTATTA
MHCβ-19_R CTAGTAATAATAAAAACAGTACCAACAACAATACCAACAAGACCAACAG
AAAGACCAAGAGCCGAGCT
MHCα-16_F CGATGCTTTCTGGTGTTGGTGGTTTTGTTCTTGGTGTTATTTTTCTTGG
TA
MHCα-16_R CTAGTACCAAGAAAAATAACACCAAGAACAAAACCACCAACACCAGAAA
GCATCGAGCT
MHCα-17_F CGATGCTTTCTGGTGTTGGTGGTTTTGTTCTTGGTGTTATTTTTCTTGG
TGCTA
MHCα-17_R CTAGTAGCACCAAGAAAAATAACACCAAGAACAAAACCACCAACACCAG
AAAGCATCGAGCT
MHCα-18_F CGATGCTTTCTGGTGTTGGTGGTTTTGTTCTTGGTGTTATTTTTCTTGG
TGCTGGTA
MHCα-18_R CTAGTACCAGCACCAAGAAAAATAACACCAAGAACAAAACCACCAACAC
CAGAAAGCATCGAGCT
MHCα-19_F CGATGCTTTCTGGTGTTGGTGGTTTTGTTCTTGGTGTTATTTTTCTTGG
TGCTGGTCTTA
MHCα-19_R CTAGTAAGACCAGCACCAAGAAAAATAACACCAAGAACAAAACCACCAA
CACCAGAAAGCATCGAGCT
Ii-23_F CGTATACTGGTTTCTCAATTTTAGTTACTTTATTATTAGCTGGTCAAGC
TACTACTGCTTATTTCTTATATA
Ii-23_R CTAGTATATAAGAAATAAGCAGTAGTAGCTTGACCAGCTAATAATAAAG
TAACTAAAATTGAGAAACCAGTATACGAGCT
Table 2.5. Oligonucleotide sequences used in the GALLEX assay
Forward (_F) and their complementary reverse (_R) oligonucleotides corresponding to the TM
domain of interest were ordered from Invitrogen and used as inserts for cloning into the GALLEX
assay.
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All plasmids used in this study were constructed by ligating synthetic
oligonucleotide inserts encoding the TMD sequence of interest (see Table 2.5)
into SpeI/SacI restriction digested pALM100 and pBLM100 vectors (see Table
2.2 and Section 2.6). Insertion of TMD sequence into pALM and pBLM plasmids
was confirmed by DNA sequencing using the primer pABLM_f (see Section2.6).
For monitoring homo-association competent E. coli SU101 cells were transformed
with pBLM100 constructs and plated out on LB-agar media containing ampicillin
at 100 μg/ml (see Section 2.6). For monitoring hetero-association, competent E.
coli SU202 cells were first transformed with the pALM100 plasmids and plated
out on LB-agar media containing tetracycline at 6 μg/ml. The transformants were
then made competent again, re-transformed with pBLM100 plasmids, and plated
out on LB-agar media containing tetracycline and ampicillin at 6 and 100 μg/ml,
respectively (see Section 2.6).
2.18.3 Monitoringβ-galactosidase activity
In bacteria the enzyme β-galactosidase performs the function of hydrolysing the
disaccharide lactose to yield galactose and glucose. The compound o-nitro-
phenyl-galactopyranose (ONPG) is a homologue of lactose and can be hydrolysed
by β-galactosidase to yield galactose and the yellow coloured compound o-
nitrophenol (ONP). This reaction is used to monitor the repression of β-
galactosidase caused by association of the TM domains bringing together the
LexA dimer.
Clones of each transformant were grown overnight in LB (37C) in the presence
of IPTG (1 mM) and the relevant antibiotics for the plasmid construct. The next
day, cells were diluted to an OD600 of 0.1 in LB medium containing the
appropriate antibiotics and 1 mM IPTG and grown at 37C to an OD600 of ~0.6, at
which point cells were harvested. 900μL of 1×Z buffer (300 mM Na2HPO4·7H2O,
200 mM NaH2PO4·H2O, 50 mM KCl, 5 mM MgSO4·7H2O, 50 mM 2-
mercaptoethanol) was added to 50μL of cell culture. 2-Mercaptoethanol is known
to activate β-galactosidase. Cells were lysed by adding 10μL of 0.1% SDS and 2
drops of chloroform with vortexing for 10 seconds until the solution became
turbid. Samples were allowed to equilibrate to room temperature before adding
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200 μL of o-nitro-phenyl-galactopyranose (ONPG, 4 mg/mL in 1×Z buffer) and
mixing thoroughly. ONPG is colourless but is hydrolysed by β-galactosidase to
produce the coloured compound ONP. The length of time taken for the colour to
appear was recorded and the reaction stopped by addition of 0.5 mL of 1 M
Na2CO3 solution. β-galactosidase operates optimally at pH 7.0, adding sodium
carbonate increases the pH to around 9, thus inactivating the enzyme and
quenching the reaction. Cell debris was pelleted by centrifugation. The
absorbance of the supernatant was monitored at 420 and 550 nm, which
corresponds to the absorbance from the ONP and the scattering from the cell
debris, respectively. The Miller units of β-galactosidase were calculated using
equation 3:
Miller units = 1000 x A420 – (1.75 x A550)
t (min) x v (mL) x OD600
(3)
where, A420 and A550 are the absorbance at 420 and 550 nm, respectively, t is the
time taken for the colour to appear, v is the reaction volume, and OD600 is the
optical density of the starting cell culture at 600 nm.
2.18.4 Controls for GALLEX assay
The E. coli strains SU101 and SU202 used in the GALLEX assay are not MBP
deficient, so the MBP-deficient E. coli strain NT326 is used to confirm expression
and membrane insertion of the chimera as described for the TOXCAT assay. To
test for membrane insertion and orientation (spheroplast assay), competent NT326
cells were prepared as described in Section 2.6.6. Cells were grown overnight in
LB plus ampicillin (100 μg/ml) and streptomycin (50 μg /mL). The next day the
culture was diluted to an OD600 of 0.1 and incubated at 37 °C for ~1.5 hrs until the
OD600 reached between 0.6 and 0.8. 1 mL of cells was normalised to an OD600 of
0.6 and the cells pelleted by centrifugation at 1700 × g. Cells were separated into
periplasmic, cytoplasmic and membrane fractions using a procedure based on the
EDTA/lysozyme/cold osmotic shock method (Randall and Hardy, 1986).
Typically cells were harvested and resuspended in 1 mL chilled buffer I (100 mM
tris-acetate pH 8.2; 0.5 M sucrose; 5 mM EDTA). 40μL lysozyme (2 mg/mL) and
500 μL dH2O was added before incubation on ice for 5 min followed by the
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addition of 20 μL MgSO4. The spheroplasts were pelleted by centrifugation at
10,000×g and the supernatant was collected as the periplasmic fraction.
Spheroplasts were washed in 1 mL chilled buffer II (50 mM tris-acetate pH 8.2;
0.25 mM sucrose; 10 mM MgSO4) and pelleted by centrifugation. The
supernatant was discarded and the spheroplasts resuspended in proteolysis buffer
(10 mM HEPES pH 7.6, 2 mM EDTA). The spheroplasts were then either treated
with Proteinase K (to a final concentration of 0.25 mg/mL) for 30 min on ice, or
broken open by 5× freeze-thaw cycles before treatment with Proteinase K. The
whole cell and soluble fractions were TCA precipitated as described in Section
2.8.
2.19 Förster Resonance Energy Transfer (FRET)
2.19.1 Principles of FRET
The phenomenon of Förster resonance energy transfer (FRET) can be observed
between pairs of molecules where the emission wavelength of one molecule (i.e.
the donor) overlaps or resonates with the excitation wavelength of the other (i.e.
the acceptor) (Johnson, 2005). This resonance between these molecules, termed a
FRET pair, allows the transfer of energy through nonradiative dipole–dipole
coupling from the donor molecule to the acceptor molecule. The energy transfer
can be monitored using spectroscopic techniques, and in those cases where the
molecules have fluorescent properties, the transfer can be measured using a
fluorimeter, so often this technique is termed fluorescence resonance energy
transfer. FRET can be exploited to study protein-protein interactions because the
energy transfer displays a strong dependency on the distance between the FRET
pair. The distance at which the energy transfer efficiency is 50% is known as the
Förster distance. The combining of different FRET pairs enables Förster distances
to be fine-tuned, and is thus an important consideration when choosing a FRET
pair. Thus the FRET pair should be chosen to ensure the structural details of
association do not impede observation of FRET. In the case of studying helix-
helix interactions, consideration must therefore be made of possible antiparallel
association or staggered alignment of the helices.
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2.19.2 Selection of fluorophores and peptide synthesis
Peptides corresponding to the TM domains of Ii, MHCα and MHCβwere
synthesised and labelled at the N-term with either fluorescein or rhodamine
fluorophores (see Table 2.6), as described in Section 2.10.1. The
fluorescein/rhodamine FRET pair was chosen on the basis that it has a favourable
Förster distance for the study of TM helix-helix interaction at ~50 Å (Cardullo,
Agrawal et al., 1988), and they have been used previously in the study of TM
helix interactions (You, Li et al., 2005; Merzlyakov and Hristova, 2008).
Name Amino acid sequence Mass (Da)
Ii-Fl Fl-KASRGALYTGFSILVTLLLAGQATTAYFLYQQQKK 4210.53
Ii-Rh Rh-KASRGALYTGFSILVTLLLAGQATTAYFLYQQQKK 4264.52
MHCα-Fl Fl-KELTETVVCALGLSVGLVGIVVGTVFIIRGLRSWK 4072.2
MHCβ-Rh Rh-KSESAQSKMLSGVGGFVLGVIFLGAGLFIYFRNQK 4165.64
Table 2.6. Amino acid sequences of FRET peptides used in this study
Peptides were synthesised and labelled with fluorophores at the Keck Facility (Yale University,
USA). The peptides were labelled at the N-term with the fluorophores fluorescein (Fl) and
rhodamine (Rh), as indicated. Labelling was performed at the time of synthesis. Underlined
residues indicate the extent of the predicted transmembrane domain. K residues were added to the
sequences to aid purification and for cross-linking purposes. Peptides were supplied as crude
product from the synthesis and purified by RP-HPLC. Expected masses were used to identify
fractions of pure peptides during RP-HPLC purification. Peptides were end capped.
2.19.3 RP-HPLC purification of fluorophore labelled
peptides
The peptides listed in Table 2.6 were purified using RP-HPLC according to
protocols developed for the unlabelled counterparts and the purity was determined
by mass spectrometry using the methods outlined in Section 2.11.
2.19.4 FRET sample preparation
Aliquots of lyophilised peptides were reconstituted in TFE and the protein
concentration determined as described in Section 2.12. The peptides were
reconstituted into detergent solution by mixing TFE-solubilised peptides with
detergent solubilised in TFE. The mixtures of peptide and detergent in TFE were
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dried under vacuum to a film, which was then solubilised in 20 mM phosphate
buffer, 200 mM NaCl, pH 7.0 (Fisher, Engelman et al., 1999).
2.19.5 Fluorescence spectroscopy
Fluorescence spectra were recorded on a JASCO FP-6500 fluorimeter. Typically,
the spectral resolution of the excitation and emission monochromators were both
set to 5 nm and the scan speed at 200 nm/min. Emission spectra between 450 and
650 nm were recorded with an excitation wavelength of 439 nm (excitation
wavelength of the fluorescein donor fluorophore) using a quartz cuvette (Starna
Optiglass Ltd, Hainault, UK).
2.19.6 FRET calculations
Determining energy transfer: The percentage energy transfer, E, was calculated
from measurements of the donor intensity at 520 nm in the absence and presence
of the acceptor. E is described by equation 4:
E(%) = (D – DA)/(D) x 100 (4)
where D and DA are the emission at 520 nm of samples containing only donor-
labelled peptides and mixed samples of both donor- and acceptor-labelled
peptides, respectively. The contribution to the emission at 520 nm from the direct
excitation of the acceptor was removed by subtracting the spectra of sample
containing only acceptor-labelled peptide from that of both donor- and acceptor-
labelled peptides.
Determining oligomeric state: As shown by Veatch et al (Veatch and Stryer,
1977) the relative fluorescence yield of the donor as a function of the mole
fraction of the acceptor can be used to distinguish amongst various oligomeric
models. FRET data was fitted to the equation 5:
Q / Q0 = 1 – E (Xd – Xd N) / Xd (5)
where, Q is the absorbance at 520 nm, Q0 is the donor-only absorbance at 520 nm
normalised to Xd, E is the transfer efficiency, Xd is the mole fraction donor and N
is the oligomeric state.
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2.20 NMR Spectroscopy
Sample preparation for NMR analyses: Samples for use in solution-state NMR
analyses were prepared by dissolving each of the selectively labelled TM peptides
shown in Figure 6.1, in deuterated sodium dodecylsulfate (SDS) (Avanti Polar
Lipids, Alabaster, USA) detergent micelles. A series of samples were prepared in
which peptide concentration was kept approximately constant (0.5–0.7 mM) while
the concentration of SDS detergent was steadily increased from ~ 25 mM up to
700 mM to achieve a range of peptide: micelle molar ratios as indicated in
Chapter 6. Briefly, the desired amount of peptide dissolved in trifluoroethanol
(TFE) (Sigma-Aldrich, UK) was added to an aqueous SDS solution of the
appropriate concentration. The final volume of TFE was kept to a minimum to
prevent precipitation of SDS. The peptide–detergent solution was then lyophilized
and resuspended in 20 mM sodium phosphate buffer (pH 5.8) containing 10%
D2O. The sample was subsequently mixed using a vortex mixer followed by
sonication at 40C for 15–30 mins. Samples were allowed to equilibrate for 24
hours before acquiring measurements. The peptide: micelle molar ratio for each
sample was calculated using a value for the SDS critical micelle concentration
(CMC) of 8 mM and an average aggregation number of 62 according to published
values (le Maire, Champeil et al., 2000). This resulted in samples with peptide:
micelle ratios ranging from 2:1 (or 2) to 1:22 (or 0.05).
NMR spectroscopy: Sensitivity enhanced 2D 15N-1H heteronuclear single
quantum correlation (HSQC) spectra were recorded at 40°C on either a 500 or 700
MHz Bruker Avance spectrometer fitted with a cryoprobe. All spectra were
processed using Topspin 2.0 (Bruker, UK) and analyzed with CcpNMR software
(Vranken, Boucher et al., 2005). Backbone amide proton and nitrogen chemical
shift assignments of the E5TM peptides were obtained from 15N-edited total
correlation spectroscopy (TOCSY) experiments with a spin-lock time of 60 ms,
and 15N-edited nuclear Overhauser spectroscopy (NOESY) spectra with mixing
times of 60 to 100 ms. Average backbone amide chemical shift differences (Δδ) 
were calculated according to equation 6:
Δδ = ((ΔδHN)2 + (ΔδN / 5) 2) 0.5 (6)
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where ΔδHN and  ΔδN are the chemical shift differences between monomeric and
dimeric species for the amide proton and nitrogen atoms, respectively according
to the method reported by Wu et al (Wu, Shih et al., 2007).
2.21 Circular Dichroism
CD spectra were measured using a Jasco J715 spectropolarimeter (Jasco UK,
Great Dunmow, UK) and 1.0 mm path-length quartz cuvettes (Starna Optiglass
Ltd, Hainault, UK). All spectra were recorded from 190 to 260 nm (data below
200 nm are not shown due to high noise of light scattering) using 2.0 nm spectral
bandwidth, 0.2 nm step resolution, 100 nm min -1 scanning speed, and 1 s
response time. 40 μM peptide samples were prepare in 50mM sodium phosphate
buffer (pH 7), 100 mM NaCl containing various concentrations of detergent as
indicated in Chapter 6. CD spectra of the buffer and detergent alone were
subtracted to obtain the final spectra.
2.22 Oriented Circular Dichroism
Oriented circular dichroism is a useful tool for determining the insertion of TM
domains into lipid bilayers, and involves a slight modification to the technique of
circular dichroism. Differential absorbance of right and left-handed circularly
polarised light by proteins of different secondary structure give characteristic
spectra for alpha helix, beta sheet, and random coil (Merzlyakov, You et al.,
2006). Peptides and lipids (DMPC) were codissolved in organic solvent (0.25
mg/mL peptide and 2.5 mg/mL lipid in 50 μL TFE). The solution was deposited
dropwise on to a quartz slide, and the solvent removed under a stream of nitrogen
forming multilamellar vesicles containing lipid bilayers and peptide. To ensure
total solvent removal, the sample was held under vacuum overnight. The sample
was hydrated by placing in a vessel with a drop of water into the chamber
containing the sample slide, and equilibrated overnight. The slide was then
mounted into a custom holder with the multilamellar layers oriented perpendicular
to the light path. A CD spectrum was acquired using the same parameters as
described in Section 2.21. The slide was then rotated in increments of 45°,
acquiring a CD spectrum each time for a total of 8 measurements through a total
rotation of 360°. The spectra were then averaged to minimise artefacts arising
Chapter 2. Materials and Methods
38
from linear dichroism to generate the OCD spectra. An OCD spectrum of lipid
alone was then subtracted from this spectrum to give the final OCD spectra.
2.23 Analytical Ultracentrifugation
Sedimentation velocity data were collected for peptide concentrations of 67, 134,
268μM solubilised in 15 mM DPC (Avanti Polar Lipids) and 100mM NaCl using
a double-channel centrepiece, a speed of 60,000 rpm, and a temperature of 25°C
using a Beckman XL-1/A analytical ultracentrifuge. Buffer was prepared in
52.5% D2O (Cambridge Isotope Laboratories, Andover MA) to match the buoyant
density of the detergent. When the solvent matches the buoyant density of the
detergent micelles, the only contribution to the buoyant molecular weight is from
the peptide (Kochendoerfer, Salom et al., 1999). A total of 400 scans were
recorded in each case, with 50 s between each scan. The moving boundary was
monitored by repetitive radial scanning at a constant step size of 0.003 cm at 280
nm using a UV absorption optical system. Fitting of the resulting profiles to
various oligomeric state models was achieved using SEDFIT (Schuck, 2000) to
generate a continuous sedimentation coefficient distribution, which was
subsequently converted to a molecular mass distribution using a peptide
monomeric molecular mass of 3924 Da, a buffer density of 1.05971 g ml-1, a
buffer viscosity of 1.0267 centipoise, and a partial specific volume of 0.7792 ml g-
1 (calculated using SEDNTERP (Hayes, D, B., Lane, T., Philo, J., University of
New Hampshire, USA)).
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3 TM domain interactions of Invariant
Chain
3.1 Introduction and objectives
As discussed in Section 1.3.2, MHC Class II-Associated Invariant Chain (Ii) is
known to be a trimeric protein that binds to three MHC Class IIα/βhetero-dimers
facilitating the release of the nonomeric complex from the ER and its subsequent
involvement in the antigen presentation pathway of mammalian immunity
(Frauwirth, Sanderson et al., 1995). The soluble domain of Ii is known to
trimerise and the MHC hetero-dimers associate with Ii via the extra-membranous
CLIP domain of Ii which occupies the antigen binding domain of MHC (Jasanoff,
Wagner et al., 1998).
The TM domain of Ii has previously been studied in isolation using in vivo assays
and synthetic peptides and was found to form a specific trimer that was potentially
stabilised by inter-helical hydrogen bonding involving residues Q49 and T50
(Ashman and Miller, 1999; Kukol, Torres et al., 2002; Barabanova, Kang et al.,
2004; Dixon, Stanley et al., 2006). Of particular note is the recent study by Dixon,
Stanley et al where the association of the TM domain of Ii was studied by a
combination of the in vivo TOXCAT assay and analysis of model peptides using
cross-linking and AUC. This was the first study to analyse the oligomeric state of
the of Ii TM domain in isolation from the rest of the molecule and suggested it
could strongly and very specifically self associate to form a trimeric oligomeric
state. Interestingly, the results from their cross-linking analysis of a peptide
corresponding to residues K26-R60 of Ii identified oligomeric states of only
trimer and hexamer in DPC whilst the AUC data was found to fit best to a
monomer-trimer model for association. Notably, Ii TM domain was not found to
associate to form intermediate oligomeric states e.g. dimer, tetramer, or pentamer.
In order to progress with our investigation of the association of the TM domain of
Ii with the α- and β-chains of MHC, the self-association of the Ii TM domain and
its oligomeric state were substantiated by further in vivo and in vitro experiments,
as described in this section. In addition, the effect of detergent concentration on
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the oligomeric state of Ii has not previously been considered but is addressed in
the studies presented here. The Ii TM domain also provided the test sequence for
developing in-house protocols.
Figure 3.1. Principle of the GALLEX assay
The GALLEX assay can be used to monitor homo- and hetero-association of TMDs. In the homo-
association assay a fusion protein composed of maltose binding protein (MalE), TMD of interest,
and wild type LexA repressor (wt-LexA) is expressed from pBLM plasmid. Oligomerisation of
this construct driven by the association of the TMDs enables LexA to dimerise and bind to the
wild type (wt) lacZ promoter in E. coli SU101, repressing the expression of the enzyme β-
Galactosidase. In the hetero-association assay two fusion proteins are expressed from pALM and
pBLM plasmids. pBLM constructs are identical to those of the homo- assay whilst pALM
constructs possess a mutant LexA domain (Mu-LexA). Oligomerisation of the different TMDs
enables dimerisation of the wild type and mutant LexA domains, which bind a wild-type/mutant
hybrid lacZ promoter (wt/mu) in E.coli SU202, repressing expression of β-galactosidase. The
activity ofβ-galactosidase can be measured using a standard Miller assay.
The objectives of this part of the project are as follows: to confirm that the Ii TM
domain can weakly self-associate and that its oligomeric state is trimeric; to
confirm the GALLEX assay (discussed in Section 2.18.1, and presented again in
Figure 3.1) can be used to monitor self-association of TM domains in vivo using Ii
and optimise the methodology for use in further studies involving MHC TM
Homo-association Hetero-association
pBLM constructs pBLM
construct
pALM
construct
lacZ lacZ
Repression ofβ-galactosidase
Expression
MalE MalE
TMD
Wt-LexA
1 1 1 2
wt wt mu
TMD
Wt-LexA Mu-LexA
E. coli SU101 E. coli SU202
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domains; to explore the possible effects of detergent concentration on self-
association of Ii TM domain peptide; to explore the use of FRET experiments in
studying TM domain association using Ii and optimise methodology for use in
subsequent studies with MHC TM domains
3.2 Monitoring self-association of Ii TM domain with
the GALLEX assay
Using the in vivo TOXCAT assay, previous studies revealed the propensity for the
Ii TM domain to oligomerise in E.coli membranes (Dixon, Stanley et al., 2006).
An alternative method for determining TM domain oligomerisation is the
GALLEX assay as proposed by Schneider et al which has the additional benefit of
enabling association of different TM domain sequences to be monitored (i.e.
hetero-association) (Schneider and Engelman, 2003).
The GALLEX assay has now been implemented at Warwick, optimized in house
and used to confirm the self-association of the Ii TM domain. The principle of the
GALLEX assay for measuring TM helix-helix association was described in detail,
and the methods provided in Section 2.18. In brief, the system enables TM
domain association in the inner membrane of E. coli to be detected by the
repression of the reporter gene β-galactosidase. In the GALLEX assay self-
association can be assayed by inserting the TM of interest into the plasmid
pBLM100 followed by transformation of the resulting plasmid into the host strain
SU101. The sequence for the wild type TM domain of Ii (see Figure 3.2a) was
cloned into the plasmid pBLM100 and assayed using the GALLEX assay as
described in Section 2.18. Positive and negative controls for self-association were
provided by the dimeric TM domain of GpA and its oligomerization-deficient
mutant GpAG83I, respectively.
The results from the GALLEX assay are presented in Figure 3.2b. The Ii signal
was intermediate between that of the positive and negative control, confirming
that Ii can self-associate in E.coli membranes. This is consistent with the self-
association observed with the alternative assay TOXCAT (Dixon, Stanley et al.,
2006).
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Figure 3.2. Monitoring self association of Ii TM domain using the GALLEX
assay
Self-association was monitored using the GALLEX system as described in the text (a) Amino acid
sequence of the Ii TM domain insert cloned into the plasmid pBLM100 and subsequently
transformed into E.coli strain SU101 as described in Section 2.18.2 (b) β-galactosidase activity
mediated by the oligomerisation propensity of the expressed constructs in E.coli SU101.
Repression of activity is indicative of association of the TM domains. Data is an average from
three independent measurements. Expression of the chimeric proteins was induced by the addition
of 1 mM IPTG. Details of the β-galactosidase assay and the calculation of Miller Units are
described in the Section 2.18.3. All plasmids and E. coli strains were kindly proved by Dr
Schneider. GpA and the dimerisation deficient mutant of GpA, G83I, act as positive and negative
controls respectively. (c) Test for insertion and orientation of the expressed chimera. Western blot
analysis of E.coli extracts: WC, whole cell; PF, periplasmic fraction; SF, spheroplast fraction; SP,
spheroplast proteolysis; BS, broken spheroplast proteolysis. The expressed chimeric proteins with
a molecular mass of 54kDa are found predominantly in the inner membrane fraction and correctly
oriented in the membrane.
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3.3 Synthesis and purification of Ii TMD peptides for
in vitro studies
The reductionist approach of using model synthetic peptides in conjunction with
in vitro techniques is proving to be a productive strategy for the study of TM
domain interactions. However, the synthesis and purification of these highly
hydrophobic transmembraneα-helices are notoriously difficult. A commonly used
strategy that has met with success is the use of Fmoc synthesis coupled with RP-
HPLC that is optimised to each peptide(Fisher and Engelman, 2001). Even with
advances in this approach it still can be difficult to separate the desired peptide
from the crude product and very often broad overlapping peaks will be observed
that may correspond to truncation products, conformational differences or
oligomers along with reactants from the synthesis. Nevertheless, this approach has
been utilised in this study to explore the self-association of the Ii TM domain.
Peptides that correspond to the TM domain of Ii were synthesised at the Keck
Facility (Yale University, USA) in addition peptides labelled with the
fluorophores fluorescein and rhodamine were produced for use in FRET
experiments. The amino acid sequences of the peptides synthesized for this study
are shown in Table 3.1.
Name Amino acid sequence Mass
(Da)
Ii KASRGALYTGFSILVTLLLAGQATTAYFLYQQQGR 3808.4
Ii_K KASRGALYTGFSILVTLLLAGQATTAYFLYQQQKK 3892.55
Ii-Fl Fl-KASRGALYTGFSILVTLLLAGQATTAYFLYQQQKK 4210.53
Ii-Rh Rh-KASRGALYTGFSILVTLLLAGQATTAYFLYQQQKK 4264.52
Table 3.1. Amino acid sequences of IiTM peptides used in the in vitro studies
of Ii TM association
Peptides were synthesised at the Keck Facility (Yale University, USA). Ii-Fl and Ii-Rh were
synthetic peptides produced for use in FRET studies and were labelled at the N-term with the
fluorophores fluorescein (Fl) and rhodamine (Rh), respectively. The wild type sequence of Ii
contains a C residues at the second position identified in bold. This was mutated to A in the
synthetic peptides to remove the complication of cysteine bond formation. Labelling was
performed at the time of synthesis. Underlined residues indicate the extent of the predicted
transmembrane domain. K residues were added to the sequence in Ii_K at N-term for cross-linking
purposes. Peptides were supplied as crude product from the synthesis and purified by RP-HPLC.
Expected masses were used to identify fractions of pure Ii peptides during RP-HPLC purification.
Peptides were end capped.
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The general details of peptide synthesis, purification and analysis by mass
spectrometry were as described in Section 2.10. The peptides were supplied as a
crude product of the synthesis and thus contained undesirable contaminants such
as fmoc protecting groups from the synthesis and truncated peptides, requiring the
peptide to be purified. Reversed phase high pressure liquid chromatography (RP-
HPLC) was employed for this task as it is a widely used technique for the
purification of hydrophobic peptides.
Typical RP-HPLC chromatograms and mass spectra of pooled pure fractions for
the peptides Ii, Ii_K, Ii-Fl and Ii-Rh are shown in Figures 3.2 to 3.5 respectively.
In each case, the peak corresponding to the peptide in the RP-HPLC
chromatogram is indicated in the figure and the major component of the pooled
fractions are the desired peptide.
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Figure 3.3. RP-HPLC purification of Ii peptide
(a) The Ii peptide was purified by reverse phase HPLC (solid line) using a linear 1% per min
Acetonitrile (ACN) gradient (broken line) and H2O as the second solvent , on a Phenomenex
Jupiter C4 column (Phenomenex, UK). 0.1% TFA was present in both solvents. Elution of
fractions was monitored by the absorbance at 280 nm. The peak generated by the elution of the Ii
peptide is indicated. (b) Purity of pooled fractions was analysed using ESI mass spectrometry. The
major peak with a mass of 1270 Da corresponds to the expected mass for the 3+ charge state of the
Ii peptide.
Ii
(a)
(b)
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Figure 3.4. RP-HPLC purification of Ii_K peptide
(a) The Ii_K peptide was purified by reverse phase HPLC (solid line) using a linear 1% per min
Acetonitrile (ACN) gradient (broken line) and H2O as the second solvent , on a Phenomenex
Jupiter C4 column (Phenomenex, UK). 0.1% TFA was present in both solvents. Elution of
fractions was monitored by the absorbance at 280 nm. The peak generated by the elution of the
Ii_K peptide is indicated. (b) Purity of pooled fractions was analysed using MALDI mass
spectrometry. The major peak with a mass of 3893 Da corresponds to the expected mass for Ii_K
peptide.
(a)
(b)
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Figure 3.5. RP-HPLC Purification of Ii-Fl peptide
(a) The Ii-Fl peptide was purified by reverse phase HPLC (solid line) using a Acetonitrile (ACN)
gradient (broken line) and H2O as the second solvent, on a Phenomenex Jupiter C4 column
(Phenomenex, UK). 0.1% TFA was present in both solvents. Elution of fractions was monitored
by the absorbance at 280 nm. The peak generated by the elution of the Ii-Fl peptide is indicated.
(b) Purity of pooled fractions was analysed using MALDI mass spectrometry. The major peak
with a mass of 4209 Da corresponds to the expected mass for Ii-Fl peptide.
(a)
(b)
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Figure 3.6. RP-HPLC purification of Ii-Rh peptide
The Ii-Rh peptide was purified by reverse phase HPLC (solid line) using a linear 1% per min
Acetonitrile (ACN) gradient (broken line) with H2O as the second solvent , on a Phenomenex
Jupiter C4 column (Phenomenex, UK). 0.1% TFA was present in both solvents. Elution of
fractions was monitored by the absorbance at 280 nm. The peak generated by the elution of the Ii-
Rh peptide is indicated. (b) Purity of pooled fractions was analysed using MALDI mass
spectrometry. The major peak with a mass of 4209 Da corresponds to the expected mass for Ii-Rh
peptide.
(a)
(b)
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3.4 Analysis of the secondary structure of Ii TM
domain using CD spectroscopy
In this study we sought to determine the effect of the peptide:micelle molar ratio
on the oligomeric state of the Ii TM peptide. Since it is well known that detergents
can denature proteins, it was not known what effect (if any) this would have on
the secondary structure of the peptide. To answer this question, circular dichroism
(CD) spectroscopy was used to assess the secondary structure of the Ii TM peptide
in the detergent DPC at varying peptide:micelle molar ratios. As shown in Figure
3.7a, the peptide was soluble at all concentrations of DPC tested, enabling CD
spectra to be acquired for all peptide:micelle ratios, and in all cases data were
truncated at 200 nm below which the absorbance was too high to give reliable
data (high tension values above 600 volts (Figure 3.7b).
As shown in Figure 3.7a, negative maxima were observed at 208 and 222nm
which is characteristic of the presence of α-helical secondary structure.
Interestingly, greater signal was observed with increasing detergent concentration
which is likely due to the increasing solubilisation of the peptide since the peptide
concentration was constant for each measurement. As shown in Figure 3.7c,
analysis of the CD spectra using the program CDSSTR (Johnson, 1999) revealed
that the percentage of α-helical content increases as the peptide:micelle ratio is
decreased (i.e. detergent concentration is increased), rising to a maximum of
~80% α-helix with a ratio of 1:1. This increase may reflect increasing
solubilisation of the protein. Interestingly, the percentage then begins to decrease
slightly as the ratio increases further. This possibly indicates that above 1:1 the
DPC detergent is beginning to denature the peptide, although the decrease is
slight.
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Figure 3.7. Analysis of the secondary structure of Ii TM peptide
(a) Circular Dichroism spectra of Ii TM peptide reconstituted into the detergent DPC at varying
peptide: DPC micelle ratios as indicated. Mean residue ellipticity (MRE) was calculated from the
measured ellipticity as described in Materials and Methods. (b) High tension for CD spectra,
typically the CD data is taken to be reliable whilst this remains below 600. (c) Percentage
secondary structure content (α-helix (blue), β-sheet (red), Random coil (yellow) at varying
peptide: DPC micelle ratios as calculated from the CD spectra using CDSSTR (Johnson, 1999).
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3.5 Cross-linking analyses of Ii TM domain self-
association
The use of covalent cross-linking of TM domains in mild detergents enables the
visualisation of oligomeric states using SDS-PAGE, which would otherwise be
denatured in SDS detergent. Such analyses were performed in this study to
confirm the oligomeric state of the Ii peptide. It is known that the concentration of
detergent can affect the dissociation constant (kd) and thus the oligomeric states of
transmembrane interactions (Fisher, Engelman et al., 1999). Therefore the effect
of varying the micelle concentration (i.e. micelle:peptide molar ratio) upon the
oligomeric state of Ii peptide was explored here as it has not previously been
considered with respect to the association of the Ii TM domain.
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Figure 3.8. Structure of detergents used in cross-linking studies
Structure of the detergents (a) DPC, (b) LPPG, (c) OG (d) SDS, used in this study to solubilise the
hydrophobic model TM peptides.
The Ii peptide was dissolved in varying micelle concentrations of the detergents
octylglucoside (OG), 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-
glycerol)] (LPPG), dodecylphosphocholine (DPC), and sodium dodecylsulfate
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(SDS) (Figure 3.8), cross-linked with Bis(sulfosuccinimidyl)suberate (BS3)
(Figure 3.9), and analysed using SDS-PAGE as described in Section 2.13. As
shown in Figure 3.10, Ii self assembles in the detergents OG and LPPG and
achieves higher order oligomeric states as the micelle concentration is decreased.
The Ii peptide self assembles in DPC, but the trend of increasing oligomeric state
with decreasing micelle concentration was not observed. It is possible that this
could be due to the higher micelle concentrations used in this case, which are
disrupting the higher order oligomers. Notably, the major oligomeric state
observed using cross-linking is dimer, which contradicts earlier work which
indicated the TM domain of Ii to be predominantly if not entirely a trimer (Dixon,
Stanley et al., 2006).
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Figure 3.9. Structure of cross-linking agent BS3
Structure of the cross-linking agent Bis(sulfosuccinimidyl)suberate (BS3) (Pierce, UK) used
in this study to monitor oligomeric states of model peptides in mild detergents by SDS-PAGE
analyses.
Since the predominant oligomeric state observed was dimer it was hypothesised
that the presence of only a single K residue in the sequence of the Ii peptide may
be limiting the cross-linking of a trimer, since this residue possesses the only free
amino group available to react with the cross-linking agent BS3. In order to test
this, a second peptide, Ii_K, was synthesised that possessed a greater number of
terminal K residues (see Table 3.1) and purified as described in Section 3.3. It
should be noted that the presence of additional K residues at the termini of TM
domain peptides has been shown to have no affect on the association of strongly-
associating TM domains (Melnyk, Partridge et al., 2003).
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As shown in Figure 3.11, cross-linking of Ii_K was performed on the peptide
solubilised in the detergents (a) LPPG and (b) DPC at varying peptide:micelle
ratio. In LPPG (Figure 3.11a), Ii_K peptide seems to be forming oligomeric states
from monomer to trimer in a detergent-concentration dependent manner similar to
the Ii peptide. For the samples of Ii_K cross-linked in DPC, higher
peptide:micelle ratios were explored to those used with Ii and as shown in Figure
3.11b, multiple oligomeric states are observed. With the higher peptide:micelle
ratio the same pattern of decreasing oligomeric size as seen in the other detergents
is observed. This result also shows that DPC is a better solubilising agent for the Ii
peptide than the other detergents and on this basis was chosen as the detergent for
use in other techniques.
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(a)
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(c)
Figure 3.10. SDS PAGE analysis of cross-linked Ii peptides in DPC
Crosslinking of Ii at varying peptide:micelle ratios of the detergents: (a) Octylglucoside (OG). The
cmc of OG was taken as 18 mM and the aggregation number as 90 for micelle:peptide
calculations. (b) LPPG. The cmc of LPPG was taken as 18μM and the aggregation number as 125
for micelle:peptide calculations. (c) DPC. The cmc of DPC was taken as 1000 μM and the
aggregation number as 56 for micelle:peptide calculations. Peptide:micelle ratios were calculated
as described in Section 2.13. Crosslinking agent was 1 mM BS3 supplied by Pierce. Lanes marked
C are cross-linked Ii in 150 mM SDS used as a control for non-specific oligomerisation. Lanes
marked with M are molecular weight standards. In all cases the concentration of Ii was 20 μM. Ii
has a mass of 3.8 kDa. Possible oligomeric states are indicated where n is the stoichiometry.
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Figure 3.11. SDS PAGE analysis of cross-linked Ii_K peptides in DPC
Crosslinking of Ii_K at varying peptide:micelle ratios of the detergents: (a) LPPG. The cmc of
LPPG was taken as 18μM and the aggregation number as 125 for micelle:peptide calculations. (b)
DPC. The cmc of DPC was taken as 1000 μM and the aggregation number as 56 for
micelle:peptide calculations. Crosslinking agent was 1 mM BS3 supplied by Pierce.
Peptide:micelle ratios were calculated as described in Section 2.13. Lanes marked C are cross-
linked Ii_K in 150 mM SDS used as a control for non-specific oligomerisation. Lanes marked with
M are molecular weight standards. In all cases the concentration of Ii was 20 μM. Ii_K has a mass
of 3.89 kDa. Possible oligomeric states are indicated where n is the stoichiometry.
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3.6 Assessing the oligomeric state of the Ii TM
domain peptide using AUC
The lack of agreement between the cross-linking studies of the Ii TM domain in
this study and those in the literature cast doubt on the oligomeric state of this
peptide. In the study by Dixon et al, the Ii peptide was also analysed by
sedimentation equilibrium analytical ultracentrifugation (AUC) where it was
found that the data fit best to a monomer trimer model (Dixon, Stanley et al.,
2006). (Dixon, Stanley et al., 2006). Therefore, in this work, sedimentation
velocity experiments were performed in collaboration with Dr Andrew Beevers
(University of Warwick, UK) in order to corroborate this finding as described in
Section 2.23. Sedimentation velocity can be difficult with peptides of low
molecular mass due to the high speeds necessary to minimize the rate of back
diffusion. A speed of 60,000 rpm was required to provide data with the required
mass resolution and this is in agreement with the previous study of Ii (Dixon,
Stanley et al., 2006).
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Figure 3.12. Sedimentation velocity analysis of Ii oligomeric state
Sedimentation velocity data obtained for Ii TM peptide in buffer containing 15 mM DPC and
52.5% D2O. Sedimentation coefficient distribution profile was calculated using SEDFIT and
converted to molecular mass. Monomer mass for Ii is 3808 Da. Data were collected and analyzed
by Dr Andrew Beevers.
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The molecular weights and distribution of the species observed for the Ii TM
peptide dissolved in the detergent DPC are shown in Figure 3.12. The data show
three distinct species in solution with molecular weights at approximately around
5000, 12000 and 22000 Da. Given that the monomer mass of IiTM peptide is 3808
Da, it is likely that the 5000 Da distribution corresponds to a mean value for the
monomer-dimer species, whilst the distributions centred at 12,000 and 22,000 Da
indicate the presence of trimer and hexamer, respectively. Again, like in the cross-
linking data a shift in oligomeric state from higher to lower order is observed as
the ratio of detergent to the peptide increases. This data agrees with that from
cross-linking and GALLEX in this work, since they show the Ii peptide is self-
associating and is forming oligomers from dimer to hexamer that are sensitive to
the concentration of detergent.
3.7 FRET analyses of Ii TM domain self-association
As discussed in Section 2.19, Förster resonance energy transfer, or FRET analyses
rely upon the phenomenon that energy can be transferred between molecules
possessing overlapping emission and excitation wavelengths (termed FRET pairs)
that are in close spatial proximity. The distance dependence of the energy transfer,
known as the Förster distance, provides a tool for determining interactions
between molecules. The FRET pairs that are often used in these studies are
fluorophores (e.g. fluorescein and rhodamine) allowing the energy transfer to be
monitored by fluorescence spectroscopy. This is done by monitoring either the
decrease in donor emission or the increase in acceptor emission with the former
approach being more commonly used.
There have been numerous examples of FRET studies in recent years that make
use of this in vitro technique to measure TM domain interactions for model
synthetic peptides solubilised in membrane mimetics (Duneau, Vegh et al., 2007).
An advantage of this technique is that it enables hetero-association to be studied
through the selective labelling of peptides with FRET pairs (Duneau, Vegh et al.,
2007), it therefore providing a means for monitoring association between the TM
domains in the Ii-MHC complex. Before proceeding to explore these hetero-
associations the technique was first applied to the study of the self-association of
Ii TM peptides in order to optimise the methodology.
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The transfer of energy between the donor and acceptor can be measured via
monitoring either the quenching of the donor emission or the enhancement of the
acceptor emission. Typically, the donor quenching is monitored using
fluorescence spectroscopy with spectra acquired at fixed excitation wavelength,
which in the case of fluorescein labelled peptides was 439 nm, whilst the emission
is monitored over the wavelength range 450 to 650 nm.
3.7.1 Design and synthesis of fluorophore labelled peptides
FRET pairs are known to vary in their Förster distances (i.e. the distance over
which energy transfer can occur). Therefore, a donor and acceptor FRET pair was
chosen that produce a FRET signal that would be independent of the manner in
which the peptides associate (i.e. parallel versus antiparallel association and
crossing angle) and would therefore report on the amount of oligomer present.
Fluorescein and rhodamine are a commonly used FRET pair which can report
over a distance of 40-90 Å and have been employed successfully in the study of
other TM domain interactions (Li, You et al., 2005; You, Li et al., 2005) making
them an appropriate choice for use in this study.
Peptides corresponding to the TM domain of Ii were synthesised, labelled with
fluorescein (Ii-Fl) and rhodamine (Ii-Rh) at their N-termini and purified as
described in Section 3.3. As shown in Figure 3.13, the excitation and emission
spectra of the labelled peptides display properties of the fluorophores that are
useful for FRET measurements. Specifically, the wavelengths over which
fluorescein labelled Ii emits display considerable overlap with the excitation
wavelengths of rhodamine labelled Ii. Advantageously, the excitation wavelengths
of Ii-Fl display minimal overlap with that of Ii-Rh below around 450 nm. An
excitation wavelength of 439 nm was chosen for use in FRET experiments, such
that fluorescein could be selectively excited with minimal direct excitation of
rhodamine.
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Figure 3.13. Absorbance and emission spectra for fluorescein and rhodamine
labelled Ii peptide
Emission and absorbance spectra for Ii peptide labelled with fluorescein (Ii-Fl) and rhodamine (Ii-
Rh) were collected at peptide concentrations of 4 μM. The emission spectra for Ii-Fl and Ii-Rh
were collected using excitation wavelengths of 439 nm and 540 nm, respectively. All peptides
were solubilised in TFE.
3.7.2 Optimising sample preparation for FRET experiments
Detergents have been successfully employed in FRET experiments to determine
interactions between TM domain peptides (Fisher, Engelman et al., 1999; Fisher,
Engelman et al., 2003; Li, You et al., 2005; Duneau, Vegh et al., 2007). Since
previous experiments on the Ii TM domain described in the preceding chapters
have revealed the propensity of this sequence to oligomerise in mild detergents
such as DPC, it seemed logical to conduct the FRET experiments using this
detergent. Since it is believed that TM peptides are in fast exchange between
detergent micelles in solution it was assumed that dissolving the donor and
acceptor peptides in buffered DPC solutions prior to mixing to produce the
‘FRET’ sample would yield a FRET signal if the peptides could indeed freely
exchange between micelles enabling energy transfer to occur (assuming that the
peptides interact). As shown in Figure 3.14, mixtures of Ii-Fl and Ii-Rh peptides
separately solubilised in the detergent DPC display a low energy transfer that
fluctuates considerably around a mean value of 7 % as the peptide:micelle molar
ratio is changed. This data indicates that no significant energy transfer is
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occurring. The samples were left for a further three days at room temperature
before taking repeat measurements but no further improvement in signal was
observed. Since other experiments present here suggest Ii can self-associate we
would have expected to observe a FRET signal.
0
2
4
6
8
10
12
14
16
0 1 2 3 4 5 6 7
Peptide:Micelle Ratio
E
n
er
g
y
Tr
an
sf
er
(%
)
Figure 3.14. Exploring preparation of FRET samples in detergent
Energy transfer for mixtures of Ii-Fl and Ii-RH peptides pre-dissolved in DPC buffer solution and
subsequently mixed. The DPC concentration was adjusted to provide varying peptide:micelle
ratios whilst keeping the individual peptide concentration at 2 μM and total concentration at 4 μM.
Energy transfer was calculated as described in Section 2.19.6.
It was considered that the sample preparation method may be restricting the
observation of FRET signal and that the peptides were not rapidly exchanging
between the micelles. To test this hypothesis a sample preparation method was
employed where the peptides and detergent were first co-dissolved in TFE,
followed by lyophilisation to remove the organic solvent and subsequent re-
dissolving of the peptide-detergent film in aqueous buffer. This method had been
used previously in the cross-linking studies shown above. It was believed that this
would allow for the random mixing of the donor and acceptor peptides upon
formation of the micelles thus enabling a FRET signal to be observed.
This method was carried out for Ii-Fl and Ii-Rh peptides. The peptides and DPC
were dissolved in TFE separately and then mixed before removing the solvent and
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reconstituting in aqueous buffer. As shown in Figure 3.15 this co-dissolving
method resulted in observation of a significant FRET signal, as indicated by the
decrease in donor emission at 520 nm and increase in acceptor emission at 570
nm. The experiments were initially carried out at a peptide:micelle molar ratio of
3:1, which was chosen on the basis that oligomers of the Ii TM domain were
observed in cross-linking experiments at this ratio. This data provides further
evidence of the ability of the Ii TM domain to self-associate and indicates that the
co-dissolving method of sample preparation is suitable for FRET analysis.
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Figure 3.15. FRET spectra for Ii samples prepared using co-dissolving
method
FRET analyses of Ii-Fl and Ii-Rh peptides in DPC micelles at a peptide:micelle molar ratio of 3:1.
All samples were prepared using the co-dissolving method where peptides and DPC were first
mixed in TFE prior to lyophilisation and re-suspension in buffer solution. The broken line is the
spectrum given by Ii-Fl, the dotted line is the spectrum observed for Ii-Rh whilst the solid line is
the spectrum for the mixture of Ii-Fl and Ii-Rh. FRET signal is evident from the decrease in the
donor emission at 520 nm and an increase in acceptor emission at 570 nm as indicated by the
arrows.
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3.7.3 Effect of the peptide:micelle molar ratio on the
association of the Ii TM domain
Since it has been shown in this study that the oligomeric state of the Ii TM domain
peptide can be modulated by detergent concentration, the dependency of the
FRET signal on the peptide:micelle molar ratio was explored. FRET samples of
Ii-Fl and Ii-Rh were prepared using the co-dissolving method, and the
peptide:micelle ratio was varied between 20:1 and 1:3 whilst keeping the total
peptide concentration constant. For each ratio, the energy transfer was calculated
as described in Section 2.19.6 and plotted versus the peptide:micelle molar ratio.
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Figure 3.16. Dependency of energy transfer on the peptide:micelle ratio
Total donor and acceptor peptide concentration was kept constant at 4 μM (2 μM Ii-Fl, 2 μM Ii-
Rh) while the detergent concentration was varied. Samples were prepared using the co-dissolving
method by mixing peptide and DPC pre-solubilised in TFE. A CMC of 1 mM was used in
calculations of the peptide:micelle molar ratio. Excitation spectra were collected and energy
transfer was calculated as described in Materials and Methods.
As shown in Figure 3.16, the energy transfer displayed a strong dependency on
the peptide:micelle molar ratio, with the highest energy transfer occurring at
higher ratios and reaching a maximum value of 65%. Since the energy transfer is
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directly related to the formation of oligomers, this indicates a shift in oligomeric
state from monomer to higher order oligomers as the ratio is increased. This is in
keeping with the known effect of detergents upon oligomeric state reported in the
literature and also with the cross-linking data on for Ii TM peptides in this study.
This data has implications for further FRET experiments which can be performed
to identify oligomeric state and thermodynamic properties since these experiments
must be performed at a constant detergent concentration.
3.7.4 Determining specificity of the Ii TM domain interaction
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Figure 3.17. Effect of unlabelled Ii peptide on FRET of Ii-Fl to Ii-Rh
Total donor and acceptor peptide concentration was kept constant at 4 μM (2 μM Ii-Fl, 2 μM Ii-
Rh) while the concentration of unlabelled Ii was varied. Samples were prepared by co-dissolving
all peptides and DPC dissolved in TFE. Experiments were performed at a peptide:micelle ratio of
10:1. The reduced FRET efficiency suggests that sequence-specific oligomerisation contributes to
the measured FRET efficiency.
It has been reported that in order to ascertain if the measured FRET signal for Ii-
Fl and Ii-Rh arises from a specific interaction, and is not due to the peptides
merely occupying the same micelle and thus being in close proximity, it is
necessary to conduct a titration with unlabelled peptide (Fisher, Engelman et al.,
1999). Since this experiment must be carried out at a fixed detergent
concentration the peptide:micelle ratio of 10:1 was chosen on the basis of the
results described in the preceding section, where significant oligomerisation was
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observed at this ratio. The concentrations of Ii-Fl and Ii-Rh peptides were kept
constant whilst varying the concentration of unlabelled Ii peptide. As shown in
Figure 3.17, the energy transfer decreases from ~60% to ~20% with increasing
concentration of unlabelled peptide. This is indicative of the unlabelled peptide
disrupting the formation of donor and acceptor partners.
3.7.5 Determining the oligomeric state of the Ii TM domain
In FRET experiments, the stoichiometry of donors and acceptors generating the
observed FRET signal (and thus the oligomeric state of the complex) can be
determined by measuring the energy transfer as a function of the donor acceptor
ratio whilst keeping the total peptide and detergent concentrations constant
(Veatch and Stryer, 1977). Since it has been shown by cross-linking that the
oligomeric state of Ii TM peptide is modulated by the peptide:micelle molar ratio,
this experiment was performed for Ii TM domain at a range of detergent
concentrations whilst keeping the peptide concentrations constant.
For Ii TM domain, the mole fraction of the acceptor peptide Ii-Rh to donor
peptide Ii-Fl was varied between 0 and 1 whilst keeping the total peptide
concentration constant at 4 μM. The energy transfer was measured and the ratios
of emission at 520 nm in the donor only sample (Q0) to that in the FRET sample
(Q) were calculated. The value of Q0 was normalised to the mole fraction of
donor present in the FRET samples.
The value of Q/Q0 for varying peptide:micelle molar ratios is plotted in Figure
3.18, as are the predicted lines for various oligomeric states calculated according
to Equation 5 in Section 2.19.6. At a ratio of 1:3 (Figure 3.18a) the data does not
fit well to any of the proposed models, and is therefore difficult to interpret but
could suggest Ii is primarily monomeric since there is no significant effect on
Q/Q0 with increasing acceptor. At a ratio of 2:1 (Figure 3.18b) the data fits best to
trimer and tetramer with reduced CHI2 values of 2.41 and 2.27, respectively, and
FRET efficiency values of 53 % and 48 %, respectively. At a ratio of 4:1 (Figure
3.18c) the data fits best to trimer with a reduced CHI2 value of 1.25 and a FRET
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efficiency value of 50 %. At a ratio of 10:1 (Figure 3.18c) the data fits best to
tetramer with CHI2 value of 8.75 and a FRET efficiency of 66 %.
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Figure 3.18. Determining oligomeric state of Ii TM domain association
Stoichiometry of Ii-Fl and Ii-Rh association in DPC detergent at peptide:micelle ratios of (a) 1:3
(b) 2:1 (c) 4:1 (d) 10:1. The energy transfer was measured and the ratios of emission at 520 nm in
the donor only sample (Q0) to that in the FRET sample (Q) were calculated. The value of Q0 was
normalised to the mole fraction of donor present in the FRET samples. The ratio of Ii-Fl to Ii-Rh
was varied between 0.2 and 1.0 whilst keeping the total peptide concentration constant at 4 μM
and the peptide: Calculated curves for monomer (solid), dimer (dotted), trimer (broken), and
tetramer (broken dotted) are shown and were calculated using Equation 5 as described in Section
2.19.6. The goodness-of-fit for the experimental data to the calculated curves was determined
using a standard reduced CHI2 curve fitting procedure.
These data strongly suggest that the Ii TM domain has a propensity to oligomerise
in DPC micelles and to adopt an oligomeric state that is detergent concentration
dependent. Interestingly, the FRET data suggests Ii TM domain adopts a trimeric
oligomeric state along with a tetrameric state. Notably, there are issues with the
reproducibility of the methodology leading to significant errors and outliers in the
data sets which confound the issue of conclusively assigning an oligomeric state,
(a) (b)
(c) (d)
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although this problem can be negated to some extent through the use of statistical
analysis such as CHI2 curve fitting as used in this study.
3.7.6 FRET analysis of Ii TM domain self-association in lipid
bilayers
Although detergent micelles are widely used and are convenient for analysing TM
domain interactions, they can be considered to be poor membrane mimetics due to
their high degree of curvature relative to planar bilayers. The forces applied to the
peptides by this curvature may disrupt the native folding. Lipid vesicles or
liposomes possessing a bilayer similar to a native membrane can be formed from
lipid molecules. It has been reported that FRET analysis can be performed on
peptides in such systems (Merzlyakov, You et al., 2006). The use of lipids is
therefore a natural progression from our studies performed in detergent micelles.
FRET analyses in lipid vesicles was performed after reconstituting the Ii-Fl and Ii-
Rh peptides into multilamellar vesicles (MLVs) composed of DMPC lipids as
described in Section 2.14. As shown in Figure 3.19, a possible FRET signal was
observed between Ii-Fl and Ii-Rh peptides as indicated by the decrease in
emission of the donor signal. However, the acceptor showed only a minimal
increase in emission. This suggests that the Ii TM peptides are self-associating in
these artificial bilayers, but is not conclusive due to the lack of a concomitant
increase in the emission of the acceptor. Further work will need to be performed
to discern if this is a real FRET signal. An improvement to the method may be the
formation of unilamellar vesicles by extrusion of the MLVs, which will place all
peptides in the same membrane and allow greater self association, since in the
MLVs the peptides may be distributed unevenly between the many bilayers
forming the MLV.
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Figure 3.19. FRET analysis of Ii TM domain association in lipid bilayers.
Fluorescence emission spectra of fluorescein (Fl) and rhodamine (Rh) labelled Ii TM peptides in
DMPC vesicles. Continuous line 0.1 mol% Ii-Fl and 0.1 .mol% Ii-Rh. Broken line 0.1 mol% Ii-Fl.
Dotted line 0.1 mol% Ii-Rh. Labelling yield was fd= 1.0 and fa = 0.9 for the donor and acceptor,
respectively. The total peptide concentration was 0.25 mol%. In the experiments, labelled peptides
were co-dissolved with DMPC lipids in TFE. The solvent was evaporated, and the samples were
hydrated and freeze-thawed four times to achieve equilibrium, as described in methods. The
excitation wavelength was fixed at 439 nm, such that only the Fl was directly excited whilst the
emission was scanned from 450 to 650 nm. The FRET efficiency was calculated from the decrease
in Fl fluorescence at 520 nm (equation 1). (a) 1 mg/mL (b) 0.25 mg/mL
(a)
(b)
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3.8 Observing insertion of Ii TM peptide into lipid
bilayers using Oriented CD
For peptides solubilised in detergent micelles we expect that the detergent
monomers aggregate in a ‘donut-like’ manner shielding the hydrophobic region of
the peptides from the aqueous environment, so the orientation of the TM in the
micelle is of little consequence (le Maire, Champeil et al., 2000). However, for
studies carried out in liposomes, such as the FRET experiment just described, the
orientation is of considerable importance so it must be established that the
peptides are inserted perpendicular to the membrane normal i.e. that the peptides
are membrane spanning and not simply associated with the membrane surface.
The use of oriented CD (OCD) has been reported in the literature as an
appropriate technique for confirming the insertion of TM peptides in lipid bilayers
(You, Li et al., 2005). It has been shown that the OCD spectra of helices that are
parallel and perpendicular to the plane of the bilayer are significantly different
(Wu, Huang et al., 1990). For helices oriented parallel to the plane of the bilayer
the OCD spectra have two minima at 205 and 225 nm and a maximum at around
192 nm. However, helices that are perpendicular to the plane (i.e. span the
membrane) display a minima and maxima at around 230 and 200 nm,
respectively. This results from the π → π* transition component at ~208 nm being
polarised parallel to the helical axis. Thus, light propagating at an angle
perpendicular to the lipid bilayer but parallel to the axis of the helix is not
absorbed eliminating the 205 nm minima.
This technique was employed to analyse the insertion of Ii TM peptide in DMPC
bilayers. A solution of lipid and peptide in TFE was deposited on a quartz slide
generating a multilamellar film consisting of aligned lipid bilayers. The slide was
placed into the spectropolarimeter such that the incident light propagates
perpendicular to the film. A lack of sample homogeneity can be averaged out by
rotating the sample through 360°, and acquiring CD spectra at 45° increments.
Spectra were then averaged and baseline corrected to give the OCD spectrum
shown in Figure 3.20a. The CD spectra of Ii-Fl and Ii-Rh in DMPC bilayers are
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shown in Figure 3.20b, and display the two minima at 208 and 222 nm
characteristic of an α-helical peptide. Comparison of the OCD and CD spectra
reveal the lack of a 208 nm minima in the OCD spectra which indicates that the
peptide is inserted in the lipid bilayer.
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Figure 3.20. Oriented CD and CD spectra of Ii in DMPC liposomes
(a) Oriented Circular Dichroism spectrum of Ii TM domain in oriented DMPC bilayers. The
samples were oriented multilayers on a quartz slide, deposited from the organic solvent, TFE. The
multilayers were placed in the spectropolarimeter perpendicular to the optical path. The sample
was rotated in increments of 45°, and spectra were collected and averaged. This spectrum is
indicative of a helix that is spanning a membrane. (b) CD spectrum of Ii-Fl (solid line) and Ii-Rh
(broken line) in DMPC lipid bilayers.
M
R
E
(m
d
eg
cm
2
dm
ol
-1
)
(a)
(b)
W elength (nm)
Chapter 3. TM domain interactions of Invariant Chain
70
3.9 Conclusions on self-association of Ii TM domain
The full length Ii protein is known to be trimeric and previous studies on the TM
domain of Ii in isolation suggest it too can oligomerise to form a strongly
interacting trimer (Dixon, Stanley et al., 2006). In order to progress to studying
the interactions of the Ii TM domain with the TM domains of MHC, we sought to
confirm the self-association of Ii and its oligomeric state in addition to using this
protein as a test-bed for developing methodologies.
Use of the in vivo assay GALLEX confirmed that Ii self-associates, corroborating
reported results with the alternative assay TOXCAT. An advantage of the
GALLEX assay over the TOXCAT assay is that it allows hetero-association of
TM domains to be explored. Therefore, the plasmid constructs created for the
studies in this section can be further utilised for exploring hetero-association
between the TM domain of Ii and those of MHCαand MHCβ.
A peptide corresponding to TM domain of Ii was synthesised and purified for in
vitro studies. Ii TM domain does not form SDS stable oligomers, therefore it was
necessary to use cross-linking in conjunction with SDS PAGE to analyse the
oligomeric state. The cross-linking results show that this peptide is capable of
assembling to form a range higher order oligomeric states with dimer being the
most abundant. The lack of a specific oligomeric state for Ii TM peptide is in
conflict with the literature where a specific trimeric oligomer was observed
(Dixon, Stanley et al., 2006). Interestingly, in the previous study the sequence
contained only one lysine residue providing only one cross-linkable group.
This lead to a question of how a trimer may be cross-linked if this is the case? A
further Ii peptide was designed with additional K residues at the N- and C-termini.
Cross-linking of this peptide reveals the same pattern with increased dimer
formation. Therefore from cross-linking results we conclude that it was not
possible to establish a dominant oligomeric state for Ii TM domain only that it can
self-assemble. Furthermore, this study shows using cross-linking that the
detergent concentration or more specifically the peptide:micelle ratio is a strong
determinant of the observed oligomeric state. This is the first time that this has
been shown for Ii. The ratios presented here represent relatively small changes in
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detergent concentration highlighting the importance for careful sample
preparation.
Using CD spectroscopy this study reveals that the peptide:micelle ratio as well as
affecting the oligomeric state also affects the secondary structure of Ii TM
peptide. This is not something that has been widely reported in the literature and
indeed for the well characterised TM domain of GpA the detergent concentration
was found to modulate only its oligomeric state and not its helicity.
The use of fluorophore labelled Ii TM peptides provided a test case for developing
the FRET assays that will be used later in the study of hetero-association. From a
technical aspect there were concerns about adding a large hydrophobic group in
the form of the fluorophore to an already very hydrophobic peptide sequence and
the impact this would have upon purification. Using RP-HPLC and standard
methods a 100% level of purity for Ii-Fl was obtained whilst Ii-Rh labelled
peptide contained around 10% unlabelled peptide. The FRET analyses showed
that the Ii TM domain is capable of homo-oligomerisation and that the energy
transfer and oligomeric state were dependent on the peptide:micelle ratio further
testifying to the importance of this parameter in the study of these domains. The
oligomeric state of the peptide was explored using FRET analyses, and suggested
that the Ii TM peptide could self-assemble to form trimeric and/or tetrameric
states depending on the detergent concentration in the form of the peptide:micelle
molar ratio. However, it is important to note that the results from the FRET
experiments do display significant variation which hinders the assignment of a
specific oligomeric state to the TM domain of Ii.
In summary, there is some evidence from this study that in isolation the TM
domain of Ii indeed self assembles to form a homo-trimer, as has been reported in
the literature (Dixon, Stanley et al., 2006). However, FRET and cross-linking
analyses suggest it also assembles into additional oligomeric states (i.e. tetramer
and higher), with the relative proportions of which are highly dependent on the
detergent concentrations in the form of the peptide:micelle ratio. One explanation
for the problem of assigning a definitive oligomeric state to the TM domain of Ii
may be because that the helix-helix interactions are mediated by H-bonds. H-
bonding between TM helices is thought to have weak specificity relative to Van
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der Waals interactions and are believed to trigger non-specific aggregation
(White, 2006). It has been proposed that van der Waals interactions in close
packing helices are the main determinants for TM helix association and that H-
bonds serve to stabilize a preformed oligomer (Schneider, 2004). If this is the case
then it suggests that although Ii TM domain can self-associate it is not the driving
force behind assembly of the full-length Ii trimer and instead plays a secondary
role to that of the luminal trimerisation domain.
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4 TM domain interactions of MHC
Class IIαand βchains
4.1 Introduction and objectives
As discussed in Section 1.3.1, Major Histocompatibility Complex Class II
proteins (MHC) are heterodimeric membrane proteins composed of non-
covalently linkedαandβchains. MHC present peptides derived from an invading
pathogen to T cells, triggering an immune response to that pathogen. The crystal
structure of the soluble extracellular domain of MHC (HLA-DR1) has been
solved confirming it can oligomerise to form dimers which can also associate to
form tetramers (Stern, Brown et al., 1994; Schafer, Malapati et al., 1998). MHCα-
and β-chains are known to bind to the MHC Class II associated Invariant Chain
(Ii) through an interaction mediated by their respective soluble domains.
However, the TM domains of MHC and Ii have also been implicated in this
association (Ashman and Miller, 1999; Castellino, Han et al., 2001; Barabanova,
Kang et al., 2004). This section describes the results from studies into the self-
and hetero-associations of the TM domains of theα- and β-chains of MHC. The
objectives of the work presented in this chapter are to determine if the TM
domains ofα(MHCα) andβ(MHCβ) can self-associate to form homo-oligomers,
if they can associate with one another to form hetero-oligomers; and should they
display helix-helix interactions, identify the residues involved.
4.2 MHC TM domains display conserved
dimerisation motifs
As discussed in Section 1.2.1, TM domains have been found to display sequence
motifs that are indicative of helix-helix interactions. Therefore, multiple sequence
alignments of the putative TM domains of MHCαand MHCβwere performed
using ClustalW2 (Larkin, Blackshields et al., 2007), to identify conserved
residues, which would suggest these residues are functionally important. As
shown in Figure 4.1, MHCαand MHCβwere found to contain highly conserved
small-xxx-small transmembrane motifs. In the case of MHCαthe small residue is
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either Gly or Ala whilst for MHCβit is predominantly Gly. As discussed in
Section 1.2.1, this motif is an important structural feature that can stabilise helix-
helix interactions in TM domains. It is therefore possible that this conserved motif
may play a role in mediating TM helix-helix interactions in the MHC Class II-Ii
complex.
Figure 4.1. Conservation of GxxxG motifs in the TM domains of MHCαand
MHCβ
Sequence alignments of the predicted TM domains of (a) 13 MHC Class IIα-chain transmembrane
domains and (b) nine MHC Class II β-chain transmembrane domains. The TM domains are both
highly conserved as are two small-xxx-small motifs (boxed) in MHCαand a single GxxxG motif
(boxed) in MHCβ. Alignments were generated using ClustalW2 (Larkin, Blackshields et al.,
2007).
The propensity for human MHCαand MHCβto self-associate to form homo-
dimers was explored using molecular dynamics simulations with the program CHI
(Adams, Arkin et al., 1995; Adams, Engelman et al., 1996). As shown in Figure
4.2a, this resulted in an energy minimised model for an MHCαhomo-dimer where
the two GxxxG motifs pack at the interface between the dimer. Similarly, as
shown Figure 4.2b, in this analysis resulted in a model for MHCβhomo-dimers
where the single GxxxG motif was also packing at the interface of the dimer.
(a)
(b)
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These data are the first suggestion that the TM domains of MHCαand MHCβare
capable of self-association to form homo-dimers and implicate the GxxxG motifs
in stabilising that interaction. The biological relevance of this observation is not
known since homo-oligomers have not as yet been observed in the full length
proteins of either MHCαor MHCβ. A tentative explanation is that they could
mediate the formation of inactive oligomers or serve to streamline the process of
multiple chains associating with Ii.
Figure 4.2. Models of homo and hetero-dimers of MHC α/βTM domains
Molecular simulations for homo-dimers of (a) MHCα, (b) MHCβand a hetero-dimer of (c) MHCα
and MHCβTM domains generated using CHI software (See Section 2.16). Simulated annealing
predicted that the dimers are stabilised by packing of the GxxxG motifs (shown in yellow).
Since the full lengthαandβchains of MHC are known to associate through non-
covalent interactions between their soluble domains, the propensity for the TM
domains of these two proteins to self-associate and further stabilise hetero-
dimers was explored using molecular dynamics studies. As shown in Figure 4.2c,
this analysis revealed a model for the MHCαand MHCβhetero-dimer where the
second GxxxG motif of MHCαis packing with the GxxxG motif of MHCβat the
dimer interface. These data, therefore predict that the TM domains ofαandβmay
be able to associate with one another to form hetero-dimers, and that the GxxxG
motifs may also be important for stabilising that interaction. These data are of
(a) (b) (c)MHCα MHCβ MHCβ-MHCα
G225
G229
G232
G236
G233
G237
G233
G237
G232
G236
G229
G225
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course in vacuo simulations that will require corroboration from experimental
data, but they do provide an important rationale for experimental mutagenesis
studies.
4.3 In vivo assays reveal self-association of TM
domains ofα- andβ- chains of MHC
In order to test the hypothesis that MHCαand MHCβare able to self-associate,
the TOXCAT assay was used. This in vivo assay enables monitoring of the
association of TM domains within the inner membrane of E. coli via expression of
the reporter gene CAT, as described in more detail in Section 2.17, and presented
again in Figure 4.3.
Figure 4.3. Principle of the TOXCAT assay
The TOXCAT assay is used to monitor self-association of α-helical TM domains. A chimeric
protein is constructed of Maltose Binding Protein (MalE), the transmembrane domain (TM) of
interest and the ToxR promoter. ToxR is a functional dimer that is incapable of dimerizing alone.
Interactions between TMDs drive dimerisation of ToxR, which binds the ctx promoter activating
transcription of the reporter gene Chloramphenicol Acyltransferase (CAT).
The amino acid sequences for the putative human MHCαand MHCβproteins
were cloned into the vector pccKan, as described in Section 2.17.2. The dimeric
TM domain of GpA is used as a positive control for association whilst the G83I
mutant of GpA which impairs association is used as a negative control. As shown
in Figure 4.4, the level of CAT activity is comparable to the positive control for
both MHCα and MHCβ suggesting these TM domains are strongly self-
ctx
Reporter gene (CAT)
ToxR
MBP
Plasma
MembraneTM
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associating within the E. coli inner membrane. This is the first time that the self-
association of the MHC TM domains has been observed and substantiates the
predictions from both the presence of a GxxxG motif and the molecular dynamics
studies.
MHCα T219VVCALGLSVGLVGIVVGTIFIIQGL244
MHCαG225LG229L T219VVCALLLSVLLVGIVVGTIFIIQGL244
MHCαG232LG236L T219VVCALGLSVGLVLIVVLTIFIIQGL244
MHCβ M227LSGIGGCVLGVIFLGLGLFI247
MHCβG233LG237L M227LSGIGLCVLLVIFLGLGLFI247
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Figure 4.4. Monitoring the self-association of MHCαand MHCβ
Self-association of TM domains was monitored using the TOXCAT assay. (a) Amino acid
sequences for the predicted TM domains of Human MHC α(MHC) and β(MHC) chains, and
the GxxxG double mutants, cloned into the plasmid pccKan. (b) Self-association was monitored
via activity of the CAT reported gene with higher values indicating association. GpA and the
dimerisation deficient mutant of GpA, G83I, act as positive and negative controls respectively.
Error bars represent the standard error from three separate measurements. (c) Western blot from
showing expression levels of the constructs. Molecular weight markers in kDa are shown to the
left of each blot. (1 and 5) GpA, (2 and 6) G83I, (3) MHCα(4) MHCβ(7) MHCαG225LG229L
(8) MHCαG232LG236L (9) MHCβG233LG237L.
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Molecular dynamics simulations predicted that the GxxxG motifs of MHCαand
MHCβmay play a role in stabilising the self association. To determine if this is
the case, mutagenesis of the wild type sequences was performed. Double mutants
were produced where the two Gly residues of the GxxxG motifs were replaced
with Leu residues. It was hypothesised that the increased steric hindrance from the
presence of a bulkier side chain at these positions would disrupt the self
association. The TOXCAT assay was used to monitor the association of these
double mutants. As shown in Figure 4.4, the mutation MHCαG225LG229L had little
effect on the self-association of MHCα, whilst the mutation MHCαG232LG236L
significantly reduced the self association implicating these residues as being
situated at the interface of the oligomer. In contrast, the mutation of the GxxxG
contained within MHCβdid not result in a loss of oligomerisation, suggesting that
this motif is not involved in the self assembly of this TM domain. Therefore, these
data suggest a role for GxxxG motifs in the self-association of MHCαbut not that
of MHCβ, and lend further evidence to the significance of this motif in stabilising
the self-association of TM domains.
4.4 In vivo evidence for the hetero-association ofα
andβTM domains
After establishing the propensity for MHCαand MHCβto self-associate using the
TOXCAT assay we sought to determine if these two TM domains could interact
with each other (i.e. can they form hetero-oligomers). This measurement can be
achieved in vivo by the use of the GALLEX assay, the principle of which is
described in Section 2.18.1. In order to progress to monitoring hetero-association
with this assay, it was first necessary to determine if self association could be
monitored by this method, and thus in the process confirm the efficacy of this
assay.
Oligonucleotide inserts encoding the amino acid sequences for MHCαand MHCβ
were designed and cloned into the pBLM100 plasmid and transformed into the
host strain E. coli SU101, as described in the Section 2.18.2. Initial experiments
were performed with the same amino acid sequence length as was used in the
TOXCAT assay in Section 4.3. As shown in Figure 4.5, the MHCαsequence with
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length 26 (MHCα26) and the MHCβsequence with length 21 (MHCβ21) did not
repress β-galactosidase activity, giving results greater than the negative control.
This indicates that these sequences of MHCαand MHCβare not self-associating
and contradicts the findings from the TOXCAT assay (see Figure 4.4).
It was hypothesised that the discrepancy between the results from the GALLEX
and TOXCAT assays may be due to the length of theα-helices incorporated into
the chimera. The crossing angle of the helices and their length may be such that
the LexA domains are held apart by the interacting TM domains thus preventing
LexA dimerisation and leading to a false negative result. To determine if this was
the case for MHCαand MHCβ, the length of the TM domain sequence was
varied. In each case the length was varied in order to maintain a centralised
location for the GxxxG motifs in the sequence. This was because it has been noted
that the strength of the interaction is dependent on the position of the GxxxG
motif (Johnson, Rath et al., 2006). As shown in Figure 4.5b, the repression of β-
galactosidase activity displays a strong dependency on the length of the sequence
studied with TM lengths of between 16 and 19 residues for both MHCαand
MHCβ repressing β-galactosidase expression. The results therefore indicate
MHCαand MHCβTM domains are interacting in E.coli membranes. This result
would seem to indicate that there is a critical sequence length for the TM insert,
above which any TM interactions can not be observed. Therefore after, sequence
length optimisation therefore, the results for the self-association of MHCαand
MHCβTM domains were found to be consistent between the TOXCAT and
GALLEX assays. The propensity for the self-association of MHCαand MHCβ
TM domains within a native membrane has therefore been substantiated by two in
vivo assays.
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MHCα26 T219VVCALGLSVGLVGIVVGTVFIIQGL244
MHCα19 A223LGLSVGLVGIVVGTVFII241
MHCα18 A223LGLSVGLVGIVVGTVFI240
MHCα17 A223LGLSVGLVGIVVGTVF239
MHCα16 A223LGLSVGLVGIVVGTV238
MHCβ21 M227LSGVGGFVLGVIFLGAGLFI247
MHCβ19 M227LSGVGGFVLGVIFLGAGL245
MHCβ18 M227LSGVGGFVLGVIFLGAG244
MHCβ17 M227LSGVGGFVLGVIFLGA243
MHCβ16 M227LSGVGGFVLGVIFLG242
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Figure 4.5. Self-association of MHCαand MHCβTM domains in GALLEX
assay
Self-association of MHCαand MHCβTM domains was monitored using the GALLEX assay, as
described in the text (a) Amino acid sequence of the human MHCαand MHCβTM domains
cloned into pBLM100 and subsequently transformed into E.coli strain SU101 as described in
Section 2.18.2 (b) β-galactosidase activity mediated by the oligomerisation propensity of the
expressed constructs in E.coli SU101. Repression of activity is indicative of association of the TM
domains. Error bars represent the standard error from three independent measurements. Expression
of the chimeric proteins was induced by the addition of 1 mM IPTG. Details of theβ-galactosidase
assay and the calculation of Miller Units are described in the Section 2.18.3. All plasmids and E.
coli strains were kindly proved by Dr Schneider. GpA and the dimerisation deficient mutant of
GpA, G83I, act as positive and negative controls respectively. Data were normalised to GpA (c)
Test for insertion and orientation of the expressed chimera. Western blot analysis of E.coli
extracts: WC, whole cell; PF, periplasmic fraction; SF, spheroplast fraction; SP, spheroplast
proteolysis; BS, broken spheroplast proteolysis. The expressed chimeric proteins with a molecular
mass of 54 kDa are found solely in the inner membrane fraction and correctly oriented in the
membrane.
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As discussed in Section 4.3, it was found using the TOXCAT assay that the C-
terminal GxxxG motif of the MHCαTM domain played a role in its self-
association and that the same motif in MHCβdid not. In order to confirm that this
effect could still be observed with the optimised sequences used in the GALLEX
assay, this mutagenesis study was repeated. As shown in Figure 4.6b, the mutation
MHCαG225LG229L had no effect on the self-association of this TM domain, whilst
MHCαG232LG236L reduced its self-association to the level of the negative control
GpAG83I. These results corroborate those from the TOXCAT assay and lend
further support to the significance of the GxxxG motif in this interaction.
However, contrary to what was observed using the TOXCAT assay (see Figure
4.4), the GALLEX assay indicates that the G233LG237L mutation of MHCβdoes
cause a moderate but significant decrease in self-association of MHCβ(Figure
4.6b) The decrease is not as large as that observed for the MHCαG232LG236L mutant,
but would suggest that the GxxxG motif in MHCmay play a role in self-
association. The cause for the discrepancy between these two assays is unknown,
but may be related to the sensitivity of the GALLEX assay to the length of the TM
domain, which required a shorter sequence for GALLEX measurements.
As discussed in Section 2.18.1, the GALLEX assay was predominantly developed
to enable determination of hetero-association between α-helical TM domains.
Since the full length MHC is known to be a hetero-dimer we therefore used the
GALLEX assay to determine the propensity for the MHCαand MHCβsequences
to associate with each other and form hetero-oligomers. As shown in Figure 4.7,
a β-galactosidase activity was observed that is comparable to that of the positive
control GpA for MHCαand MHCβ, suggesting they associate within the inner
membrane of E.coli. This is the first data to demonstrate association between the
TM domains ofα- andβ-chains of MHC.
Mutagenesis of the GxxxG motifs was performed and the effect on the association
of MHCαand MHCβmonitored by the GALLEX assay. As shown in Figure 4.7,
the mutation of the second GxxxG motif in MHCα(MHCαG232LG236L) significantly
reduced the association of MHCαand MHCβ. This effect was also apparent when
the GxxxG in MHCβwas mutated (MHCβG233LG237L) although to a less extent.
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The mutation of the first GxxxG in MHCα(MHCαG225LG229L) did not affect the
hetero-association of MHCαand MHCβ. These data are in agreement the findings
from molecular modelling where the G232G236 motif in MHCαwas shown to
pack with the G233G237 motif in MHCβ. These findings therefore strongly
implicate the GxxxG motif as stabilising heterodimer formation of in the TM
domain of theα- andβ-chains of MHC.
MHCαG225LG229L A223LLLSVLLVGIVVGTIFII241
MHCαG232LG236L A223LGLSVGLVLIVVLTIFII241
MHCβG233LG237L M227LSGVGLFVLLVIFLGAGL245
0
1
2
3
4
5
6
7
8
Gp
A
G8
3I
Transmembrane Domain
N
o
rm
al
is
ed
β-
G
al
.A
ct
iv
it
y
(M
ill
er
U
n
its
)
pBLM MHCαG225G229L
WC PF SF SP BS
38
49
62
pBLM MHCαG232LG236L
WC PF SF SP BS
38
49
62
pBLM MHCβG233LG237L
WC PF SF SP BS
38
49
62
Figure 4.6. Self-association of mutated MHCαand MHCβTM domains in
GALLEX assay
Self-association of MHCαand MHCβTM domains. (a) Sequences of the human MHCαand
MHCβTM domains cloned into pBLM100 as described in methods. Positions of the GxxxG
motifs are indicated. (b) The propensity for the TM domains to self-associate was measured with
the GALLEX assay (Schneider and Engelman, 2003). Internal standards of human GpA (very
strong interaction producing minimal β-galactosidase activity) and G83I (mutant of GpA that
shows minimal interaction producing a high β-galactosidase activity). Data were normalised to
GpA (c) Test for insertion and orientation of the expressed chimera. Western blot analysis of
E.coli extracts: WC, whole cell; PF, periplasmic fraction; SF, spheroplast fraction; SP, spheroplast
proteolysis; BS, broken spheroplast proteolysis. The error bars represent the standard error from
three separate measurements.
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MHCα A223LGLSVGLVGIVVGTVFII241
MHCβ M227LSGVGGFVLGVIFLGAGL245
MHCαG225LG229L A223LLLSVLLVGIVVGTIFII241
MHCαG232LG236L A223LGLSVGLVLIVVLTIFII241
MHCβG233LG237L M227LSGVGLFVLLVIFLGAGL245
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Figure 4.7. Hetero-association of MHCαand MHCβTM domains
Monitoring hetero-association of MHCαand MHCβTM domains using the GALLEX assay. (a)
Sequences of the human MHCαand MHCβTM domains cloned into pALM100 and pBLM100
respectively and transformed together into E.coli SU202, as described in Section 2.18.2. (b)
Measurement of β-galactosidase activity. Internal standards of human GpA (very strong
interaction producing minimal β-galactosidase activity) and G83I (mutant of GpA that shows
minimal interaction producing a high β-galactosidase activity). Data were normalised to GpA. (c)
Test for insertion and orientation of the expressed chimera. Western blot analysis of E.coli
extracts: WC, whole cell; PF, periplasmic fraction; SF, spheroplast fraction; SP, spheroplast
proteolysis; BS, broken spheroplast proteolysis. The error bars represent the standard error from
three individual measurements.
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4.5 Synthesis and purification of MHC TM domain
analogues
In Section 4.4, the results from in vivo assays suggested that the α-helical TM
domains MHCαand MHCβhave a propensity to self-associate to form homo-
oligomers and to associate with one another to form hetero-oligomers, via well
known GxxxG interaction. In order to confirm that these motifs oligomers
represent helix-helix interactions, and determine the possible oligomeric states
these domains could adopt in those oligomers, a strategy of studying model
peptides that are derived from the TM domains of the α- and β-chains of MHC
was employed.
As was discussed for studies of Ii in Chapter 3, the approach of studying peptide
analogs has in recent years been useful in discerning the helix-helix interactions of
TM domains. Model peptides for MHCαand MHCβwere synthesised at the Keck
Facility (Yale University, USA), using the amino acid sequences given in Table
4.1 and purified by RP-HPLC as described in Section 2.10. Additionally, two
further peptides, MHCα-Fl and MHCβ-Rh, were synthesised that were
differentially labelled at the N-termini with the fluorophores fluorescein and
rhodamine, respectively, for use in subsequent FRET experiments to study the
hetero-association of these peptides.
Name Sequence Mass
(Da)
MHCα KELTETVVCALGLSVGLVGIVVGTVFIIRGLRSWK 3757.55
MHCβ KSESAQSKMLSGVGGFVLGVIFLGAGLFIYFRNQK 3791.72
MHCα-Fl Fl-KELTETVVCALGLSVGLVGIVVGTVFIIRGLRSWK 4072.2
MHCβ-Rh Rh-KSESAQSKMLSGVGGFVLGVIFLGAGLFIYFRNQK 4165.64
Table 4.1. TM domain sequences and labels used in the MHCα-MHCβFRET
assay
Peptides were synthesised at the Keck Facility (Yale University, USA). MHCα-Fl and MHCβ-Rh
were synthetic peptides produced for use in FRET studies and were labelled at the N-term with the
fluorophores fluorescein (Fl) and rhodamine (Rh), respectively. Labelling was performed at the
time of synthesis. Underlined residues indicate the extent of the predicted transmembrane domain.
K residues were added to the sequences to aid purification and for cross-linking purposes. Peptides
were supplied as crude product from the synthesis and purified by RP-HPLC. Expected masses
were used to identify fractions of pure Ii peptides during RP-HPLC purification.
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In brief, purification of MHCαwas achieved by solubilisation of the crude peptide
in formic acid and HFIP, followed by purification on a reverse phase C4 column.
The peptide was eluted using a solvent gradient that consisted of water and a
mixture of isopropanol and ACN as the mobile phase. A typical RP-HPLC
chromatogram for MHCαis shown in Figure 4.8a, and the fraction containing the
MHCαpeptide is indicated. It is likely that the separation could be improved and
the peptide yield increased by the use of a more hydrophobic column, however
this equipment was not available for testing. Typically, eight runs of RP-HPLC
purification were performed and the purity of the fractions confirmed by MALDI
mass spectrometry, as described in Section 2.11. Pure fractions were pooled and
lyophilised. As shown in Figure 4.8a, the MALDI mass spectrum of the pooled
fractions reveals the major component is the MHCαpeptide with a mass of 3756
Da which corresponds to the H+ ionisation state.
The purification of MHCβby RP-HPLC was optimised as detailed in Section
2.10.2. Typically, 8 runs of RP-HPLC purification were performed and fractions
checked by mass spectrometry. A typical chromatogram MHCβis shown in
Figure 4.9a, with the fraction containing the MHCβpeptide indicated. As shown
in Figure 4.9b, the mass spectrum of the pooled fractions reveals the major
component is the MHCβpeptide with a mass of 4209 Da which corresponds to the
H+ ionisation state.
The purification of the fluorophore labelled peptides MHCα-Fl and MHCβ-Rh
were carried out according to the protocols developed for the purification of their
unlabelled counterparts. For MHCα-Fl, a typical RP-HPLC chromatogram and
mass spectrum of the purification product are shown in Figure 4.10. The presence
of the unlabelled peptide can be detected in the mass spectrum indicating that the
purity of MHCα-Fl is not 100%. This is due to the fluorophore not significantly
altering the hydrophobicity of this peptide relative the unlabelled peptide, thus
100% separation is difficult to achieve.
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Figure 4.8. RP-HPLC purification of MHCαpeptide
(a) The MHCαpeptide was purified by reverse phase HPLC (solid line) using a Isopropanol
(IPA)/Acetonitrile (ACN) gradient (broken line) and H2O as the second solvent, on a Phenomenex
Jupiter C4 column (Phenomenex, UK). 0.1% TFA was present in both solvents. Elution of
fractions was monitored by the absorbance at 280 nm. The peak generated by the elution of the
MHCαpeptide is indicated. (b) Purity of pooled fractions from reverse-phase HPLC purification
of MHCαpeptide was analysed using MALDI mass spectrometry. The major peak with a mass of
3756 Da corresponds to the expected mass for MHCαpeptide.
(a)
(b)
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Figure 4.9. RP-HPLC purification of MHCβpeptide
(a) The MHCβpeptide was purified by reverse phase HPLC (solid line) using a Acetonitrile
(ACN) gradient (broken line) and H2O as the second solvent, on a Phenomenex Jupiter C4 column
(Phenomenex, UK). 0.1% TFA was present in both solvents. Elution of fractions was monitored
by the absorbance at 280 nm. The peak generated by the elution of the MHCβpeptide is indicated.
(b) Purity of pooled fractions from reverse-phase HPLC purification of MHCβpeptide was
analysed using MALDI mass spectrometry. The major peak with a mass of 3792 Da corresponds
to the expected mass for MHCβpeptide.
(a)
(b)
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Figure 4.10. RP-HPLC purification of MHCα-Fl peptide
(a) The MHCα-Fl peptide was purified by reverse phase HPLC (solid line) using a isopropanol
(ACN) gradient (broken line) and H2O as the second solvent, on a Phenomenex Jupiter C4 column
(Phenomenex, UK). 0.1% TFA was present in both solvents. Elution of fractions was monitored
by the absorbance at 280 nm. The peak generated by the elution of the MHCα-Fl peptide is
indicated. (b) Purity of pooled fractions from reverse-phase HPLC purification of MHCα-Fl
peptide was analysed using MALDI mass spectrometry. The major peak with a mass of 4072 Da
corresponds to the expected mass for MHCα-Fl peptide.
(a)
(b)
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Figure 4.11. RP-HPLC purification of MHCβ-Rh peptide
(a) The MHCβ-Rh peptide was purified by reverse phase HPLC (solid line) using a Acetonitrile
(ACN) gradient (broken line) and H2O as the second solvent, on a Phenomenex Jupiter C4 column
(Phenomenex, UK). 0.1% TFA was present in both solvents. Elution of fractions was monitored
by the absorbance at 280 nm. The peak generated by the elution of the MHCβ-Rh peptide is
indicated. (b) Purity of pooled fractions from reverse-phase HPLC purification of MHCβ-Rh
peptide was analysed using MALDI mass spectrometry. The major peak with a mass of 4162 Da
corresponds to the expected mass for MHCβ-Rh peptide.
(a)
(b)
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4.6 Secondary structure of peptide analogues of α
andβTM domains
Since the amino acid sequences of the model peptides MHCα and MHCβ
correspond to the predicted α-helical TM domains of the respective full length α
and βproteins, it was necessary to characterise their secondary structure to
confirm they were α-helical, which is most readily achieved by using circular
dichroism (CD). CD spectra were acquired for both the MHCαand MHCβ
peptides at a range of peptide:micelle molar ratios since it had been shown
previously for the Ii peptide (see Section 3.4) that this ratio could impact upon the
secondary structure of TM peptide analogues.
As shown in Figure 4.12a, for MHCα, minima were observed at 208 and 222 nm
for all ratios, indicating the presence of α-helical content in the secondary
structure. The CD spectra showed a dependency on the peptide:micelle ratio. As
shown in Figure 4.12c, analysis of the CD spectra using the program CDSSTR
(Johnson, 1999) revealed that the percentage of α-helix increases as the
peptide:micelle ratio is decreased (i.e. detergent concentration is increased), and
rises to a maximum of ~40 % α-helix at a ratio of 1:5. The greater signal and
increased α-helical content observed at the higher detergent concentrations
possibly reflect the improved solubilisation of the peptide.
As shown in Figure 4.13a, for the MHCβpeptide, as the ratio approaches 1:1, an
increasing proportion of α-helical content is apparent which rises to a maximum
of ~60 % with a concomitant decrease in the percentage of β-sheet and random
coil, as shown in Figure 4.13c. It is likely this shift from β-sheet to α-helical
secondary structure reflects the increasing solubility of the peptides, and that the
b-sheet observed at high peptide:micelle molar ratio represents an aggregated
state.
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Figure 4.12. CD spectra for MHCαin varying DPC concentrations
(a) Circular Dichroism spectra of MHCαTM peptide reconstituted into the detergent DPC at
varying peptide: DPC micelle ratios. Mean residue ellipticity (MRE) was calculated from the
measured ellipticity as described in Materials and Methods. (b) High tension for CD spectra,
typically the CD data is taken to be reliable whilst this remains below 600. (c) Percentage
secondary structure content (α-helix (blue), β-sheet (red), Random coil (yellow) at varying
peptide: DPC micelle ratios as calculated from the CD spectra using CDSSTR (Johnson, 1999).
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Figure 4.13. CD spectra for MHCβin varying DPC concentrations
(a) Circular Dichroism spectra of MHCβTM peptide reconstituted into the detergent DPC at
varying peptide: DPC micelle ratios. Mean residue ellipticity (MRE) was calculated from the
measured ellipticity as described in Materials and Methods. (b) High tension for CD spectra,
typically the CD data is taken to be reliable whilst this remains below 600. (c) Percentage
secondary structure content (α-helix (blue), β-sheet (red), Random coil (yellow) at varying
peptide: DPC micelle ratios as calculated from the CD spectra using CDSSTR (Johnson, 1999).
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It is likely, that these data are not wholly representative of the actual percentage of
α-helical content in the MHCαand MHCβpeptides, since this is a global average
and the fitting programs typically place a heavy weighting on the data between
190 and 200. This is particularly problematic for peptides solubilised in detergent
micelles since the presence of the micelles introduces a significant level of noise
in this region due to light scattering. MHCαand MHCβpeptides are expected to
be analogous to the TM domains of the α- and β-chains of MHC. The data
presented in this section suggests that they are indeed forming structures with
significantα-helical content in membrane mimetics and therefore were considered
representative models for theseα-helical TM domains.
4.7 SDS-PAGE analysis of MHCαand MHCβTM
domain peptides
The preceding results from this study implicated the conserved small-xxx-small
motifs in the TM domains of the α- and β-chains of MHC in the self-association
of these TM domains. It has been shown for TM domains possessing small-xxx-
small motifs, that their peptide analogues have the potential to form highly stable
homo-oligomers that are observable by SDS-PAGE (Lemmon, Flanagan et al.,
1992). In order to determine if this behaviour could be observed for MHCαand
MHCβpeptides and also for their fluorophore labelled counterparts, SDS-PAGE
analyses were performed.
The results for the MHCαpeptide and the fluorescein labelled MHCαpeptide are
shown in Figure 4.14, at peptide concentrations over a range of 25 to 125μM. For
MHCαtwo distinct bands are observed that possibly correspond to monomer
(3.76 kDa) and dimer (7.52 kDa) oligomeric states, and indicate that the MHCα
peptide is self-associating. These results corroborate those from the in vivo
TOXCAT and GALLEX self-association studies and indicate it is a strong
interaction is since it occurs even in the denaturing detergent SDS. The
fluorophore-labelled variant of MHCαpeptide, MHCα-Fl was also assessed by
SDS-PAGE and gave similar results to the unlabelled peptide, although the lower
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band is stronger and appears to be at slightly higher mass in the lanes with higher
concentrations of peptide.
Figure 4.14. SDS PAGE analysis of MHCαand MHCα-Fl peptides
Analysis of (a) MHCα(MW 3.76 kDa) and (b) MHCα-Fl (MW 4.07 kDa) peptides carried out
over a range of concentrations as indicated below each lane were dissolved in SDS sample loading
buffer, analysed by SDS-PAGE and visualized using coomassie-G250. Molecular mass standards
(MW) with masses in kDa are shown in the far left-hand lane of each gel.
The results of SDS-PAGE analysis for the MHCβpeptide and its rhodamine-
labelled counterpart, MHCβ-Rh, are shown in Figure 4.15a. For MHCβpeptide a
single band is observed for both peptides at a mass that is possibly intermediate
between monomer (3.79 kDa) and dimer (7.58 kDa). This is also the case for the
rhodamine-labelled MHCβ peptide. There is possibly a second band in the
unlabelled peptide but the origin of this is not known. Cross-linking analyses were
performed before an oligomeric state was assigned.
Recent data shows transmembrane peptides can run anomalously on SDS-PAGE
gels which could lead to a possible mistaken assignment of oligomeric states for
the MHCαand MHCβpeptide bands (Rath, Glibowicka et al., 2009; Walkenhorst,
Merzlyakov et al., 2009). Therefore, cross-linking analysis was performed before
bands were definitively assigned oligomeric states.
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Figure 4.15. SDS PAGE analysis of MHCβand MHCβ-Rh peptides
Analysis of (a) MHCβ(MW 3.79 kDa) and (b) MHCβ-Rh (MW 4.17 kDa) TM peptides carried
out over a range of concentrations as indicated below each lane were dissolved in SDS sample
loading buffer, analysed by SDS-PAGE and visualized using coomassie-G250. Molecular mass
standards (MW) with masses in kDa are shown in the far left-hand lane of each gel.
4.8 In vitro analysis of self-association ofαandβ
TM domains
As noted in Section 3.5, the solubilisation of TM peptides in the detergent SDS
can disrupt some of the weaker helix-helix interactions of TM domains preventing
the assembly of the peptides into their native oligomeric states. In order to
investigate the formation of oligomers by MHCαand MHCβpeptides in a milder
detergent, the peptides were subjected to cross-linking prior to analysis by SDS-
PAGE, as described in Section 2.13. MHCαand MHCβpeptides were dissolved
in DPC detergent micelles and then treated with the water soluble cross-linker
BS3. Cross-linking reactions were carried out at increasing peptide:micelle molar
ratio to investigate the effect of detergent concentrations on the oligomeric state.
Cross-linked species were analyzed using SDS-PAGE and visualised by staining
with silver nitrate for its increased sensitivity over coomassie staining.
As shown in Figure 4.16a, for MHCα several bands are observed at
peptide:micelle ratios between 10:1 and 4:1 that correspond to oligomeric states
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from monomer (n=1) to tetramer (n=4) and higher, suggesting the peptides are not
soluble at these detergent concentrations leading to aggregation. As the
peptide:micelle ratio is varied from 2:1 to 1:3 the number of oligomeric states is
reduced with monomer (3.76 kDa), dimer (7.52 kDa), trimer (11.28 kDa) and
tetramer (15.04 kDa) bands being most clearly delineated. Furthermore, the
abundance of the oligomeric states clearly shifts to lower order states as the
peptide:micelle molar ratio is reduced. This data shows that the bands observed in
SDS-PAGE correspond to dimer and monomeric states for MHCαpeptide.
Therefore, in the milder detergent DPC, MHCαis capable of forming higher order
oligomers above dimer but these states are not stable since they can be modulated
by the detergent concentration. As a negative control, cross linking was carried
out with the peptide dissolved in SDS and two bands were observed as observed
in the results of the previous section.
Figure 4.16. Analysis of self-association propensity of MHCαand MHCβTM
derived peptides in DPC detergent
SDS-PAGE analysis of BS3-mediated cross-linking of (a) MHCα(MW 3.76 kDa) and (b) MHCβ
(MW 3.79 kDa) TM peptides dissolved in DPC at varying peptide:micelle ratios as indicated.
Molecular weight markers are shown in the far left- and right hand lanes (Mr). Protein bands were
visualized by staining with silver nitrate. Oligomeric states (e.g. dimer indicated by n = 2) are
indicated at the far right of the gels. A negative control reaction in which cross-linking was carried
out for the peptide dissolved in SDS buffer is shown in the first lane.
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The results from the cross-linking of MHCβpeptide are shown in Figure 4.16b.
No distinct bands are observed at peptide:micelle ratios below 4, but peptide is
evident at the top of the gel near the wells suggesting that the peptide is insoluble
in DPC at these ratios. At peptide:micelle ratios of 4 and 2 bands corresponding to
monomer (3.79kDa), dimer (7.58 kDa) and trimer (11.37 kDa) are observed. At
ratios of 1 and 0.3 (i.e. 1:3) we see bands corresponding to monomer and dimer
only, with monomer becoming more prevalent as the ratio decreases. Compared
to MHCα, MHCβpredominantly self-assembles into dimers, this is interesting
considering that MHCαhas two GxxxG motifs whilst MHCβhas only one,
indicating that MHCαmay have different modes of interaction. In a similar
manner to MHCαand Ii, the oligomeric state of MHCβcan be modulated by the
detergent concentration.
4.9 FRET analyses of TM domain associations of
MHC
Results from the in vivo GALLEX assay described in Section 4.4 suggested that
the TM domains of the α- and β-chains of MHC can associate to form hetero-
oligomers. We would therefore expect to observe this same behaviour in the
model peptides. However, to date relatively few techniques are available to study
the hetero-association of hydrophobic peptides in vitro. As discussed in Section
2.19, and as was shown in the preceding studies of Ii (see Section 3.7), the
phenomenon of FRET can be used to monitor the self-association of synthetic
peptides in membrane mimetics such as detergents or lipids. Fortunately, it is
possible to extend this approach to the study of hetero-association through the
differential labeling of peptides with fluorophores that constitute a FRET pair,
which for the purposes of this study were fluorescein and rhodamine. FRET
analyses were therefore employed in this study to confirm the hetero-association
of the MHCαand MHCβpeptides predicted from our in vivo studies and to
determine the oligomeric state of that interaction.
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4.9.1 Association of theα- andβ-chain TM domains
The FRET between MHCα-Fl and MHCβ-Rh in the detergent DPC was
monitored using fluorescence as described in Section 2.19.5. Since it has been
shown that the association of the model peptides is dependent on the detergent
concentration or more specifically the peptide:micelle molar ratio, the dependence
of the FRET with this parameter was explored.
Model peptides of MHCαand MHCβwere synthesised and labelled with the
fluorophores fluorescein and rhodamine to produce the peptides MHCα-Fl and
MHCβ-Rh, respectively, and purified using RP-HPLC as described in Section 4.5.
For the purposes of FRET measurements MHCα-Fl provides the donor and
MHCβ-Rh, the acceptor. All FRET samples used in the studies in this section
were prepared using the co-dissolving method as described in Section 2.19.4. The
FRET between MHCα-Fl and MHCβ-Rh was monitored at peptide:micelle molar
ratios of between 1:3 and 4:1 in the detergent DPC whilst keeping the total
peptide concentration constant. For each ratio the energy transfer was calculated
as described in Section 2.19.6, and plotted versus the peptide:micelle molar ratio.
As shown in Figure 4.17, energy transfer between MHCαand MHCβpeptide was
observed strongly suggesting these peptides are interacting. Furthermore, the
FRET was found to be dependent on the peptide:micelle molar ratio with the
greatest energy transfer being observed at ratios above 1:1 whilst below this ratio
no or minimal energy transfer is observed. A maximum energy transfer of around
50% is observed. At a ratio above 4:1, the decreased solubility of the peptides
prevents the interpretation of FRET measurements.
Since both MHCαand MHCβhave been shown in this study to self-associate it is
possible that the observed energy transfer is being modulated by the formation of
homo-oligomers. Furthermore, the presence of unlabelled MHCβ could be
modulating the energy transfer leading to a reduced FRET signal. To see if this is
the case it would be necessary to analyse the homo interaction by FRET in future
work.
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Figure 4.17. Change in energy transfer between MHCα-Fl and MHCβ-Rh
with detergent concentration
(a) Plot of percentage energy transfer versus peptide:micelle ratio. The total donor and acceptor
peptide concentrations were kept constant at 4 μM (2μM MHCα-Fl, 2μM MHCβ-Rh) while the
detergent concentration was varied. Samples were prepared by mixing peptide and DPC pre-
solubilised in TFE. A CMC of 1 mM and aggregation number of 56 were used in calculations of
the peptide:micelle molar ratio. Emission spectra were collected and energy transfer was
calculated as described in Materials and Methods. (b) FRET spectra for MHCα-Fl and MHCβ-Rh
in DPC micelles at a peptide:micelle ratio of 4:1. The broken line is MHCα-Fl only spectra, the
dotted line is the spectra of MHCβ-Rh on its own whilst solid line is the spectra for a mixture of
MHCα-Fl and MHCβ-Rh. A FRET signal is evident from the decrease in the donor emission at
520 nm and an increase in acceptor emission at 570 nm as indicated by the arrows.
(a)
(b)
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4.9.2 Determining specificity of MHC TM domain
association
In order to determine if the FRET signal measured between MHCαand MHCβ
arises from a specific interaction, a competition assay was performed by the
titration with increasing concentrations of unlabelled MHCβpeptide. Since this
experiment must be carried out at a fixed detergent concentration, the
peptide:micelle molar ratio of 3:1 was chosen since this yielded a high energy
transfer and . The concentrations of MHCα-Fl and MHCβ-Rh peptides were kept
constant whilst varying the concentration of unlabelled peptide. As shown in
Figure 4.18, the energy transfer decreases with increasing concentration of
unlabelled MHCβ peptide. This is indicative of unlabelled MHCβ peptide
disrupting the formation of donor and acceptor partners by competing with
MHCβ-Rh for binding to MHCα-Fl.
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Figure 4.18. Effect of unlabelled MHCβpeptide on FRET from MHCα-Fl to
MHCβ-Rh
Plot of energy transfer between MHCα-Fl and MHCβ-Rh versus the concentration of unlabelled
MHCβ. Total donor and acceptor peptide concentration was kept constant at 4 μM (2μM MHCα-
Fl, 2 μM MHCβ-Rh) while the concentration of unlabelled MHCβwas varied. Samples were
prepared by co-dissolving all peptides and DPC dissolved in TFE. Experiment was performed at a
peptide:micelle molar ratio of 3:1. The reduced FRET efficiency suggests that sequence-specific
oligomerisation contributes to the measured FRET efficiency.
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4.9.3 Determining the oligomeric state of MHC TM domain
It has been noted in the preceding chapters that the oligomeric state of interacting
TM domain peptides can be monitored using FRET analyses. This is achieved by
the measurement of energy transfer as a function of the mole fraction of acceptor.
Since it was shown in Section 4.9.1 that the energy transfer between MHCα-Fl
and MHCβ-Rh was dependent on the peptide:micelle molar ratio, the oligomeric
state as a function of this ratio was explored. As shown in Figure 4.19, at the
peptide:micelle ratio of 1:1 the data fits best to the calculated line for monomer
with a reduced CHI2 value of 2.26, indicating that there is no association of the
peptides at this ratio. This corroborates the findings of Section 4.9.1 where no
FRET signal was observed at this ratio. At a ratio of 2:1 the data fits to the
calculated curve for a dimer oligomeric state with a reduced CHI2 value of 3.86
and FRET efficiency of 60%, indicating MHCα-Fl and MHCβ-Rh are assembling
into dimers in the DPC micelles. At a ratio of 3:1 the data fits to the calculated
curve for a tetramer oligomeric state with a reduced CHI2 value of 3.17 and FRET
efficiency of 30%. Therefore MHCαand MHCβpeptides seem to be associating
to form dimers and with decreasing detergent concentration they are assembling
into higher order oligomeric states, which is in keeping with the findings for the
other TM peptides in this study. This is the first data to show that the MHCαand
MHCβTM domains can associate to form hetero-dimers and hints at a possible
role for the TM domain in stabilising the assembly of the full length MHC hetero-
dimer.
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Figure 4.19. Determining oligomeric state of the MHCα and MHCβ
association
Stoichiometry of MHCα-Fl and MHCβ-Rh association in DPC detergent at peptide:micelle ratios
of (a) 1:1 (b) 2:1 (c) 3:1. The energy transfer was measured and the ratios of emission at 520 nm
in the donor only sample (Q0) to that in the FRET sample (Q) were calculated. The value of Q0
was normalised to the mole fraction of donor present in the FRET samples. The ratio of MHCα-Fl
to MHCβ-Rh was varied between 0.2 and 0.8 whilst keeping the total peptide concentration
constant at 4 μM. Calculated curves for monomer (solid), dimer (dotted), trimer (broken), and
tetramer (broken dotted) are shown and were calculated using Equation 5 as described in Section
2.19.6. The goodness-of-fit for the experimental data to the calculated curves was determined
using a standard reduced CHI2 curve fitting procedure.
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4.10 Conclusions on the association of the MHC TM
domains
MHC Class II proteins are hetero-dimericα-helical membrane proteins composed
ofα- and β-chains. The work presented here represents the first studies of the TM
domains of the MHC Class II hetero-dimer, here termed MHCαand MHCβ
respectively, in isolation from the soluble domains.
MHCα and MHCβTM domains possess highly conserved dimerisation
motifs
Sequence analysis revealed the presence of highly conserved small-xxx-small
motifs in MHCαand MHCβ, where for both proteins the small residues are
predominantly Gly. MHCαcontains two such motifs whilst MHCβcontains just
one. The GxxxG and similar small-xxx-small motifs are well known to stabilise
dimer formation in TM domains including that of the extensively characterised
TM domain of GpA (ref). The presence of these motifs in MHCαand MHCβTM
domains suggests they may be capable of self-association to form dimers.
Molecular models of the TM domains of MHCαand MHCβgenerated using CHI
suggested the GxxxG motifs could mediate helix-helix interactions by packing of
the residues at the interface of homo-dimers.
MHCαand MHCβTM domain sequences can self associate
Using the in vivo assay TOXCAT it was shown that MHCαand MHCβTM
domains are capable of self-associating in E.coli membranes. This observation
was further corroborated through the use of the GALLEX in vivo assay which
also showed these domains are capable of self-association. Intriguingly, the
GALLEX assay showed a strong dependence on the length of TM domain
sequence used, requiring this parameter to be optimised for both MHCαand
MHCβ. Initial attempts with the sequences used in TOXCAT generated negative
results with GALLEX but as the sequence was shortened the result resembled that
observed with TOXCAT. This length dependence suggests caution should be
applied when interpreting data from these in vivo assays and moreover shows why
it is necessary to study the association of TM domains with a number of
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complimentary techniques in order to reach a consistent result before a conclusion
on the association of TM domains can be made. Mutation of the two GxxxG
motifs in MHCαmonitored by the GALLEX assay confirmed the TOXCAT result
that the mutation G232LG236L could disrupt the self association of this TM domain
whilst mutation of the other motif did not. The GALLEX results for the GxxxG
mutation in MHCβwere a little more inconclusive and seemed to hint that there
had been a disruption which was not apparent from the results from the TOXCAT
assay.
Purification ofα-helical peptide analogues of MHCαand MHCβ
The TOXCAT and GALLEX assays identified that MHCαand MHCβcan self-
associate but they are incapable of reporting on the oligomeric state of that
interaction e.g. dimer, trimer, tetramer..etc. To explore the oligomeric state of
MHCα and MHCβTM domains required the use of in vitro methods in
conjunction with model synthetic peptides. Synthetic peptides corresponding to
the TM domains of MHCαand MHCβwere synthesised and purified using
standard fmoc chemistry and RP-HPLC, respectively. The MHCαand MHCβ
peptides contained a high proportion of hydrophobic residues making them
difficult to purify. It was found that formic acid was a better solubilising agent
than TFA and that a combination of formic acid and HFIP could be used
successfully to purify these highly hydrophobic peptides. Since these peptides
were predicted to be TM domains, CD analysis was performed on MHCαand
MHCβpeptides which showed that when solubilised in detergents they possessed
significant α-helical content and were therefore likely to represent the TM
domains of theαandβ-chains of MHC.
Detergent sensitive self-association of MHCαand MHCβrevealed by SDS
PAGE
SDS PAGE analysis of MHCαand MHCβTM peptides was performed to identify
possible self association since the presence of GxxxG motifs in other TM domains
has been known to mediate the formation of SDS stable dimers. The result for
MHCαTM domain peptide suggested that this TM domain can form oligomers at
a range of peptide concentrations, even in the strongly denaturing detergent SDS,
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suggesting strong helix-helix interactions. SDS stable dimers have been observed
for other TM domains that have been subsequently been shown to have very
specific and strong helix-helix interactions e.g. GpA (Lemmon, Flanagan et al.,
1992), E5 (Oates, Hicks et al., 2008). MHCβTM domain displayed a single band
that could not be assigned an oligomeric state until cross-linking analysis was
performed.
In order to determine if the denaturing nature of SDS was disrupting the
association of these peptides, covalent cross-linking was performed which
involves covalently linking the peptides in the milder detergent DPC prior to
analysis by SDS-PAGE. Cross-linking studies revealed MHCαTM domain
peptide can self associate in detergent micelles to form higher order oligomers
above those observed in the absence of cross-linking. The oligomeric state can be
seen to be modulated by the concentration of DPC. At low peptide:micelle ratios
the observation of laddering is likely due to low solubility of this very
hydrophobic sequence. Notably as the peptide:micelle ratio approaches 1:3,
MHCαforms dimer, trimer and tetrameric oligomers. Dimer and tetramer are the
most prevalent oligomers suggesting that the tetramer is possibly a dimer of
dimers, whilst the trimer is possibly a result of incomplete cross-linking of the
tetramer. Interestingly, the cross-linking of MHCβTM domain in DPC reveals it
can form higher order oligomers, with dimers and trimer being observed between
peptide:micelle ratios of 2:1 and 1:3. The fact that these are not observed in the
uncross-linked SDS-PAGE suggests these interactions are weaker than those of
MHCα. Bands are not observed below a peptide:micelle ratio of 4:1 suggesting
that the peptide is insoluble beyond this ratio. At 2:1 a possible trimer band is
observed. The cross-linking data helps to identify peptide:micelle ratios to be used
in further experiments. This cross-linking data for MHCαand MHCβcorroborates
the observation in vivo of self-association of MHCαand MHCβTM domain
peptides.
GxxxG motifs implicated in self-association of MHCαand MHCβ
CHI models suggested a possible role for the GxxxG motifs in the self-association
of MHCαand MHCβTM domains. To investigate their possible role mutation of
these motifs in both TM domains was performed and their effect upon the self-
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association monitored with TOXCAT and GALLEX. Mutation of both the GxxxG
motifs in MHCαwas performed with the Gly residues being changed to the
bulkier residue Leu. The TOXCAT assay showed mutation of the G225 and G229
residues in the motif to the more bulky Leu residues could significantly reduce the
self-association of MHCαTM domain. This result was further confirmed by
making the same mutation in the homo- GALLEX assay. Mutation of the G232
and G236 residues in the second GxxxG motif in MHCαTM domain did not have
an effect upon its oligomerisation as observed in both the TOXCAT and
GALLEX assays. This was an interesting result since it has been noted for the TM
domain of ErB1, which also possesses two GxxxG motifs that one motifs seemed
to play a role in homo-dimerisation whilst the other played a role a in hetero0-
dimerisation with ErB2 (Gerber, Sal-Man et al., 2004).
Intriguingly, a similar mutation of the GxxxG motif in MHCβTM domain did not
attenuate the TOXCAT or GALLEX signal suggesting this motif does not play a
role in the self association of this TM domain. This raises the important questions
of what the interacting residues are and what is the role of the highly conserved
GxxxG motif in MHCβ?
The high propensity for self-association exhibited by MHCαand MHCβis an
unexpected finding since this interaction has not been observed in the full length
proteins. The fact that MHCα and MHCβcan self-associate has important
implications for further studies on the hetero-association and may lead to
complications in data interpretation from such studies. The self-association may
be due to the TM domain being studied in the absence of the soluble domain
which may be the main driving force behind the control of oligomerisation. This
work on the self-association of GxxxG containing TM domain sequences adds
further evidence to the importance of such motifs in mediating TM domain
oligomerisation.
MHCαand MHCβTM domain analogues can associate to form hetero-
oligomers
The preceding discussion focused on the self association of MHCαand MHCβ
TM domains and the obvious next step is to determine if they can interact with
one another. There are limited techniques available to study hetero-association
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and little literature available where hetero-systems have been studied. The options
for studying hetero-oligomerisation in vivo are particularly limited. The GALLEX
assay was designed for use for studying hetero-interactions but surprisingly has
been little used since its conception. FRET has been reported in the literature as
also being suitable for studying hetero-association. Both of these techniques were
applied in this study to determine if MHCαand MHCβTM domains were sites of
important interactions that would contribute to the stability of the MHC
heterodimer.
Using the in vivo assay GALLEX it was shown that the sequences corresponding
to the predicted TM domains of MHCαand MHCβcan interact in E. coli
membranes. Furthermore, it was shown that the N-term GxxxG motif
(G225xxxG229) from MHCαand the single motif from MHCβmay play a role in
this association since the signal could be attenuated by the double mutation of the
Gly residues in this motif to a sterically bulker Leu residue. Use of the molecular
modelling software CHI produced a structure where these two motifs were
packing at the interface of the hetero-dimer. The purpose of the second GxxxG
motif in the TM domain of MHCαis not clear.
MHCαand MHCβTM domain analogues can associate to form a dimer
Monitoring hetero-association in biomolecules and determining the oligomeric
state of that interaction is technically challenging for membrane proteins and few
techniques have been developed for making such measurements. FRET has
proven to be a useful tool for studying the self-association of model TM domain
peptides as shown in the preceding chapter for Ii, and can be easily extended to
the problem of monitoring the association of TM domains with differing
sequence, by labelling the peptides accordingly with the FRET pair. FRET has
been employed in this study in order to determine if peptides corresponding to the
TM domains of MHCαand MHCβcan associate in vitro to form hetero-oligomers
and to identify the oligomeric state for that interaction.
For fluorophore-labelled peptide analogues of MHCαand MHCβan energy
transfer was observed indicating they are associating in micelles of the detergent
DPC. Furthermore, the energy transfer and therefore the association could be
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disrupted by decreasing the peptide:micelle molar ratio i.e. increasing the
detergent concentration. Since both MHCαand MHCβhave been shown in this
study to self-associate it is possible that the observed energy transfer is being
modulated by the formation of homo-oligomers. Furthermore the presence of
unlabelled MHCβas a contaminant could be modulating the energy transfer
leading to a reduced FRET signal. To see if this is the case would need to analyse
the homo interaction by FRET in future work. Using FRET it was also shown that
the oligomeric state of the association is a dimer at peptide:micelle ratios of 2:1
and 3:1 indicating that these domains are forming hetero-dimers.
This data is the first indication that the interactions between theα- and β-chains of
MHC may be important for the formation and hence function of MHC proteins.
This is therefore in keeping with the literature regarding the assembly of the full
length MHCαand β-chains prior to associating with Ii. It has been shown in vivo
that Ii is essential for optimal presentation of MHC at the cell surface and thatα
and β-chains can form dimers in the absence of Ii (Elliott, Drake et al., 1994). It
has additionally been shown in vitro that in the presence of microsomes ( i.e.
membrane vesicles formed from the ER by the disruption of eukaryotic cells), α
and β-chains can form dimers (Bijlmakers, Benaroch et al., 1994). Therefore it
was suggested that a preformed α/βheterodimer binds to Ii (Lamb and Cresswell,
1992; Bijlmakers, Benaroch et al., 1994). However, there is some controversy in
the literature regarding the pre-assembly of the MHC hetero-dimer prior to
association with Ii, since it has also been shown that Ii can associate with
individual MHC subunits (Kvist, Wiman et al., 1982; Lotteau, Teyton et al., 1990;
Teyton, Osullivan et al., 1990). This lead to the development of a further model
for assembly of the Ii-MHC complex where Ii sequentially binds first to the α-
chain then the Ii-αcomplex selects for matched β-chain to form the export-
competent Ii-MHC complex (Koch, McLellan et al., 2007). The data presented in
this chapter would seem to support the former model for Ii-MHC assembly.
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5 TM domain interactions between Ii
and MHC
5.1 Introduction and objectives
As described in Section 1.3.2, an essential first step in the process of antigen
presentation is the association of the Ii homo-trimer to three MHC α/βhetero-
dimers to form a nonomeric Ii3(MHC α/β)3 complex within the endoplasmic
reticulum of antigen presenting cells. In the preceding chapters it was shown
using multiple techniques that the TM domains of Ii can self associate to form
oligomeric states including trimer and that the TM domains of MHCαand MHCβ
can self-associate and with each other to form hetero-dimers. This implicates
these domains as sites of important protein-protein interactions in the formation of
the Ii-MHC complex. An association between the TM domain of Ii and full length
MHC Class II proteins has been reported by Castellino et al but the exact details
of this interaction are unknown (Castellino, Han et al., 2001). Furthermore, a
sequential mechanism for the assembly of the Ii-MHC complex has been
proposed in which Ii initially binds MHC αsubunits, then β-subunits bind to the
α-Ii complex (Koch, McLellan et al., 2007). Using the techniques outlined in the
preceding chapters we sought to explore the TM domain interactions between Ii
and MHC further and also determine if the proposed sequential assembly could be
observed for the TM domains.
5.2 Monitoring hetero-association of Ii and MHC TM
domains in natural membranes
As discussed in Section 2.18.1, the GALLEX assay can be used to monitor the
hetero-association of TM domain sequences, making it an obvious choice for
identifying possible TM domain interactions between Ii and theα- and β-chains of
MHC. The sequence for the Ii TM domain was cloned into the plasmid pALM100
as described in Section 2.18.2, whilst the pBLM constructs of MHCαand MHCβ
TM domains with a length of 19 residues, constructed for the work in Section 4.3,
were used again. For the purposes of performing the assay pALM- and pBLM-
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constructs were combined in the host strain E.coli SU202, the fusion protein from
the two plasmids were simultaneously expressed, and the activity of the reporter
geneβ-Galactose (β-gal) assayed as described in Section 2.18.
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Figure 5.1. Hetero-association between TM domains of the Ii-MHC α/β
complex
Hetero-association was monitored using the GALLEX assay as described in the text. Amino acid
sequence of the Ii TM domains of Ii, GpA and GpAG83I were cloned into the plasmid pALM100
and subsequently transformed into E.coli strain SU202 along with the pBLM constructs of GpA,
GpAG83I, MHCαand MHCβas described in Section 2.18.2. (a) β-galactosidase activity mediated
by the oligomerisation propensity of the expressed constructs in E.coli SU202. Repression of
activity is indicative of association of the TM domains. Data is an average from three independent
measurements. Expression of the chimeric proteins was induced by the addition of 1 mM IPTG.
Details of theβ-galactosidase assay and the calculation of Miller Units are described in the Section
2.18.3. All plasmids and E. coli strains were kindly proved by Dirk Schneider. GpA and the
dimerisation deficient mutant of GpA, G83I, act as positive and negative controls respectively.
Error bars represent the standard error from three separate measurements (b) Test for insertion and
orientation of the expressed chimera from pALM plasmid. The similar tests for the pBLM
constructs were reported in the preceding chapters. Western blot analysis of E.coli extracts: WC,
whole cell; PF, periplasmic fraction; SF, spheroplast fraction; SP, spheroplast proteolysis; BS,
broken spheroplast proteolysis. The expressed chimeric proteins with a molecular mass of ~54kDa
are found solely in the inner membrane fraction and correctly oriented in the membrane.
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As shown in Figure 5.1a, the combination of Ii and MHCαTM domains leads to
repression of β-galactosidase activity suggesting these two TM domains are
associating within the inner membrane of E .coli. Similarly, the combination of Ii
with MHCβresults in the repression ofβ-galactosidase activity also suggesting an
association between these TM domains. These data indicate that, in isolation, the
TM domains of the Ii and αand β-chains of proteins are sites of significant
protein-protein interactions, which has important implications for the role of the
TM domains of these proteins in the formation of the Ii-MHC complex. These
findings support those of Castellino et al (Castellino, Han et al., 2001). Through
the use of mutagenesis studies, it may be possible in future work to identify the
residues that are mediating this interaction.
5.3 Analysis of self-association of Ii and MHC TM
domains by cross-linking
In the preceding chapters, the method of covalently cross-linking peptides derived
from the TM domains of Ii, αand β-chains of MHC in mild detergents was used
to monitor self-association using SDS-PAGE. In an attempt to determine if cross-
linking could be used to monitor hetero-association, mixtures of Ii, MHCαand
MHCβpeptides were dissolved in DPC micelles and cross-linked with BS3, as
described in Section 2.13. Given the similar size of the peptides and the fact that
they each exhibit self-association it was expected that this form of analysis would
be difficult to interpret. When performing this analysis, we initially cross-linked
each peptide independently, and then cross-linked the mixture. A result of no
interaction was assigned if the banding pattern in the mixture was simply a
combination of the bands from each component. Any differences between the
banding patterns were attributed to association of the different peptides.
The results from cross-linking peptides separately and mixed and are shown in
Figure 5.2b lanes 1-7 and uncross-linked samples are shown in Figure 5.2b lanes
1a-7a. For cross-linking of MHCαand MHCβ, comparison of lane 3 (MHCαplus
MHCβ) to lanes 1 (MHCα) and 2 (MHCβ), shows the loss of a band at 14 KDa
and possibly a more intense band at ~6 KDa (see highlighted regions of lane 3),
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although the latter band could be the two dimers of each peptide coinciding in the
gel. These differences possibly indicate the MHCαand MHCβpeptides have
assembled into hetero-dimers. For the cross-linking of Ii and MHCα, comparison
of lane 5 (Ii plus MHCα) to lanes 1 (MHCα) and 4 (Ii) does not reveal any
significant differences due to the large number of bands, it is not possible to
resolve any changes. For the cross-linking of Ii and MHCβ, comparison of lane 6
(Ii plus MHCβ) to lanes 2 (MHCβ) and 4(Ii) reveals the loss of the highest order
band observed for Ii peptide alone. It is still possible to see the MHCβdimer band
and possibly the monomer band, indicating that any association is only weak.
Ii KASRGALYTGFSILVTLLLAGQATTAYFLYQQQKK
MHCα KELTETVVCALGLSVGLVGIVVGTVFIIRGLRSWK
MHCβ KSESAQSKMLSGVGGFVLGVIFLGAGLFIYFRNQK
Figure 5.2. Analysis of hetero-association of Ii, MHCαand MHCβpeptides
(a) Amino acid sequence of the synthetic peptides used in cross-linking studies, corresponding to
the TM of Invariant chain (Ii) andαandβchains of the Major Histocompatibility Complex Class
II proteins (MHCαand MHCβ, respectively). Predicted TM domains are underlined. Additional
Lys residues are added at the N and C term to aid solubility and avoid non-specific aggregation.
(b) Lanes 1-7 show BS3-mediated cross-linking of TM peptides dissolved in DPC at 3:1
peptide:micelle ratio also shown are peptides uncrosslinked, lanes 8-14. Molecular weight markers
are shown in the far left-hand lane in kDa. Protein bands were visualized by staining with silver
nitrate. Differences between lanes of hetero- and homo- cross-linked peptides are indicated by
white boxes.
Finally, the interaction between all of the three TM domains was studied. For the
cross-linking of Ii, MHCαand MHCβ, comparison of lane 7 (Ii plus MHCαand
MHCβ) to lanes 1, 2 and 3 shows the loss of the higher order bands observed for
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MHCαand Ii. Interestingly, there is a loss of the band corresponding to dimer for
all three peptides suggesting the peptides have associated into higher order
oligomers.
Despite the obvious difficulties inherent in using the approach of cross-linking to
probe the association of TM domain peptides of similar mass, we can clearly see
that it is possible to discern differences between the peptides when cross-linked
separately and mixed. Although these results are not conclusive and are
challenging to interpret they do suggest that Ii may be associating with MHCαand
MHCβ.
5.4 FRET analyses to measure the interactions
between the TM domains of Ii and MHC
In order to explore the interactions of the Ii and MHC TM domain peptides
further, FRET analyses were performed. FRET analyses have been used so far in
this study to confirm the self-association of Ii (Section 3.7), and reveal that MHCα
and MHCβTM domains can associate to form hetero-dimers (Section 4.9). This
section describes the use of FRET analyses to determine if there are interactions
between the TM domain of Ii, and those of MHCαand MHCβ.
5.4.1 FRET sample preparation
The synthesis and purification of fluorophore labelled peptides of Ii-Fl, Ii-Rh,
MHCα-Fl and MHCβ-Rh, has been described previously in Sections 3.7 and 4.5
respectively. For the purposes of FRET measurements these peptides were
combined as appropriate to generate a FRET pair of fluorescein- and rhodamine-
labelled peptides (e.g. Ii-Fl and MHCβ-Rh). All FRET samples were prepared
using the co-dissolving method as described in Section 3.7.2.
5.4.2 Monitoring FRET between MHCαand Ii peptides and
its dependency on the peptide:micelle ratio
FRET samples of MHCα-Fl and Ii-Rh were prepared at peptide:micelle molar
ratios of between 1:3 and 4:1 in the detergent DPC, whilst keeping the total
peptide concentration constant at 8 µM. For each ratio the percentage energy
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transfer was calculated as described in Section 2.19.4 and plotted versus the
peptide:micelle molar ratio.
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Figure 5.3. Change in energy transfer between MHCαand Ii with detergent
concentration
Plot of Energy transfer (%) versus peptide:micelle ratio (a) Total donor and acceptor peptide
concentrations were kept constant at 8 μM (4 μM MHCα-Fl, 4 μM Ii-Rh) while the detergent
concentration was varied. Samples were prepared using the co-dissolving methods by mixing
peptide and DPC pre-solubilised in TFE. A CMC of 1 mM and aggregation number of 56 were
used in calculations of the peptide:micelle ratio. Emission spectra were collected and energy
transfer was calculated as described in Section 2.19.6. (b) FRET spectra for MHCα-Fl and Ii-Rh in
DPC micelles at a peptide:micelle ratio of 4:1. The broken line is spectrum of MHCα-Fl on its
own, the dotted line is spectrum of MHCβ-Rh on its own, whilst the solid line is the spectrum for a
mixture of MHCα-Fl and Ii-Rh. The FRET signal is evident from the decrease in the donor
emission at 520 nm and an increase in acceptor emission at 570 nm as indicated by the arrows.
(a)
(b)
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As shown in Figure 5.3, energy transfer was observed between the MHCα-Fl and
Ii-Rh which indicates that these peptides are associating within DPC micelles. The
greatest energy transfer is observed at peptide:micelle ratios of greater than 1
whilst below this ratio no or minimal energy transfer is observed. A maximum
energy transfer of around 50% is observed between ratios of 1 and 4. These data
agree well with GALLEX data and suggests the TM domains of Ii and theα-chain
of MHC are associating.
5.4.3 Determining specificity of MHCα-Fl and Ii-Rh FRET
signal by competition with unlabelled peptide
In order to ascertain if the FRET signal measured between MHCα-Fl and Ii-Rh
arises from a specific interaction, and was not due to random co-localisation of the
peptides merely occupying the same micelle and thus being in close proximity, it
is necessary to do a competition assay with unlabelled peptide. Since this
experiment must be carried out at a fixed detergent concentration the
peptide:micelle molar ratio of 4:1 was chosen on the basis that it produced the
highest energy transfer between Ii and MHCα. The concentrations of MHCα-Fl
and Ii-Rh peptides were kept constant whilst varying the concentration of
unlabelled Ii peptide. As shown in Figure 5.4, the energy transfer decreases with
increasing concentration of unlabelled peptide. This is indicative of the unlabelled
Ii peptide competing for binding sites on MHCα-Fl and disrupting the formation
of donor and acceptor partners.
In order to confirm the specificity of the interaction between MHCαand Ii, the
effect of adding unlabelled MHCβpeptide on the energy transfer between MHCα-
Fl and Ii-Rh was explored. As shown in Figure 5.5, the addition of MHCβhad
little or no impact upon the energy transfer between MHCα-Fl and Ii-Rh,
requiring the addition of 10μM unlabelled MHCβto reduce the energy transfer by
~15%. This indicates that the peptides are not simply being forced together by co-
localisation in the micelles. Furthermore since it has been shown that MHCαcan
interact with MHCβthis result suggests that MHCβis not competing for the
interaction interface between MHCαand Ii.
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Figure 5.4. Effect of unlabelled Ii on FRET between MHCa-Fl and Ii-Rh
Total donor and acceptor peptide concentration was kept constant at 4μM (2 μM MHCα-Fl, 2 μM
Ii-Rh) while the concentration of unlabelled Ii was varied. Samples were prepared by co -
dissolving all peptides and DPC dissolved in TFE. Experiments were performed at a
peptide:micelle ratio of 4:1. The reduced FRET efficiency suggests that sequence-specific
oligomerisation contributes to the measured FRET efficiency.
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Figure 5.5. Effect of unlabelled MHCβon FRET between MHCa-Fl and Ii-
Rh
Total donor and acceptor peptide concentration was kept constant at 4 μM (2 μM MHCα-Fl, 2 μM
Ii-Rh) while the concentration of unlabelled MHCβwas varied. Samples were prepared by co-
dissolving all peptides and DPC dissolved in TFE. Experiments were performed at a
peptide:micelle ratio of 3:1.
Chapter 5. TM domain interactions between Ii and MHC
117
5.4.4 Determining the oligomeric state of MHCαand Ii TM
domain association by FRET analysis
The measurement of energy transfer as a function of the mole fraction of acceptor
was used as described in Section 2.19.5, to determine the oligomeric state of the
MHCαand Ii hetero-oligomers at varying peptide:micelle molar ratios. As shown
in Figure 5.6, at a peptide:micelle ratio of 1:1 the data fits to the calculated curves
for tetramer oligomeric state with a reduced CHI2 value of 0.66 and FRET
efficiency of 52%, indicating MHCα-Fl and Ii-Rh are assembling into tetramers in
the DPC micelles. Similarly, at a ratio of 2:1 the data also fits best to tetramer
with a CHI2 value of 0.68 and a FRET efficiency of 55%. As the peptide:micelle
molar ratio is increased to 3:1 the data fits to the higher order oligomeric state of
pentamer with a CHI2 value of 1.68 and a FRET efficiency of 54%, showing that
the detergent can modulate the oligomeric state of the Ii-MHCαhetero-oligomer
in a manner
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Figure 5.6. Oligomeric state of MHCαand Ii interaction
Stoichiometry of MHCα-Fl and Ii-Rh association in DPC detergent at peptide:micelle ratios of (a)
1:1 (b) 2:1 (c) 3:1. The energy transfer was measured and the ratios of emission at 520 nm in the
donor only sample (Q0) to that in the FRET sample (Q) were calculated. The value of Q0 was
normalised to the mole fraction of donor present in the FRET samples. The ratio of MHCα-Fl to
Ii-Rh was varied between 0.2 and 1.0 whilst keeping the total peptide concentration constant at 4
μM. Calculated curves for monomer (solid), dimer (dotted), trimer (broken), and tetramer (broken
dotted) are shown and were calculated using Equation 5 as described in Section 2.19.6. The
goodness-of-fit for the experimental data to the calculated curves was determined using a standard
reduced CHI2 curve fitting procedure.
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5.4.5 Monitoring FRET between MHCβand Ii peptides and
its dependency on the peptide:micelle molar ratio
In order to determine if the TM domain of Ii could associate with that of MHCβ,
FRET analyses were performed using the fluorophore labelled peptides Ii-Fl and
MHCβ-Rh. FRET was monitored at varying peptide:micelle molar ratios since it
was expected this would impact upon any FRET signal observed. As shown in
Figure 5.7, a FRET signal was observed with a maximum efficiency of ~35% for
peptide:micelle molar ratios above 4:1. This is slightly lower than the values
observed in our previous FRET studies, which were around 50-60%. Notably, the
spectra for Ii-MHCβat a ratio of 3:1, shown in Figure 5.7b, displays a very small
increase in acceptor emission at 570 nm compared to those observed in previous
FRET experiments. Furthermore, it is interesting that a FRET signal was observed
at peptide:micelle ratios above 4:1 since in cross-linking experiments MHCβdoes
not appear to be soluble at these concentrations. These observations make it
difficult to conclude that the energy transfer observed between Ii-Fl and MHC-Rh
constitutes a real FRET signal. It is possible that the FRET signal is being reduced
by the presence of unlabelled MHCβpeptide which could not be completely
removed during the purification of MHCβ-Rh (Section 4.5). We therefore sought
to validate the energy transfer observed between Ii and MHCβusing competition
assays.
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Figure 5.7. Change in FRET between Ii-MHCβwith detergent concentration
(a) Total donor and acceptor peptide concentration was kept constant at 4 μM (2μM Ii-Fl, 2 μM
MHCβ-Rh) while the detergent concentration was varied. Samples were prepared using the co-
dissolving methods by mixing peptide and DPC pre-solubilised in TFE. A CMC of 1mM was used
in calculations of the peptide:micelle molar ratio. Emission spectra were collected and energy
transfer was calculated as described in Section 2.19.6 (b) FRET spectra for Ii-Fl and MHCβ-Rh in
DPC micelles at a peptide:micelle molar ratio of 3:1. The broken line is a spectrum of Ii-Fl on its
own, the dotted line is a spectrum of MHCβ-Rh on its own, whilst the solid line is the spectrum for
a mixture of Ii-Fl and MHCβ-Rh. A possible FRET signal is evident from the decrease in the
donor emission at 520 nm and an increase in acceptor emission at 570 nm as indicated by the
arrows.
(b)
(a)
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5.4.6 Determining specificity of Ii-MHCβ FRET signal by
competition with unlabelled MHCβpeptide
In order to determine if the FRET observed between Ii-Fl and MHCβ-Rh arises
from a specific interaction, a titration with unlabelled MHCβpeptide was
performed. Since this experiment must be carried out at a fixed detergent
concentration the peptide:micelle molar ratio of 4:1 was chosen, as measurement
at this ratio resulted in the largest energy transfer, as described in the preceding
section. The concentrations of Ii-Fl and MHCβ-Rh peptides were kept constant
whilst varying the concentration of unlabelled MHCβpeptide. As shown in Figure
5.8, although the error bars for this experiment are quite large, it appears that the
energy transfer is not affected by the presence of any concentration of unlabelled
MHCβpeptide. This strongly suggests the unlabelled MHCβpeptide is not
competing with the MHCβ-Rh peptide for binding to the Ii-Fl peptide and that the
observed FRET is merely an experimental artefact and not indicative of an
interaction between Ii and MHCβ.
0 2 4 6 8 10
0
10
20
30
40
50
60
70
80
90
[MHCß] (µM)
%
E
ne
rg
y
T
ra
ns
fe
r
Figure 5.8. Effect of unlabelled MHCβon FRET between Ii and MHCβ
Energy transfer between Ii-Fl and MHCβ-Rh peptide as a function of concentration of unlabelled
MHCβpeptide. Total donor and acceptor peptide concentration was kept constant at 4μM (2μM
Ii-Fl, 2 μM MHCβ-Rh) while the concentration of unlabelled MHCβwas varied. Samples were
prepared by co-dissolving all peptides and DPC dissolved in TFE. Experiments were performed at
a peptide:micelle molar ratio of 3:1.
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5.4.7 Determining the oligomeric state of MHCβ and Ii
association by FRET analysis
To further investigate the possibility of an interaction between Ii-Fl and MHCβ-
Rh the measurement of energy transfer as a function of the mole fraction of
acceptor was monitored at varying peptide:micelle molar ratios, as described in
Section 2.19.5. As shown in Figure 5.9, at a peptide:micelle ratio of 1:1 the data
fits best to a calculated curve for dimer with a CHI2 value of 0.69 but with a
FRET efficiency of just 20 %, suggesting a possible interaction between Ii and
MHCβpeptide. At higher ratios of 2:1 and 3:1 however, the data fits best to
monomer oligomeric state indicating no interaction is occurring. From this data
and the preceding FRET data it is difficult therefore to confirm that Ii and MHCβ
are specifically interacting since the general trend observed for the other TM
peptides in this study of increasing oligomeric state with increasing
peptide:micelle ratio was not observed. The observation of an interaction at a
peptide:micelle ratio of 1:1 and not at higher ratios may result from poor
solubility of the MHCβpeptide in DPC since it was found previously in the cross-
linking analyses (see Figure 4.6b) that this peptide has limited solubility above a
peptide:micelle ratio of 2:1 in this detergent. However, the observation of an
interaction however weak it may be does fit with the findings from the GALLEX
assay in this study. Further study will be required before conclusions can be
drawn on whether the peptide models of the Ii and MHCβTM domains also
display this propensity for hetero-association.
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Figure 5.9. Determining oligomeric state of Ii MHCβTM domain association
Stoichiometry of Ii-Fl and MHCβ-Rh in DPC detergent at peptide:micelle ratios of (a) 1:1 (b) 2:1
(c) 3:1. The energy transfer was measured and the ratios of emission at 520 nm in the donor only
sample (Q0) to that in the FRET sample (Q) were calculated. The value of Q0 was normalised to
the mole fraction of donor present in the FRET samples. The ratio of Ii-Fl to MHCβ-Rh was
varied between 0.2 and 1.0 whilst keeping the total peptide concentration constant at 4μM and the
peptide: Calculated curves for monomer (solid), dimer (dotted), trimer (broken), and tetramer
(broken dotted) are shown and were calculated using Equation 5 as described in Section 2.19.6.
The goodness-of-fit for the experimental data to the calculated curves was determined using a
standard reduced CHI2 curve fitting procedure.
(b)
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5.4.8 Determining effect of adding unlabelled peptide MHCα
on the FRET between Ii and MHCβ
It has been suggested that in the assembly of the full-length Ii-MHC complex, the
initial step is the binding of the Ii trimer to individual MHCαchains followed by
the Ii-MHCαcomplex binding MHCβchains (Koch, McLellan et al., 2007). Since
it has been shown in this study that the TM domains of these proteins are sites of
important protein-protein contacts, it was hypothesised that this order of
interaction may be observable in the TM domains of these proteins using FRET
analyses. If this is the case, then it would be expected that the observed energy
transfer between Ii and MHCβwill increase upon the addition of MHCα.
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Figure 5.10. Effect of MHCαon the association of Ii and MHCβ
Energy transfer between Ii-Fl and MHCβ-Rh as a function of MHCαconcentration. Total donor
and acceptor peptide concentration was kept constant at 4 μM (2 μM Ii-Fl, 2 μM MHCβ-Rh)
whilst unlabelled MHCαwas added at increasing concentrations. Samples were prepared using the
co-dissolving methods by mixing peptide and DPC pre-solubilised in TFE to give a
peptide:micelle ratio of 2:1. A CMC of 1mM was used in calculations of the peptide:micelle ratio.
Excitation spectra were collected and energy transfer was calculated as described in materials and
methods.
In order to test this hypothesis, increasing concentrations of unlabelled MHCα
peptide were added to a mixture of Ii-Fl and MHCβ-Rh peptides. The experiment
was carried out in DPC at a peptide:micelle molar ratio of 2:1. This ratio was
chosen on the basis that it had yielded a low energy transfer between Ii and
MHCβpreviously and was able to solubilise all the peptides. As shown in Figure
Chapter 5. TM domain interactions between Ii and MHC
125
5.10, the addition of unlabelled MHCαdid not enhance the energy transfer
between Ii and MHCβ, thus suggesting that the TM domain of MHCβdoes not
play a role in the proposed sequential assembly of the Ii-MHC complex.
5.5 Conclusions on TM domain association of Ii and
theα- andβ-chains of MHC
The full length Ii trimer is known to associate with three MHC Class II hetero-
dimers containing α(MHCα) and β(MHCβ) chains. This interaction is known to
be mediated by the association of the CLIP domain of Ii occupying the antigen
binding site of the MHCα/βhetero-dimer. Castellino et al mapped a further site of
interaction between Ii and MHC to the transmembrane segment of Ii using
mutagenesis (Castellino, Han et al., 2001).
The work presented in Chapters 3 and 4 of this study reveals that the TM domains
of Ii and MHCαand MHCβproteins are sites of potentially important helix-helix
interactions that may further stabilise the Ii-MHC complex. Using the limited
number of methods available for studying hetero-interactions between
hydrophobic proteins we sought to determine if in isolation the TM domain of Ii
could associate with those of MHCαand MHCβand determine the stoichiometry
of these interactions. This will verify the findings of Castellino et al. and provide
the basis for further study into identifying the residues involved in these
interactions.
A method for studying the hetero-association of isolated TM domains in vivo is
the GALLEX assay. Use of this assay suggested that the TM domain of Ii can
interact with those of MHCαand MHCβin the E.coli inner membrane. This is the
first time that such an interaction has been observed between these proteins. It is
important to remember that GALLEX can only report on association and does not
provide details on the oligomeric state of the interaction so that information has to
be obtained using other techniques.
In order to confirm the findings from the GALLEX assay, and determine the
stoichiometry of these interactions, model peptides derived from the TM domains
of Ii, MHCαand MHCβwere produced and their association was monitored using
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biophysical techniques. Chemical cross-linking of the peptides in a mild detergent
hinted at the possible association of these domains since differences could be
observed between the peptides cross-linked separately and when mixed. The
analysis of such an experiment is complicated by to the similar size of the
peptides under study and the complications involved when those peptides can
self-associate as is the case for Ii, MHCαand MHCβ. Cross-linking is not
frequently employed to study hetero-interactions of TM domains for this reason.
FRET analyses of fluorophore labelled model peptides suggested that the TM
domains of Ii and MHCαcould associate. Furthermore, the oligomeric states of
that association could be determined and were found to from dimers or trimers
depending on the peptide:micelle molar ratio. FRET analyses also suggested that
the TM domain of Ii may interact with that of MHCβbut the findings were
difficult to interpret conclusively. It is possible the solubility of the MHCβpeptide
in the chosen detergent DPC, is an issue for this type of analyses. Intriguingly, it
was found that the FRET between Ii with MHCβcould not be enhanced by the
presence of MHCα. This data, is consistent with the finding in the full length
proteins that individualα-chains coisolate with Ii, whereasβ-chains exhibit only a
low-affinity interaction with Ii (Neumann and Koch, 2005). Therefore, the TM
domain of MHCβwould not appear to play a role in the assembly of the Ii-MHC
complex. It should be noted that given the findings from the in vivo analysis of the
association of Ii and MHCβperformed using the GALLEX assay (see Section
5.2), which suggested they were interacting, we would expect to see significant
interaction in the FRET analyses also. The reasons for this discrepancy are
uncertain at present, but it is possible that they may reflect the differing
environment in which the analyses were performed, since the GALLEX assay is
performed on proteins inserted into the inner membrane of E.coli compared to
peptides solubilised in detergent for FRET measurements. Further study will be
required to conclusively determine if the model peptides of Ii and MHCβTM
domains are interacting.
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6 Developing NMR Methods for
investigating protein interactions
Identifying helix-helix interactions and the structural determinants that drive α-
helical membrane protein folding is a technically challenging problem due to their
hydrophobicity. Of particular interest is accessing detailed structural information
regarding the interacting side chains and hence enabling identification of the non-
covalent bonds stabilising the association of the helices. Using current methods
for studying TM interactions (e.g. TOXCAT, GALLEX, Cross-linking, FRET,
AUC) it is possible to identify homo- and hetero- association between TM
domains and to also determine their oligomeric state, as has been shown in the
previous chapters of this work. Current studies on the hetero-association of TM
domains have used the GALLEX assay, FRET experiments and immune-
precipitation. Complementing these techniques, molecular modelling and
mutagenesis studies can suggest residues that are important for the interactions.
However, the results from these studies in our experience are often difficult to
interpret conclusively. Furthermore, ultimately these methods, though powerful,
do not provide information on the arrangements of atoms in these oligomers and
ultimately the definitive test for any predictions made from such studies is to
solve the atomic structure of the domains.
Currently the two most successful methods for solving the atomic structures of
membrane proteins are X-ray crystallography and NMR spectroscopy. In
particular, solution-state NMR spectroscopy has been applied to the study of
transmembrane domains in isolation, which due to their small size are most
amenable to analysis by this technique. We therefore sought to develop protocols
for using NMR to solve the structure of TM domain oligomers and additionally
designed a novel assay for determining the association of these domains that also
has the potential to provide important structural information.
This section describes work carried out in this study on developing these NMR –
based methodologies for identifying interacting α-helical TM domains and for
determining the atomic structure of those oligomers. Preliminary work has been
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performed on solving the structure of a TM domain from the well characterised
E5 protein and on developing paramagnetic NMR methods for the rapid
determination of TM domain structure. It is hoped that the results from these
studies will facilitate future investigation of the Ii, and MHC proteins.
6.1 Towards solving the structure of the TM domain
of E5
The E5 protein from Bovine Papillomavirus is the product of the smallest known
oncogene at only 44 amino acid residues in length. E5 triggers tumour formation
through activation of the platelet derived growth factor βreceptor (PDGFβr)
within the plasma membrane of host cells. Recently a 26-residue segment of this
membrane protein, encompassing the α-helical TM domain, has been shown to
form strongly interacting homo-dimers even in SDS that are stabilized by non-
covalent helix-helix interactions (Oates, Hicks et al., 2008). AUC analysis of the
E5 TM domain dimer revealed a ΔGapp for association of 7.4 Kcal mol-1 at 25 °C
in DPC (Oates, Hicks et al., 2008). Interfacial residues that play a role in
stabilising the dimer were predicted from in-vivo mutagenesis studies and
computational models (Oates, Hicks et al., 2008). To date there are no atomic
level structural data available on the E5 dimer identifying residues that stabilise its
formation. This is due mainly to in vitro studies of these hydrophobic systems
presenting significant technical challenges in terms of synthesis and purification
and the requirement of NMR compatible membrane mimetics and sample
optimisation.
Amphipathic detergents such as SDS are commonly used as membrane mimetics
for in vitro membrane protein studies, provided it can be shown that the SDS will
not disrupt oligomer formation for the protein of interest (which is common for
SDS). However, when considering the use of detergents as solubilising agents for
membrane proteins the micelle concentration (i.e. the concentration above which
detergent monomers aggregate to form micellar structures) is often overlooked in
favour of the bulk detergent concentration or specific physicochemical properties
of the particular detergent. Strong detergents such as SDS are known to
destabilise membrane protein structure and have been shown to modulate the
oligomerisation of TM domains (Fisher, Engelman et al., 1999). Detergent
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concentration has been shown to modulate the oligomerisation of TM domains but
not helicity as shown for the dimerisation of the protein Glycophorin A (Fisher,
Engelman et al., 1999). However, this work considered only the total detergent
concentration and did not explicitly consider the detergent micelle concentration.
We consider the micelle concentration here and show that it is crucial for
maintaining non-covalent interactions in oligomeric species.
In this study we have performed a systematic investigation on the effect of SDS
detergent micelle concentration on the NMR spectra of the transmembrane
domain of E5 with a view to atomic level structural information for this domain
using solution state NMR techniques. We also provide a rationale for the effect of
micelle concentration on these oligomeric systems.
6.1.1 Synthesis of E5 Peptide and its purification
Previous studies revealed that a synthetic peptide analogous to the TM domain of
E5 is able to self-associate to form a homo-dimer in detergent solutions (Oates,
Hicks et al., 2008). This strategy of using synthetic peptides is advantageous for
analysis by NMR spectroscopy since it enables NMR-active isotopes to be
incorporated at specific positions. Two selectively 15N-labelled peptides
corresponding to residues F9 to H34 and encompassing the TM domain of E5
were synthesised with the sequences presented in Figure 6.1, as described in
Section 2.10.
Figure 6.1. Primary sequence of full length E5 from Bovine Papillomavirus
and synthetic peptides used in this study
Amino acid sequence of full length E5 with the predicted transmembrane domain highlighted in
grey. The synthetic peptides E5TM1 and E5TM2 analogous to the TM domain of E5 were produced
at the Keck facility (Yale University, USA). Underlined residues in the peptides are those
predicted to be at the interface (Mattoon, Gupta et al., 2001). Backbone amide nitrogen atoms of
residues highlighted in bold were selectively 15N labelled during synthesis. In both peptides Ala12
was 15N labelled as a control. Lysine residues were incorporated at the termini of the peptides to
increase solubility and aid purification.
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Figure 6.2. Molecular simulation of the E5 TM domain dimer
Predicted molecular model for the TM domain of E5. A homo-dimer was generated using the CHI
program as described in Oates et al (Oates, Hicks et al., 2008) that predicted residues that are
positioned at the interface and are therefore implicated in stabilising the helix-helix interactions.
15N-labelled residues predicted to be at the interface are represented in space filling whilst those
residues not expected to be interfacial are shown in ball and stick.
The amino acid sequences for E5TM1 and E5TM2 peptides are truncated compared
to the full length E5 sequence so as to encompass just the TM domain. Lysine
residues were incorporated at the N- and C- termini to aid solubility of this highly
hydrophobic peptide and reduce non-specific aggregation, and this approach has
been shown not to disrupt the oligomerisation of the E5 TM domain (Oates, Hicks
et al., 2008). The peptide E5TM1 was synthesised with 15N-labelled residues at
positions Ala14, Leu21 and Phe28 which are predicted to reside at the dimer
interface, whilst E5TM2 had 15N-labelled residues at positions Ala14 and Leu24
that are predicted to be interfacial and at positions Gly11, Val13, Leu19, and
Val30 which are expected to be outside the interface (Mattoon, Gupta et al.,
2001).
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A molecular model for the E5 TM domain generated using the CHI program, as
described in Oates et al, shows the relative positions of the interfacial and non-
interfacial 15N labelled residues (Figure 6.2)(Oates, Hicks et al., 2008). The E5TM1
and E5TM2 peptides were purified by Dr Joanne Oates using RP-HPLC as
described in Oates et al (Oates, Hicks et al., 2008).
6.1.2 NMR analyses of E5 TM peptides in trifluoroethanol
In order to characterise the E5TM1 and E5TM2 peptides, initial NMR experiments
were performed on samples of the peptides solubilised in 80% deuterated
trifluoroethanol (dTFE)/ 20% H2O. The correct labelling of the peptides was
confirmed by acquiring a 2D heteronuclear single quantum coherence spectrum
(15N-1H HSQC), which enables resonances from 15N-labelled amide groups to be
observed. As shown in Figure 6.3a, the expected three resonances were observed
in the spectra for the E5TM1 peptide. This indicates that the labelling was
successful and that the peptide is adopting one conformation in TFE. Presumably,
this conformation is the monomeric helix since TFE is known to promoteα-helix
formation but disrupt helix-helix interactions (Luo and Baldwin, 1997). Similarly,
15N -1H HSQC spectrum of the E5TM2 peptide revealed the expected six
resonances, as shown in Figure 6.3b.
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Figure 6.3. 15N-1H HSQC of E5TM1 and E5TM2 peptides in TFE
15N-1H HSQC spectra acquired on a Bruker 700 MHz instrument for (a) E5TM1 and (b) E5TM2
peptides solubilised in 80% dTFE/20% H2O. The number of resonances observed corresponds to
the number of 15N-labelled residues in the peptides.
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In order to assign the resonances observed for the E5 TM peptides in the 15N-1H
HSQC spectra, 3D 15N-edited-1H-1H HSQC TOCSY spectra were acquired which
enable only those resonances from 15N-labelled residues to be observed. By
reference to published chemical shifts, the amide backbone and side chain
resonances for the labelled residues in E5TM1 and E5TM2 were assigned as shown
in Figure 6.4 and Figure 6.5, respectively using the proton labelling scheme
shown in Figure 6.6. It was hoped that these would help guide assignments in
subsequent NMR experiments on E5 peptides solubilised in detergent.
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Figure 6.4. 15N-edited 1H-1H TOCSY of E5TM1 peptide in TFE
15N-edited 1H-1H TOCSY spectra acquired on a Bruker 700 MHz instrument for E5TM1 peptide
solubilised in 80% dTFE/20% H2O. Assignments made with reference to known resonance
patterns and tables of chemical shifts.
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Figure 6.5. 15N-edited 1H-1H TOCSY of E5TM2 peptide in TFE
15N-edited 1H-1H TOCSY spectra acquired on a Bruker 700 MHz instrument for E5TM2 peptide
solubilised in 80% dTFE/20% H2O. Assignments made with reference to known resonance
patterns and tables of chemical shifts.
C
H
CH3
NH2HOOC α
β C
H CH3CH3
CH2
C
H
NH2
HOOC α
β
γ δδ
CH
CH CH
CH
C
H
CH2
C
HNH2
COOH
βα
C
H
C
H
NH2HOOC
CH3CH3
β γγ
Figure 6.6. Labelling of amino acid side chains used in resonance assignment
Labelling of amino acid protons used in resonance assignments in 15N-edited 1H-1H TOCSY
spectra of E5 peptides, for (a) alanine, (b) leucine, (c) phenylalanine, (d) valine.
6.1.3 E5 adopts detergent-dependent conformations
TFE however is not representative of a native membrane environment, and the
study then progressed to exploring the assembly of E5 homo-dimers in SDS
detergent micelles which provide a more membrane-like environment and have
been shown previously to maintain the formation of the E5 TM domain
(a) (b) (c) (d)
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homodimer (Oates, Hicks et al., 2008). Since it has been shown for other TM
domains, including for Ii and MHC in this study, that the oligomeric state can be
modulated by the detergent concentration, the affect of SDS concentration on the
NMR spectra of E5 was explored and 15N-1H HSQC spectra of E5TM1 were
acquired at varying SDS concentrations.
Figure 6.7. Overlay of 15N-1H HSQC spectra for E5 TM peptides in TFE and
SDS
Comparison of 15N-1H HSQC spectra of (a) E5TM1 and (b) E5TM2 peptides acquired in TFE
(grey) and SDS (black) showing the same pattern of distribution of the resonances and thus
facilitating the assignment of the resonance observed for spectra acquired of E5 peptides in SDS.
Assignment of resonances for E5 peptides acquired in SDS is difficult due to the
increased signal broadening introduced by the slower tumbling of the larger
peptide-micelle complex. To aid assignment, the spectra acquired in SDS were
compared to those acquired in TFE. Comparison of Figure 6.7 to Figure 6.3, the
relative position of the resonances does not significantly change upon
solubilization of the E5 TM peptides in SDS micelles, thus the assignments made
for resonances acquired in TFE can aid those in SDS. Notably, as expected the
peak widths are greatly increased for resonances from peptides solubilised in SDS
micelles.
For spectra acquired in SDS, as shown in Figure 6.8a, 2D contour plots revealed
the presence of two sets of three resonances with each doublet separated by
(a) (b)
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fractions of a ppm. Comparison of 1D projections through the HSQC spectrum
(Figure 6.8b) revealed the relative intensities of these two sets were dependent
upon the concentration of SDS with one diminishing as the concentration was
increased with concomitant increase in the second set, as shown in Figure 6.8b.
This is indicative of the presence of two species that are in slow exchange on the
NMR timescale. It has been shown for other TM peptides that the oligomeric state
of the protein can be modulated by the concentration of detergent with shifts to
lower oligomeric states as the detergent concentration is increased, so it is likely
therefore that these two sets of resonances represent dimeric and monomeric
species of E5. Therefore, the set of resonances observed at low detergent
concentration were assigned to the dimeric state of E5TM1. This type of splitting
pattern has been observed previously in other NMR studies of TM helix-helix
interactions and also attributed to the assembly of monomers into oligomers
(Gratkowski, Dai et al., 2002; Wu, Shih et al., 2007).
Interestingly, Leu21 displays a multiplet signal at low micelle concentration in
contrast to the broad singlet observed for the other two resonances. It is possible
that this is due to the close packing of the helices in the dimer interface restricting
the motion of the Leu side chain causing it to adopt multiple rotameric forms.
Rotamers of Leu side chains at closely packed dimer interfaces have been
observed previously for closely packed dimers of transmembrane domains
(MacKenzie, Prestegard et al., 1996). It is conceivable that this could lead to small
changes in the backbone conformation and hence small changes in the amide 1H
chemical shift. Consistent with this interpretation is the observation that the
multiplet collapses to just a single peak as the detergent is increased and E5
becomes more monomeric, which presumably releases the Leu side chain from its
restricted motion at the interface.
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Figure 6.8. 15N-1H HSQC spectra of E5TM1 in SDS detergent
(a) Stacked 2D contour plots from 15N-1H HSQC spectra of E5TM1 as a function of SDS detergent
concentration. (b) 1D projection of plane from 2D spectra showing the resonance doubling and
change in relative intensity with detergent concentration. Residue assignments are indicated at the
top and the set of peaks attributed to monomer (M) and dimer (D) are indicated.
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Figure 6.9. 15N-1H HSQC spectra of E5TM2 in SDS detergent
Contour plot of two-dimensional 15N-1H HSQC spectra of E5TM2 solubilised in 40 mM SDS
detergent. (b) 1D projections of plane from 2D spectra showing the resonance doubling and
change in relative intensity with the peptide:SDS micelle ratio.
It has been suggested that such a change could be due to non-specific interactions
(Wu, Shih et al., 2007). To determine if this was a specific interaction or merely
an artefact of low micelle concentration we designed a further peptide, E5TM2
which possessed 15N-labelled residues at three positions in the expected interface
and at three positions distal to the interface. For residues residing at the interface
of the E5 dimer we would expect to observe chemical shift changes upon
association of the peptides due to their altered chemical environment. However, as
shown in Figure 6.9a, all the resonances observed in the 15N-1H HSQC spectra of
E5TM2 also exhibit the same resonance splitting. Furthermore, as shown in Figure
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6.9b, the relative intensities of the two sets of resonances are modulated by
increasing detergent concentration in a similar fashion to E5TM1, and were
therefore assigned to monomer and dimer forms as indicated.
It has been reported that the average difference in backbone amide chemical shifts
in a 15N-1H HSQC can be used to identify interfacial residues in oligomers since
theoretically resonances from interfacial residues should undergo a more
significant shift than those of other residues in the helix due to the significantly
altered chemical environment (Wu, Shih et al., 2007). The average 15N 1H
backbone chemical shift difference for the assigned resonances from E5TM1 and
E5TM2 were calculated as described in Section 2.20, according to the method in
Wu et al (Wu, Shih et al., 2007). As shown in Figure 6.10, the greatest average
differences were observed for those residues in the helix expected to be at the
interface namely, Ala14, Leu21, Leu24, and Phe28.
Figure 6.10. Average backbone 1H and 15N amide chemical shift differences
Average backbone 1H and 15N amide chemical shift differences for all assigned resonances from
15N-1H HSQC spectra of E5TM peptides in SDS. Δδ was calculated as described in Section 2.20.
These data show that the oligomeric state of TM domains in detergent micelles
can be monitored by changes in chemical shift using 15N-1H HSQC spectra and
that the shift in equilibrium between monomeric and oligomeric species is highly
dependent on the detergent micelle concentration. Our data suggest that the E5
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TM domain forms dimers in SDS micelles and moreover provides atomic level
information about the structure of the E5 dimer consistent with previous published
results.
6.1.4 Helical content of E5 is unaffected by peptide: micelle
molar ratio.
Figure 6.11. Secondary structure of E5TM peptide at varying detergent
concentrations
Circular dichroism spectra of 40 µM E5TM1 peptide reconstituted into the detergent SDS at
peptide:micelle ratios of between 0.1 and 2.0 . Mean residue ellipticity (MRE) was calculated from
the measured ellipticity as described in Section 2.21.
Since it is possible that the doubling of resonances observed in the 15N- 1H HSQC
was a result of a conformational change such as an interchange between β-sheet
and α-helical conformations of the E5 peptides. CD spectra were acquired to
determine the effect of varying the concentration of SDS detergent micelles on the
secondary structure of the E5TM peptides. As shown in Figure 6.11, all CD spectra
show a characteristicα-helical profile, with negative absorption maxima at 208nm
and 222nm. This demonstrates that the E5 peptide forms a very stableα-helix in
SDS micelles with no significant differences in helicity being observed upon
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varying the micelle concentration. This confirms that the two sets of resonances
do not result from changes in conformation but instead represent monomeric and
oligomeric species.
In summary the data the data presented here shows that E5 is forming a dimer in
detergent micelles which is in agreement with all previous works, that the dimer is
relatively stable to SDS being present at even high detergent concentrations, and
that the interfacial residues may be identified by an increased backbone amide
chemical shift relative to those residues not at the interface.
6.1.5 Conclusions on the study of E5 TM domain by NMR
spectroscopy
The E5 protein is the smallest known oncogenic protein, little more than a TM
domain that can activate cellular receptors in a completely unique way. It is
therefore desirable to have an enhanced understanding of its structure and the
implications this has for its function. Previous studies have shown E5 is dimeric
and that in isolation its TM domain can self assemble to form homo-dimers
(Oates, Hicks et al., 2008). In vivo and in vitro mutagenesis studies identified
residues that potentially play a role in mediating the helix-helix interaction (Oates,
Hicks et al., 2008). This study attempted to confirm those predictions by obtaining
atomic level structural data for the E5 TM domain. The optimisation of sample
preparation and the acquisition of NMR spectra were also explored.
15N-1H HSQC spectra of two selectively 15N-labelled peptide analogues of the E5
TM domain revealed twice as many resonances as expected if the peptide were
adopting a single conformation, which was expected to be that of a dimer. The
relative intensities of these two sets of resonances were dependent on the
detergent concentration, with one set of peaks increasing and the other decreasing
as the detergent concentration was increased. The two sets were attributed to
monomeric and dimeric forms of the E5 peptides with increasing monomer at
higher detergent concentrations. The secondary structure of the E5 peptide was
predominantly α-helical at all SDS detergent concentrations confirming that the
splitting was not due to alterations in the secondary structure of the peptide. These
results therefore correlate with other group’s observations that detergent
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concentration can modulate the oligomeric state but not the helicity of TM domain
peptides (Fisher, Engelman et al., 1999). We suggest there are two possible
explanations for this behaviour. One possibility is dynamic exchange of
dissociated peptides with an ever increasing number of empty micelles reducing
the chance of a peptide finding a partner as the micelle concentration is increased.
Another scenario is one where, as the detergent concentration is increased, the
SDS molecules compete for the interfacial region forcing the dimer apart as the
monomer concentration is increased.
It has been reported that the E5 TM dimer has a low dissociation constant and was
found to be predominantly dimeric. It is therefore surprising that such a
significant proportion of monomer is observed in these NMR studies. However
previous studies were carried out in DPC detergent which is a relatively mild
detergent in comparison to SDS, so the results shown here are consistent with
SDS being a more denaturing detergent. These findings highlight the need to
consider the choice of detergent and the detergent concentration (particularly the
peptide:micelle ratio) when studying these hydrophobic systems.
In this study we have provided the first atomic level structural information on the
association of the E5 transmembrane domain dimer which has recently been
found to be a functional subunit of the smallest known oncoprotein (Talbert-
Slagle, Marlatt et al., 2009). We have also demonstrated the applicability of
solution state NMR methods using detergent micelles as membrane mimetics to
the study of the E5 oncoprotein which will provide a good foundation for a full
structural characterisation of the protein.
6.2 Novel assay for determining protein-protein
interactions
The phenomenon of paramagnetic alignment in NMR studies is a rapidly
developing tool that has been applied to the problem of determining protein
structure. Here we have exploited this phenomenon to develop a novel method for
studying the helix-helix interactions of α-helical TM domains using NMR
spectroscopy. It is hoped that this method will facilitate the identification of
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homo- and hetero-interactions, as well as provide valuable molecular modelling
restraints enabling the rapid structure determination of TM domain oligomers.
The method utilises the ability of paramagnetic lanthanide ions to drive the weak
magnetic alignment of proteins with the magnetic field of an NMR spectrometer
(Contreras, Ubach et al., 1999; Ikegami, Verdier et al., 2004). Lanthanides possess
paramagnetic properties due to the presence of unpaired electrons in the f-orbitals
of their trivalent ions. The presence of a paramagnetic ion results in a small
anisotropic orientation of the protein with respect to the magnetic field. This weak
alignment with the magnetic field facilitates the observation of the through-space
interactions between the magnetic fields of bonded atoms, which are termed
residual dipolar couplings (RDCs)(Fowler, Tian et al., 2000; Bax, 2003). Such
interactions would otherwise be averaged to zero by the rapid tumbling of the
molecules in the absence of the weak alignment. Weak alignment is preferential to
complete alignment since extensive coupling would result in extensive resonance
splitting in the NMR spectrum that would be too complicated to interpret. The
magnitude of a RDC between two bonded atoms is dependent on the angle
between the vector of the bond (e.g. N-H) and the vertical axis of the magnetic
field (B0). The determination of this angle provides protein backbone restraints for
use in molecular modelling, enabling the global fold of a protein to be determined
rapidly (Bax, 2003; Bax and Grishaev, 2005).
In this study we have developed a novel means for exploiting RDCs to identify
interactions between α-helical TM domains, called HELICS (helix-LBT
interactions via RDCs), but which could be extended to exploring any kind of
protein-protein interactions. The scheme developed in this study for performing
this kind of analysis is shown in Figure 6.12, and involves the differential
incorporation of a lanthanide-binding tag (LBT) or isotopic labels into peptide
analogues of TM domains. As an example, in the case of two peptides that can
interact, one peptide would be isotopically labelled with 15N whilst its partner
would possess a LBT encompassing a paramagnetic lanthanide ion e.g.
dysprosium (Dy3+). The association of the two peptides would result in the weak
alignment of the 15N labelled peptide with the magnetic field of the NMR
spectrometer, resulting in the observation of 15N-1H RDCs for this peptide. A key
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point is that should no interaction between the two peptides occur then no RDCs
would be observed from the isotopically labelled peptide. The measurement of
RDCs can be achieved using standard 15N-1H HSQC NMR experiments on the
peptides in the presence of a paramagnetic lanthanide or the control which would
be the diamagnetic ion lanthanum. Thus, this scheme enables the interaction
between two peptides to be determined rapidly by the presence or absence of a
RDC.
In addition to molecular alignment in the magnetic field the presence of a
paramagnetic metal ion results in distance-dependent paramagnetic shifts
(Pintacuda, Park et al., 2006), and enhanced nuclear relaxation of neighbouring
resonances (Prudencio, Rohovec et al., 2004), which can be used as molecular
modelling restraints for structure refinement. Paramagnetic shifts are of particular
interest as they can provide useful long-range structural information and have for
some time been employed in structure determinations by NMR spectroscopy
(Pintacuda, Park et al., 2006).
Figure 6.12. Overview of the HELICS assay for hetero-association
NMR-based assay for determining TM domain association. Molecular tumbling of the peptide-
micelle complexes averages RDCs to zero. Labelling with paramagnetic lanthanide ions aligns
peptides with the magnetic field (B0). Interaction between isotopically labelled peptide a, and
lanthanide labelled peptide c, results in alignment of the hetero-oligomer ac with B0 and
measurable RDCs for the isotopically labelled peptide a. There is no interaction with peptide b so
no alignment occurs and hence no measurable RDCs are observed for this peptide.
In addition to molecular alignment in the magnetic field the presence of a
paramagnetic metal ion results in distance-dependent paramagnetic shifts
(Pintacuda, Park et al., 2006), and enhanced nuclear relaxation of neighbouring
RDCs
B0
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resonances (Prudencio, Rohovec et al., 2004), which can be used as molecular
modelling restraints for structure refinement. Paramagnetic shifts are of particular
interest as they can provide useful long-range structural information and have for
some time been employed in structure determinations by NMR spectroscopy
(Pintacuda, Park et al., 2006).
A benefit to using lanthanide metals for generating alignment is that their ions
vary in paramagnetic strength whilst retaining similar chemical properties, which
enables them to be interchanged (Pintacuda, Keniry et al., 2004). This allows
different members of the series to be used with the same lanthanide binding
group. This is important for optimising signal loss due to paramagnetic relaxation,
eliminating the degeneracy inherent in angle measurements from RDCs by
varying the alignment. Moreover, it allows for use of the diamagnetic La3+ or Lu3+
ions as references for measuring RDCs and PCSs by taking the difference in
chemical shift measured in the presence of a paramagnetic or diamagnetic
lanthanide (Pintacuda, Keniry et al., 2004).
To instigate alignment of the proteins a paramagnetic lanthanide ion must be
incorporated into the peptide of interest. For proteins that possess native metal
binding sites this is a simple matter of exchanging the metals, however TM
domains do not possess such sites, therefore other methods are required. Two
methods have been reported for the incorporation of lanthanide ions into proteins
that lack a native metal binding domain. One methods involves the covalent
linking of a metal chelating group, usually one based on the metal chelating agent
EDTA (Rodriguez-Castaneda, Haberz et al., 2006), to a Cys residue within the
peptide, whilst another involves fusing the domain of interest to a protein metal-
binding domain that has been optimised for the specific binding of lanthanide ions
(Ma and Opella, 2000; Wohnert, Franz et al., 2003).
In this study we chose to produce a fusion protein consisting of the TM domain of
interest coupled with a LBT sequence. This LBT sequence been reported to bind
terbium (Tb3+) ions with 50 nm binding affinity (Nitz, Franz et al., 2003), and its
crystal structure has been determined (Nitz, Sherawat et al., 2004). Furthermore,
the LBT sequence has the additional benefit of providing a means of performing
FRET-like luminescence resonance energy transfer (LRET) experiments, and is
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therefore a very versatile probe for protein studies (Sculimbrene and Imperiali,
2006). The LBT sequence YIDTNNDGWYEGDELLA includes 6 lanthanide
coordinating residues (shown in bold) including a tryptophan residue that in
addition to providing a coordinating carbonyl oxygen acts as a sensitizer for
LRET experiments (Sculimbrene and Imperiali, 2006). To test the HELICS assay
will require the use of two peptides; a 15N-labelled peptide and a fusion protein
consisting of the TM domain of interest and the lanthanide-binding tag (TM-
LBT). For the purposes of performing the assay, the peptides will be reconstituted
into detergent micelles. Synthetic and heterologous expression systems were
explored in order to produce a TM-LBT fusion protein. This section details the
efforts to-date in developing this novel method.
6.2.1 Choosing a model peptide to test efficacy of the novel
method
It was first necessary to choose a TM domain with which to test the assay. The
protein Glycophorin A (GpA) from erythrocytes represents perhaps the best
understood example of a dimeric α-helical membrane protein. It has been shown
to be a strongly associating homo-dimer that is stabilised by a GxxxG motif for
which a solution state NMR structure has been determined (MacKenzie,
Prestegard et al., 1997). Therefore, this TM domain was considered a suitable
candidate for testing the efficacy of the HELICS assay presented above.
GpA KKITLIIFGVMAGVIGTILLISYGI
GpA-LBT KKITLIIFGVMAGVIGTILLISYGIYIDTNNDGWYEGDELLA
Figure 6.13. Sequences for 15N-labelled GpA peptide and GpA-LBT Fusion
protein
Sequence of the TM domain peptide analogues to be produced for testing the novel method
developed in this study. The TM domain of GpA has been extensively characterised over many
years and found to be a strongly associated dimer. 15N-labelled residues were incorporated into
GpA during synthesis at the underlined positions. The sequence for the peptide GpA-LBT is a
fusion of the TM domain of GpA with the optimised LBT of Franz et al (Franz, Nitz et al., 2003).
The sequence of the LBT is presented in bold at the C-terminus of the GpA TM domain sequence.
Peptides were synthesised at the Keck Facility (Yale University, USA).
The sequences of peptides to be produced for this study are shown in Figure 6.13.
GpA represents the TM domain of the full length GpA protein and was selectively
15N labelled at the positions indicated, whilst GpA-LBT is a designed sequence
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which fuses an optimised LBT developed by Franz et al to the C term of GpA TM
domain sequence (Franz, Nitz et al., 2003). The placement of the LBT at the C- or
N- termini was considered to be arbitrary since it was not known how or if this
would impact on the results.
6.2.2 Attempts to synthesise and purify GpA-LBT and 15N-
labelled GpA
GpA and GpA-LBT peptides with the amino acid sequences shown in Figure
6.13, were synthesised at the Keck Facility (Yale University, USA). The peptides
were supplied as a crude product containing undesirable contaminants such as
fmoc protecting groups and truncated peptides, and thus required the desired
peptide to be purified. Reverse Phase High Pressure Liquid Chromatography (RP-
HPLC) was employed for this task as it is a widely used technique for the
purification of hydrophobic peptides. The details of peptide purification were
described in Section 2.19.
For the peptide GpA, solubilisation of the crude peptide was optimised and the
solution loaded onto a C4 column equilibrated at 30% ACN and eluted against an
optimised gradient of ACN and H2O containing 0.1% TFA with a flow rate of 2
mL /min. Elution was monitored by the absorbance of the amide backbone at 222
nm. Multiple runs of RP-HPLC purification were performed and fractions
containing pure peptide were pooled and lyophilised. Following lyophilisation the
purity of the peptide was assessed by MALDI mass spectrometry as described in
Section 2.11. The peptide was successfully purified (data not shown).
Attempts to purify the synthetic GpA-LBT peptide however were unsuccessful.
Analysis of the crude synthesis product by MALDI mass spectrometry and SDS-
PAGE revealed that the peptides synthesis had not been successful, since the
GpA-LBT peptide was present at very low yield (data not shown). It is believed
that this is due to the coupling of the hydrophobic sequence of the TM domain
with the hydrophilic sequence of the LBT making synthesis of such a sequence
very technically challenging.
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6.2.3 Expression of lanthanide-binding tag fusion peptide
Due to the technical challenges of synthesising the GpA-LBT peptide, the use of
heterologous expression systems was explored. Multiple systems for the
production of hydrophobic peptides are commercially available. Two commonly
used systems, the pET and pGEX systems, were identified and trialled in this
study for the production of the GpA-LBT peptide. Both of these expression
systems involve the fusing of the peptide to a larger domain that facilitates
purification but they differ in the nature of that domain and the method used to
remove the domain to release the peptide of interest.
Expression of hydrophobic peptides using the pET expression system
Substantial work was performed to optimise the pET system for expression of TM
domain peptides. Attempts were made to produce Ii and MHCαpeptides but
without success. This expression system involves cloning of the TM domain of
interest into the commercially available plasmid pET31 (Novagen, UK), to
produce the fusion protein KSI-TM-His6 where KSI is ketosteroid isomerise, a
large hydrophobic protein that results in the fusion protein being directed to
inclusion bodies during overexpression, TM is the TM domain of interest and His6
is a 6-residue histidine tag for use in affinity chromatography. Purification of the
fusion protein was successfully achieved by solubilisation of the inclusion bodies
in 6M guanidine hydrochloride and Ni2+ chromatography. The cleavage of the
KSI from the TM is reportedly achieved by treatment of the purified fusion
protein with CNBr, which cleaves at junctional Met residues present between the
TM and the KSI and His6 moieties. The CNBr cleavage reaction was found to be
unsuccessful at the standard reaction conditions reported in the literature.
Attempts were made to optimise this reaction involving trialling several solvent
conditions, but despite many attempts extensive cleavage of the product was
apparent by SDS-PAGE analysis, and the low mass products which were expected
to be the desired peptide could not be identified using amino acid sequence
analysis. This approach was therefore abandoned in favour of an alternative
expression system.
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Production of GpA-LBT peptide using the pGEX expression system
An alternative expression system that has been successfully employed in the
production of hydrophobic peptides is the pGEX system (Antolini, Lo Bello et al.,
2003; Luo, Mo et al., 2007). This system involves the cloning of the TM of
interest in the commercially available plasmid pGEX6T (GE Healthcare, UK) to
produce the fusion protein GST-TM, as described in Section 2.15. GST, or
Glutathione S-transferase, is a ~26 kDa protein that facilitates purification of the
fusion protein using glutathione affinity chromatography. GpA-LBT was cloned
into the pGEX vector to generate the vector pGEX-GpA-LBT with which BL21
cells were then transformed.
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Figure 6.14. Growth curve for BL21 cells expressing GST-GpA-LBT fusion
protein
Monitoring the growth of BL21 cells transformed with the plasmid pGEX-GpA-LBT. 10 mL of
fresh LB media was inoculated with 1/40 dilution from overnight culture. When the OD600 reached
0.3, expression of the fusion protein was induced by addition of 1 mM IPTG. The OD600 was
subsequently measured at hourly intervals until it began to plateau indicating the optimum point to
harvest cells.
In order to test the effect of fusion protein expression on the ability of the BL21
cells to propagate, the cell growth following induction of fusion protein
expression by the addition of 1 mM isopropyl β-thiogalactoside (IPTG) was
monitored over 6 hours by measuring the optical density at 600 nm (OD600). As
shown in Figure 6.14, after 6 hours the OD600 reached over 2.0 showing that a
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high cell density could be achieved before harvesting of the cells was performed.
This indicates that the expression of the fusion protein is not detrimental to cell
growth, and that a potentially high yield of fusion protein could be obtained,
depending on the expression level of the fusion protein per cell.
Figure 6.15. SDS-PAGE of induced expression of GST-GpA-LBT fusion
protein
SDS-PAGE analysis of the induced expression of GST-GpA-LBT. BL21 cells were transformed
with the plasmid pGEX-GpA-LBT. When an OD600 of 0.3 was reached the expression of the
fusion protein was induced by the addition of 1 mM IPTG. At hourly intervals cell aliquots
normalised to 0.6 were removed for analysis. The sample at time zero represents the cell
expression immediately before induction. The band corresponding to the fusion protein is
indicated. Molecular weight markers (MW) are shown in the left most lane, in kDa. Bands were
visualised using Coomassie.
In order to confirm the expression of the fusion protein was being induced by the
addition of 1 mM of IPTG and to measure the yield, the induction of expression
was monitored by SDS-PAGE. Cells were grown to an OD600 of 0.3 and then
expression of the fusion protein was induced by the addition of 1 mM IPTG.
Aliquots of cells were taken immediately prior to induction and subsequently at
hourly intervals over 5 hrs. Cell aliquots were normalised to an OD600 of 0.6 in
order to monitor the level of expression per cell. As shown in Figure 6.15, at zero
hours there is no expression of the fusion protein which indicates the expression
of this protein is under tight control prior to induction. Following induction, an
intense band at the expected mass for the fusion protein (~30 kDa) is observed
which reaches a maximum after ~3 hours, and thus indicates that induction of
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fusion protein was successful. This result indicates that a high yield can be
expected from the expression of the fusion protein with the BL21 cell line.
In order to progress with purifying the fusion protein it was necessary to identify
the cellular fraction (i.e. soluble or insoluble) containing the fusion protein. It is
expected that the coupling of the hydrophobic GpA sequence to the larger soluble
domain GST would result in the fusion protein being localised to the soluble
fraction of the cell lysate. In order to identify whether the fusion protein was in
the soluble or insoluble fraction after cell lysis, SDS-PAGE analysis of the cell
lysate was performed, as described in Section 2.15.2. Lysis of the cells was
performed in phosphate buffer and the lysate was then centrifuged to separate
soluble and insoluble material. As shown in Figure 6.16, the fusion protein is
present in whole cell samples, and very little is present in the soluble fraction.
Instead, the fusion protein is found predominantly in the insoluble fraction. This is
most likely in the form of inclusion bodies, which are commonly formed by the
overexpression of hydrophobic proteins. This result indicates that to proceed with
purifying the fusion protein will require the use of solubilising agents to solubilise
this fraction.
Figure 6.16. Isolating the fusion protein in cellular fractions
SDS-PAGE analysis of GST-GpA-LBT fusion protein overexpressed in BL21 cells. Cells were
lysed in phosphate buffer followed by centrifugation of the lysate. The supernatant representing
the soluble proteins and the pellet representing the insoluble proteins were analysed. Lanes 1 and
2 show the whole cell fraction with 2 being a 1 in 2 dilution. Lanes 3 and 4 show the soluble
fraction with 4 being a 1 in 2 dilution. Lanes 5 and 6 show the insoluble fraction with 6 being a 1
in2 dilution. The GST-GpA-LBT fusion protein as indicated. Molecular weight markers (MW) are
shown in the first lane. Bands were visualised using Coomassie.
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The solubilising agent must possess certain properties to be suitable for use in this
purification protocol. It must not only dissolve the insoluble fraction releasing the
fusion protein, but must also not disrupt the native fold of the GST domain. The
latter is necessary since it is a requirement for the binding of GST to the affinity
chromatography column, which will be the next step in the purification. A review
of the literature revealed that a 1% solution of the detergent sarkosyl can
solubilise the fusion protein from inclusion bodies whilst maintaining the native
GST fold (Frangioni and Neel, 1993). The protocol for production of the cell
lysate was therefore modified by the incorporation of a detergent solubilisation
step, where 1% sarkosyl is added to the cell lysate.
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Figure 6.17. Purification of GST-GpA-LBT fusion protein
SDS-PAGE analysis of small scale purification of GST-GpA-LBT fusion protein to confirm
binding to the affinity column. Cell lysate was solubilised in 1% sarkosyl and added to GST-
binding sepharose matrix. Aliquots were taken at each stage of the purification. Lane 1 represents
the whole cell fraction, Lane 2 the soluble fraction, Lane 3 the insoluble fraction, Lane 4 the
supernatant after affinity chromatography, Lane 5 Wash 1, Lane 6 wash 2, Lane 7 wash 3, lane 8
elution of the Fusion protein. Molecular weight markers (MW) are shown in the first lane. Bands
were visualised using Coomassie.
In order to confirm that the use of 1% sarkosyl detergent did not denature the GST
domain, a small scale batch purification of the fusion protein was performed using
GST-binding affinity chromatography, as described in Section 2.15.3. As shown
in Figure 6.17, the fusion protein is observed in the whole cell (lane 1) and
insoluble fractions (lane 3) prior to batch binding to GST sepharose. Following
Fusion
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binding not all the protein is bound due to the small scale nature of the
purification (lane 4), and washing the matrix removed any unbound protein from
the matrix (lane 5-7). Following the treatment of the matrix with glutathione
elution buffer the fusion protein is observed to elute (lane 8). These data indicates
solubilisation of the cell lysate with 1% sarkosyl does not impede binding of the
fusion protein to the affinity matrix and furthermore suggests that the fusion
protein may be purified in high yield.
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Figure 6.18. Purification of GST-GpA-LBT fusion protein
SDS-PAGE analysis of eluted GST-GpA-LBT fusion proteins measuring the effect of Triton X-
100 on column binding. Aliquots were taken at each stage of the purification. Lane 1 represents
the whole cell fraction. Lane 2 1% sarkosyl, Lane 3 plus 0.5% Triton, Lane 4 plus 1.0% Triton
X100, Lane 5 1.5% Triton X100. Molecular weight markers (MW) are shown in the first lane.
Bands were visualised using Coomassie.
Since the GST domain must remain in its native fold during the purification to
bind the affinity column we attempted to optimise binding of the fusion protein to
the matrix. It has been suggested that the addition of the detergent Triton-X100
can stabilise the fold of GST (Frangioni and Neel, 1993). To test the efficacy of
this approach, the purification of fusion protein was performed at varying
concentrations of Triton X-100 and aliquots of the eluted fusion protein analysed
by SDS-PAGE. As shown in Figure 6.18, the intensity of the bands for samples
that did (lanes 3-5) and did not (lane 2) contain Triton X-100 are identical. This
suggests that the addition of triton does not enhance the binding of the fusion
protein to the matrix.
With it established that the fusion protein can be purified from the cell lysate, the
next stage in the purification is optimising the cleavage of the fusion protein to
Fusion
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release the GST domain which is followed by the purification of the GpA-LBT
peptide. In the fusion protein a protease cleavage site is present between the GST
domain and the GpA-LBT peptide, enabling the use of proteolysis to cleave the
two domains. This can be performed using on-column cleavage by the addition of
the protease Prescission (GE Healthcare, UK). In this method, the GST protein
remains bound to the matrix and the desired peptide is released. Cleavage of the
fusion protein was monitored by SDS-PAGE. However when this was performed
the cleavage of the fusion protein could not be observed, since no band at the
expected mass of the GpA-LBT peptide nor a decrease in the weight of the fusion
protein band were observed.
P S P S
0.5% 2.0%
MW WC
17
14
28
6
3
38
Figure 6.19. Cleavage of GST-GpA-LBT fusion protein in OG
SDS-PAGE analysis of cleaved GST-GpA-LBT fusion proteins. Molecular weight markers (MW)
are shown in the first lane. Cleavage of fusion protein in OG at 0.5% and 2.0% OG. Following
cleavage the sample was centrifuged. P is pellet, S is supernatant after centrifugation. Bands in left
gel were visualised using Coomassie whilst those in the right gel were visualised using silver
staining.
Attempts were subsequently made to optimise the number of units of protease
used in the cleavage reaction but this had no effect. It was then hypothesised that
the protease may be inactivated by the detergent. Attempts were then made to
minimise the detergent concentration used in the purification, but without success.
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A literature survey revealed the activity of the protease could be maintained in
Triton X100. The use of this detergent in the cleavage reaction resulted in the
fusion protein being cleaved. However, it was subsequently found that this
detergent cannot be removed by dialysis due to its very low critical micellar
concentration (CMC). It is necessary to able to remove or exchange the detergent
since the large size of the Triton X-100 micelle will not be amenable to
subsequent NMR analysis.
The detergent octylglucoside (OG) has a high CMC of ~19 mM making it a more
suitable detergent for use in purification procedures requiring dialysis. Trials of
fusion protein cleavage were performed in varying amounts of this detergent to
determine if activity of the protease would be retained in the presence of OG. This
was performed in batch mode enabling the sepharose matrix to be pelleted by
centrifugation. The supernatant and the pellet were subsequently analysed by
SDS-PAGE. It was expected that the GpA-LBT would be found in the
supernatant. As shown in Figure 6.19, cleavage of the fusion protein was observed
indicating that the protease does indeed retain its proteolytic activity in OG.
However, the peptide was found predominantly in the pelleted fraction suggesting
that either the peptide is remaining bound to the sepharose matrix or more likely
that the peptide is not soluble at the concentrations of OG that are needed to
maintain activity of the protease. Attempts were made to increase the OG
concentration following the cleavage reaction in order to solubilise the peptide
however these proved unsuccessful. Due to time constraints the project has not
progressed past this stage. Future work on the purification of the GpA-LBT
peptide would involve attempting to solubilise the products from cleavage in
organic solvent such as TFE, filtering the sample to remove the sepharose matrix,
and then performing RP-HPLC.
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7 Conclusions
Determining the rules for helix-helix interactions that govern the assembly of α-
helical membrane proteins represents an important and challenging area of
research. Studies on membrane proteins such as Glycophorin A (GpA) have
shown that the transmembrane domains of these proteins serve a greater function
than merely anchoring them within the membrane and are actually centres of
significant protein-protein interactions that play a role in the assembly of
membrane proteins.
In this study we have explored the interactions between the TM domains of twoα-
helical membrane proteins from the immune system, using a range of in vivo and
in vitro techniques. Major Histocompatibility Complex Class II (MHC) α- and β-
subunits and Invariant Chain (Ii) associate in the ER to form a nonameric (nine
chains) complex as part of the initial steps in the process of antigen presentation.
This is necessary for optimal export of the MHC proteins from the ER. Although
the association between the soluble domains of MHC and Ii has been well-
characterised over many years and their respective structures are known, recent
work has implicated interactions between their TM domains in the formation of
this complex. The TM domain of Ii was shown to self assemble into a trimer
whilst it was shown MHC α/βheterodimers could associate with Ii in a manner
independent of the soluble domains. By conducting the work presented in this
thesis we sought to gain further understanding of the role played by theα-helical
TM domains of Ii and theα- andβ-chains of MHC in the assembly of the Ii-MHC
complex. This chapter summarises how the results of this study have furthered our
knowledge of the assembly of Ii, MHC, and the Ii-MHC complex.
7.1 Studies on the helix-helix interactions in the Ii-
MHC complex
As presented in Chapter 3, we sought to confirm the findings reported by Dixon et
al (Dixon, Stanley et al., 2006), that in isolation, the TM domain of Ii self-
assembled to form a trimer in the mild detergent DPC. In the process of
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performing this work, the TM domains of Ii also served as the test subject for
developing protocols for performing the GALLEX assay and FRET analyses
which would be used in studying the association of Ii with MHC. Results from the
in vivo GALLEX assay and in vitro cross-linking and FRET analyses of a model
peptide homologous to that used in the study by Dixon et al were unable to
confirm the TM domain of Ii forms a specific trimer. However, but they did
confirm that Ii TM domain can self-assemble into a range of oligomeric states
from dimer to pentamer, with dimer being the most prevalent. Furthermore,
results from both cross-linking and FRET showed the oligomeric state of the Ii
TM domain was highly dependent on the detergent concentration or more
specifically the peptide:micelle ratio. This was shown in a range of detergents. So
though the self-association of Ii TM domain is now well established by this study
and others (Ashman and Miller, 1999; Kukol, Torres et al., 2002; Dixon, Stanley
et al., 2006), it is uncertain that a single trimeric state for the Ii TM domain can be
assigned. However, since the TM domain can self-associate and one of the
observed oligomeric states was trimer and the full length protein is a trimer, it is
possible that the native membrane environment may be contributing significantly
to specifying the oligomeric state of the Ii TM domain. This could be tested by
further studies on the model peptides in lipid bilayers that more closely resemble
the native environment of these domains.
The difficulty in assigning a definitive oligomeric state to Ii TM domain may
reflect the challenge of studying weakly associating TM domains in which the
association is stabilised by H-bonds. To-date relatively few studies have been
made of TM domains that are not stabilised by very strong interactions, such as in
the case of the GpA TM dimer which is stabilised by the GxxxG motif to such an
extent that its oligomeric state is visible by SDS-PAGE. As noted in Section 1.2.1,
H-bonds bonds are thought to have weak specificity relative to Van der Waals
interactions and are believed to cause non-specific aggregation (White, 2006). It
has been proposed that van der Waals interactions in close packing helices are the
main determinants for TM helix association and that H-bonds serve to stabilize a
preformed oligomer (Schneider, 2004). Despite the difficulties in studying the TM
domain of Ii, this section of the study facilitated the development of protocols for
performing the GALLEX and FRET measurements which then enabled the study
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to progress to studying hetero interactions between the TM domains ofα- and β-
chains of MHC and also the interactions between those and Ii.
In this study we have shown using the in vivo assays TOXCAT and GALLEX that
the TM domains of the MHCαandβchains are capable of self-associating, which
is the first time this behaviour has been observed. Furthermore, highly conserved
small-xxx-small motifs that are known to infer a propensity for self-association
were identified in the TM domains of the α- and β-chains of MHC. Modelling of
the homo-dimers of MHCαand MHCβusing molecular dynamics suggested that
the motifs could pack at the interface and stabilise homo-dimer formation.
Subsequent mutagenesis studies using TOXCAT implicated one of the two motifs
in the assembly of MHCαhomo-oligomers, which suggests they are stabilised by
to the formation of interhelical induced dipoles resulting from the close packing of
the helices. Mutagenesis of the motif in MHCβdid not affect the homo-
oligomerisation as measured with the TOXCAT assay, however the same
mutation in an optimised sequence measured with the GALLEX assay did
succeed in disrupting homo-oligomerisation. The discrepancy between the two
assays is not fully understood at present, however the latter result is more in
keeping with the results from molecular modelling and with what is known about
GxxxG motifs. The sequence in the GALLEX assay was different from that used
in the TOXCAT assay so future experiments could be designed to test this
sequence in TOXCAT or perhaps a range of sequence lengths, and mutagenesis
studies with model peptides could be performed in conjunction with cross-linking
or FRET. The self-association of MHCαand MHCβwas also observed in studies
on model peptide analogues using SDS-PAGE, with both forming SDS-stable
dimers, which is in agreement with the known strength of GxxxG interactions in
some proteins. Cross-linking studies showed MHCαcould self-assemble into a
range of oligomeric states whilst MHCβformed predominantly dimers in mild
detergent. The self-association of the MHC TM domains has not been observed
before nor has this behaviour been observed in the full length MHC proteins,
hence the biological significance of this finding is unknown. We could speculate
that this interaction may drive the formation of inactive MHC homo-dimers,
which has been observed for other membrane proteins such as receptor tyrosine
kinases (Yu, Sharma et al., 2002; Seubert, Royer et al., 2003). Alternatively, self
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association may facilitate the localisation of the MHC α- and β-chains for rapid
assembly with their partner and Ii.
Since it is known that the full-length α- and β-chains of MHC associate via their
soluble domains to form hetero-dimers we investigated the propensity for the
MHCαand MHCβTM domains to do the same. This was performed using the in
vivo GALLEX assay and in vitro FRET analyses, which are two of the few
methods currently available for performing analysis of hetero-oligomerisation.
The results from the GALLEX assay suggested that the TM domains of MHCα
and MHCβcould associate with one another to form hetero-oligomers, which is in
keeping with what is known about the full length proteins. A subsequent
mutagenesis study implicated the small-xxx-small motifs in this association. This
result was corroborated by the findings from molecular modelling, which
implicated these residues as being at the heterodimer interface. Subsequent
analyses of model peptides with FRET showed that the peptides were also
associating with one another, lending further support to our findings from
GALLEX. FRET enabled the oligomeric state of the interaction to be monitored
and the results suggest that MHCα and MHCβ are associating to form
predominantly hetero-dimers, which is also in agreement with our understanding
of the full length proteins.
It has been reported that MHC can bind to Ii in a manner that is independent of
the soluble domains, and thus implicated the TM domain in mediating these
interactions. We therefore explored the interactions between the TM domains of
theα- and β-chains of MHC and Ii. Use of the in vivo GALLEX assay suggested
that Ii could associate with MHCαand MHCβin the inner membrane of E. coli,
thus corroborating the reported findings. However, FRET analyses of peptide
analogues suggested that Ii only associates strongly with MHCαand not MHCβ,
since no energy transfer was observed between Ii and the MHCβTM peptide.
This discrepancy could be due to the environments the different measurement are
carried out in, with GALLEX measurements being conducted for TM domains
inserted into a biological membrane and FRET measurements being conducted for
TM peptides solubilised in mild detergent. The observation in this work that Ii
preferentially binds MHCαis interesting since it has been proposed previously
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that, rather than MHCαand MHCβassociating to form a heterodimer prior to
associating with Ii, MHCαand Ii associate first, followed by binding of MHCβto
the Ii-MHCαcomplex (Koch, McLellan et al., 2007).
7.1.1 Implications for the assembly of TM domains in the Ii-
MHC complex
In summary, the results from this study suggest the following: (a) the TM domain
of Ii self-associates into a range of specific oligomeric states from dimer to
tetramer; (b) the TM domains of the α- and β-chains of MHC can self-associate
and formhetero-dimers; (c) the TM domains of Ii can associate with those of
the α- and β-chains of MHC, but in vitro measurements indicate there is a
preferential interaction between the TM domains of Ii and α. Collectively, these
data show the TM domains of Ii and MHC are sites of potentially important
protein-protein interactions that may play a role in the assembly of the MHC-Ii
complex and ultimately in antigen presentation. We therefore consider how the
findings from this study impact upon our current understanding of the assembly of
the Ii-MHC complex.
Whilst this study was unable to show the TM domain of Ii self-associates into a
specific trimer, as was observed previously, we did show that it can self-associate
and that one of the oligomeric states it adopts is a trimer. Given that the full length
protein is known to be trimeric it could be reasoned that the TM domain in its
native environment is adopting this stoichiometry also, and that in detergents the
forces (e.g. H-bonds) driving the self-assembly are too weak to specify that state.
For the purposes of the following discussion we therefore treat the TM domain of
Ii as if it were trimeric.
The results from this study suggest that the TM domains of MHCαand β-chains
can associate to form a hetero-dimer, and that in vivo the TM domain of Ii can
bind to those of the MHCα- and β-chains. Consistent with this finding, full length
MHC α- and β-chains have been observed to associate in the absence of Ii
(Bijlmakers, Benaroch et al., 1994; Elliott, Drake et al., 1994), leading to the
suggestion thatα- andβ-chains chains of the same isotype first assemble to form a
heterodimer prior to associating with Ii (Lamb and Cresswell, 1992; Bijlmakers,
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Benaroch et al., 1994). However, in the presence of Ii, MHC α-β dimer
intermediates have not been observed (Cresswell, 1994). This study also showed
that in vitro Ii preferentially binds to MHC α-chains. This behaviour has also been
observed in a number of studies on the full length proteins (Lamb and Cresswell,
1992; Bijlmakers, Benaroch et al., 1994), leading to an alternative model for the
assembly of MHCα- andβ-chains being proposed where MHCα-chains first bind
to Ii, and then the MHCα-Ii complex selects for a isotypically matched MHC β-
subunit, with Ii sandwiched in the middle (Neumann and Koch, 2005; Neumann
and Koch, 2006). It is believed that this model has the advantage that a
mismatched MHC β-subunit can dissociate from the MHCα-Ii matrix and be
replaced by a matched MHC β-subunit in a more efficient manner. Our findings
on the TM domain interactions in the Ii-MHC complex seem to support both
models for the assembly of the full length proteins.
Figure 7.1. Models for association of TM domains in the Ii-MHC complex
Top down view of models for the association of the TM domains of Ii, and those of theα- andβ-
chains of MHC in the Ii-MHC complex.
In previous models of the assembly of the Ii-MHC complex, the role of the TM
domains has not been considered; rather the emphasis is placed on the role of the
soluble domains. However, the findings of this study and others (Castellino, Han
Chapter 7. Conclusions
161
et al., 2001; Kukol, Torres et al., 2002; Dixon, Stanley et al., 2006) strongly
implicate the TM domains in the formation of the Ii-MHC complex and therefore
any future model for the assembly of the Ii-MHC complex should address the role
played by the TM domains.
Using the results from this study and those reported in the literature we can begin
to build a model for the association of the TM domains in the Ii-MHC complex.
All of the possible arrangements that the TM domains could adopt are shown in
Figure 7.1. MHCαand MHCβwere observed to associate to form hetero-dimers,
which would support all the models in Figure 7.1. Ii was found to associate
preferentially with MHCα, which is consistent with the models shown in Figure
7.1a, b, d, and e. There are difficulties in the data regarding the association of Ii
with MHCβ, since an interaction was observed in vivo but this was more difficult
to conclusively determine in vitro, as such it is not possible at the present time to
discount any of the models shown in Figure 7.1a, b, d, or e until this has been
resolved. Interestingly, the results from FRET experiments suggested that the
interactions between Ii and MHCβcould not be enhanced by the presence of
MHCαwhich we would not expect if the models shown in Figure 7.1a and b were
correct. It may be possible in future work to discount the model shown in Figure
7.1a by exploring the interactions of MHC α and βTM domains with the TM
domain mutants of Ii that were shown to disrupt its oligomer formation (Dixon,
Stanley et al., 2006).
7.2 Development of NMR methods to study helix-
helix interactions
Solution state NMR spectroscopy has the potential to conclusively determine TM
domain interactions by investigation of model peptides solubilised in detergent
micelles. In this study we therefore sought to develop NMR methodologies to
facilitate the determination of the atomic structure of TM domain oligomers.
Furthermore we sought to develop an NMR-based method that exploits
paramagnetic effects to identify helix-helix interactions in TM domains and which
also has the potential to provide valuable structural restraints for structure
determination.
Chapter 7. Conclusions
162
Recently, the TM domain of the protein E5 was shown to self-associate via non-
covalent interactions to form a strongly interacting dimer in the detergent SDS
using a range of techniques including TOXCAT, SDS-PAGE and AUC (Oates,
Hicks et al., 2008). NMR spectra of selectively-labelled peptides corresponding to
the TM domain of E5 showed that when solubilised in TFE, the expected numbers
of cross-peaks are observed in the 15N-1H HSQC spectrum, which display
resonances for every 15N labelled residue in the peptide. When the peptides were
solubilised in the detergent SDS multiple resonances were observed that indicated
the presence of several conformational states. Subsequent HSQC spectra acquired
at varying detergent concentrations revealed the resonances could be assigned to
two groups whose relative heights could be modulated by the detergent
concentration. CD spectra indicated that the change in detergent concentration
was not modulating the secondary structure since the CD spectra were identical,
indicating that the two populations were not folded and unfolded peptide.
Furthermore, since work carried out in this thesis had shown that the oligomeric
state of TM domains can be modulated by the peptide:micelle ratio, the two sets
of resonances were assigned to monomer and dimer states of the E5 TM domain,
with the dimer state dominating at lower detergent concentrations. This work
provides a foundation for progressing with determination of the structure of the
E5 TM domain dimer and for subsequent analysis of the TM domains of the Ii-
MHC complex by NMR spectroscopy.
Methods to study self-association are well established, however of particular
interest is determining the association between TM domains of differing proteins,
since these kinds of interactions are important in a range of biological processes in
particular the assembly of polytopic membrane proteins, such as GPCRs.
However, there are relatively few methods available to make such measurements,
two being the GALLEX assay and FRET measurements. We sought to develop a
method for achieving this using NMR spectroscopy. A method was developed that
could be used to determine helix-helix interactions between TM domains, which
would also be applicable to identifying any protein-protein interactions. The
method uses the phenomenon of magnetic alignment of proteins with the
magnetic field of the NMR spectrometer to enable the measurement of RDCs
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from 15N-labelled peptides. The principle behind the methods was discussed in
Section 6.2. The method calls for the production of a peptide, TM-LBT, which is
a fusion protein containing the TM domain of interest and an optimised amino
acid sequence that binds lanthanide ions, or lanthanide binding tag (LBT). In
order to test the method the TM domain of GpA was used since this is perhaps the
most well characterised example of a dimeric TM domain.
Attempts to produce the GpA-LBT peptide using the approach of fmoc synthesis
and RP-HPLC purification used for other peptides in this study was not
successful. Analysis of the product from synthesis using mass spectrometry
showed that synthesis had not been successful and that the peptide was present at
very low yield. We believe the poor yield is due to the technical difficulties in
producing a peptide with the contrasting hydrophobic and hydrophilic segments
that the GpA-LBT possesses. We therefore decided to attempt to heterologously
express the GpA-LBT peptide. If this approach was successful it would present a
much more cost effective method for generating such peptides in the future.
During the course of this study the pET expression system for the expression of
hydrophobic peptides had been evaluated for the production of isotopically
labelled peptides for use in structure determination by NMR spectroscopy. The
pET system involves expression of a fusion protein composed of the TM of
interest and ketosteroid isomerase (KSI). The successful use of this method has
been reported by several researchers. In this system cleavage of the fusion protein
to release the desired peptide is reportedly achieved by reaction with CNBr which
it is alleged, specifically reacts with junctional methionine residues to cleave the
protein and yield the peptide with a C-terminal homoserinelactone residue.
However, despite attempts with the TM sequences of Ii, MHCαand MHCβ, the
cleavage products from the treatment of the fusion protein with CNBr could not
be identified by mass spectrometry or peptide sequencing. Numerous attempts at
optimising the conditions of the CNBr cleavage reaction were made but none
yielded the desired results. Therefore, this method was abandoned and an
alternative approach was sought for producing the TM-LBT peptide.
The use of the pGEX expression system has been reported to be successful in the
production of hydrophobic peptides by heterologous expression. In this system the
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TM is expressed as part of a fusion protein with a GST moiety. This approach
enables the fusion protein to be purified using affinity chromatography. The
expression of the GST-GpA-LBT fusion protein was optimised, as was the
purification of the fusion protein. Cleavage of the fusion protein with protease
was optimised, however it was subsequently found that the GpA-LBT peptide was
not soluble in the chosen detergent. Therefore it is expected that a further step will
be required to separate the sepharose and GST tag from the GpA-LBT peptide
following cleavage of the GST. This is likely to involve solubilisation in organic
solvent, e.g. TFE, followed by filtration to remove the sepharose and then
separation of the cleavage products by RP-HPLC.
7.3 Future Directions
Future work on the TM domain interactions of Ii-MHC could explore the
necessity for the TM domain of Ii to assemble into an oligomer before associating
with the TM domains of the α- and β-chains of MHC. This would allow us to
distinguish between models a and b in Figure 7.1. Dixon et al showed that
mutations of Thr and Gln residues in Ii disrupted oligomerisation. The affect of
the mutants on the oligomeric state of the Ii is still to be determined, and could be
studied by cross-linking or FRET of peptide analogues of the mutants. The
deleterious effect of the mutation of the Ii TM domain should be corroborated
with the GALLEX assay prior to determining the association of the Ii mutants
with the TM domains of αand β-chains of MHC using the same assay. The
oligomeric state of the Ii mutants could also be assessed using FRET analyses in a
similar manner to that used in this study. Consideration should also be made as to
the discrepancy between the results from the TOXCAT and GALLEX assays for
the GxxxG mutant of MHCβ. Future work on the role played by the TM domains
of Ii and MHC in the formation of the Ii-MHC complex should also involve
mutational studies conducted on the full-length proteins in vivo. Regarding the
development of NMR methods, the work should progress to attempting to solve
the solution state structure of the E5 TM domain and continue to develop the
methods utilising paramagnetic lanthanide ions for determining the interactions
and structures of transmembrane domains.
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